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8 Chapter 1
H o m e  P a r e n t e r a l  N u t r it io n
Home Parenteral Nutrition (HPN), i.e. parenteral nutrition in the home setting, was initiated by North 
American and European pioneers in the early seventies and was initially conceived to provide 
nutrition to patients who were suffering from life threatening chronic intestinal failure.1 Parenteral 
nutrition involves the administration o f nutrients using routes other than the gut. This could include 
infusion o f  nutrients into veins, arteriovenous shunts, subcutaneous tissue, muscle or bone. Although 
all o f  these access routes have been tried at one time or another, parenteral nutrition usually involves 
the intravenous route, and for patients on H PN  in the Netherlands, it almost invariably involves 
central venous catheters, subcutaneous ports, or arteriovenous fistulae.
In the early years o f  HPN, the most common indication in different countries was the short bowel 
syndrome due to surgical resection, as sometimes found in patients with Crohn's disease and 
mesenteric vascular disease.2;3 Over time, the indications for H PN  have widened. In some countries, 
such as the USA, Japan, and Italy, 40-60% o f the H PN  patients suffer from malignant conditions.4-6 
However, international differences in the indications to provide H PN  have become apparent, and 
probably also in relation to this, the prevalence o f H PN  varies considerably between countries.7 Part 
o f  the differences may be explained by economic reasons, for instance in the United States o f 
America, where there is no unified national health system. Here, hospitals financially benefit from 
rapid patient discharges even while this throws a burgeoning demand and cost on home care services.8 
Since 1990, professionals from different European countries who were interested in the field o f  H PN  
have collaborated in the Home Artificial Nutrition (HAN) working group, which was officially 
recognised as an E SP E N  (European Society for Clinical Nutrition and Metabolism) working group in 
1997. The main goals o f  the ESP E N -H A N  group are to perform epidemiological surveys throughout 
Europe, to harmonise the use o f H PN  and to formulate recommendations for good practice.
Previous epidemiological surveys carried out by the H A N  Working Group o f E SP E N  reported a 
prevalence range o f  0.3 (Spain) to 12.2 (Denmark) adult patients on H PN  per one million 
inhabitants.9;10 Incidence and prevalence in the different European countries are dependent o f  several 
factors: date o f starting a H PN  programme in the country, experience o f  H PN  training centres, local 
incidence o f  some diseases such as Crohn's disease, diagnostic indications for H PN , and encouraging 
results obtained from the therapeutic management o f  patients with non-malignant digestive disease 
such as Crohn's disease.9 A  more recent study in Denmark reported a prevalence o f  19.2 per million at 
the end o f 2000, and the average annual incidence was 5.0 per million per year over the 5 year period 
studied (1996-2000).11 Prevalence o f  H PN  in the two major H PN  centres in the Netherlands is shown 
in figure 1.
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Figure 1 Prevalence o f HPN in adults in the HPN centres in the Netherlands
RUNMC =  Radboud University Nijmegen Medical Centre 
AMC =  Academic Medical Centre Amsterdam
A  European survey by the ESP E N -H A N  group between December 1998 and March 199912, included 
five European countries, and showed different benign diseases in patients on HPN. Underlying 
conditions were Crohn's disease (33%), mesenteric vascular diseases (25%), post-surgical 
complications (19%), intestinal pseudo-obstruction (8%), radiation enteritis (4%), abdominal trauma 
(2%), and others (8%).12
N u t r it io n  T e a m
Because H PN  implies a radical change o f  life for the patient, relatives, and the caregiver, each 
potential candidate for H PN  must be assessed on an individual basis using a multidisciplinary team 
approach. Within this assessment, several factors must be considered, including treatment suitability, 
assessment o f home environment, duration o f  treatment, and psychosocial assessment.1 H PN  is a 
huge psychosocial strain for the patient and relatives during 24 hours a day, seven days a week. The 
m ost common criteria for excluding patients from the H PN  programme in European countries are 
lacking intellect, social situation, physical disability, underlying disease, and age.13 To make patient 
instruction successful, a specialised team is available in the two H PN  centres in the Netherlands. After 
successful training, the patient is monitored by the nutrition team, including a gastroenterologist, an
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H PN  nurse, and a dietician. Patients must be able to recognise and cope with complications. A  study 
o f  Wengler et al.13 showed that in 42 centres that were engaged in the monitoring process o f H PN  
patients nearly all o f these had a dedicated multidisciplinary nutrition support team for this task. A 
physician evaluated all o f the H PN  patients in almost every centre, and a nurse was involved in 
monitoring in 81% o f the centres. In other centres the nurse only took care o f part o f the patients. In 
62% o f all centres, a dietician was also assigned to the task o f  monitoring, and in 50% o f the centres a 
pharmacist was involved. In addition, a psychologist, a social worker, a general practitioner and a 
community nurse were involved at the monitoring visits, if their knowledge was required.
Quality and quantity o f  complete professional care in H PN  patients has not been well described. In 
the Netherlands, the Corporation Registration Enteral and Parenteral nutrition at home ('Stichting 
Registratie enterale En parenterale voeding Thuis; RET') reported some bottlenecks in care, but 
conclusions cannot be generalised to the Dutch H PN  population because only 3 H PN  patients were 
included in this study.14
V e n o u s  a c c e s s  c o m p l ic a t io n s
Infectious complications are the most serious events related to vascular access devices. In patients on 
H PN , infections o f this kind add significantly to the morbidity and mortality. The pathogenesis is 
generally bacterial or fungal growth colonising the catheter, with both the luminal and outer surfaces 
becoming contaminated. From there, pathogens can reach the bloodstream and clinical signs o f 
infection may become evident. The hub, a broken line, or the use o f the catheter for non-nutritional 
purposes (i.e. using the line to withdraw blood) are probably the most common endoluminal causes o f 
infection. I f  micro-organisms migrate along the catheter or are introduced during the insertion, the 
infection is o f  extra-luminal origin.1 The observed blood stream infection (BSI) rates in central venous 
catheter's (CVC) reported in various studies range from 0.17 to 2.19 episodes per catheter year.11’15-20 
Next to infectious complications, catheter occlusions are also common. Occlusion rates are associated 
with the lifespan o f  the catheter, the type o f catheter used, handling procedures and repeated events o f 
blood flushing back, and possibly also the type o f intravenous nutrition used.1 Central venous catheter 
occlusion rates in the literature range from 0.06 to 1.6 episodes per catheter year.3’21-25 
It is evident that the success o f  H PN  depends on a reliable, long-term form o f venous access. Loss o f 
access is associated with prolonged periods o f hospital care, deterioration in nutritional status, often 
painful attempts to insert a new access device and is feared by patients.26 In addition, repeated 
episodes o f catheter loss eventually inevitably result in the inability to obtain adequate venous access 
and hence provide an indication for intestinal transplantation.
P s y c h o s o c ia l  p r o b l e m s  a n d  Q u a l it y  o f  L i f e
It has been demonstrated in the literature that H PN  patients report alterations in physical, 
psychological and social functioning.27’28 Although parenteral nutrition is a potentially lifesaving 
therapy, thanks to its positive effects on managing the nutritional and hydration status o f  these 
patients, the psychosocial effects are considerable. The quality o f  life o f patients receiving H PN  has 
been found to be lower than that o f  the general population and o f similar clinical groups such as H PN  
independent patients with short bowel syndrome, those who have undergone intestinal
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transplantation, and those with end stage renal disease and renal transplant.29-33 Even if  the symptoms 
o f  the underlying disease have subsided, the impact o f  managing the technology o f  the H PN  infusion 
system has a significant impact on lifestyle as well as the effect o f  hospital readmission for the 
treatment o f  catheter-related complications such as infections and thrombosis.34
There are a few studies on the quality o f  life o f  H PN  patients. The interpretation o f the results 
however, is hampered by the fact that there are numerous definitions o f quality o f life. In the context 
o f  health, quality o f  life describes health status from the patients' perspective and has evolved from 
the need to estimate the impact o f disease and treatment to the physical, physiological, social, and 
somatic domains o f  functioning and well-being.35
Both H PN  and the underlying disease may affect quality o f life, and an evaluation o f  quality o f  life 
requires the separation o f  these two issues. For example, a patient with a history o f good health who 
suffers from a mesenteric infarction has a massive reduction in quality o f  life as he suddenly becomes 
dependent on H PN. In contrast, someone who spent many years with Crohn's disease may have had 
several operations and many hospital admissions with exacerbation o f disease and a substantial 
reduction in quality o f life during the course o f the disease. This patient will have had time to cope 
with the underlying disease and can usually accept the need for H PN  or even experience benefits.
In a study o f Galandiuk36, quality o f life was examined before and after H PN  was started in patients 
with Crohn's disease, and results showed that quality o f life improved on HPN. For these patients, 
H PN  obviates the abdominal pain associated with eating. Decreased stoma output or diarrhoea may 
lead to a marked improvement in social activity and the general quality o f  life, while nutritional 
repletion o f  malnourished patients results in an increased sense o f  well-being.37 Furthermore, patients 
with malignancy have an improved quality o f  life if they are provided with H PN  and survive for over 
three months.27 While early studies did not provide evidence for a significant improvement in quality 
o f  life in patients with malignancy3’38, more recent studies indicate that quality o f  life can improve with 
H PN  when compared to pre-HPN status.39’40
Little information is available about quality o f  life and the problems HPN-dependent patients 
experience in daily life. Chambers and Powell-Tuck41 report lowest quality o f  life scores in the first 
year on H PN , especially if  the patient previously was well and experienced an acute life-changing 
event such as a mesenteric infarct. Quality o f  life issues never have been systematically assessed. 
Furthermore, information is lacking concerning the association o f venous access device-related 
problems and experienced psychosocial problems.
Given this lack o f  insight into H PN  patient problems, venous access device-related complications and 
a possible relation between these problems, further research is mandatory. The same applies for the 
follow up care for H PN  patients.
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Our general aim is to establish a body o f knowledge on topics relevant to the professional care o f 
outpatients with HPN. This general aim is specified in three sub aims:
1) To describe available evidence on the quality o f life -including somatic, psychological, and social 
aspects o f daily life- as experienced by H PN  patients;
2) To delineate the Dutch population on H PN  with regard to problems experienced in daily life, 
venous access device-related complications, and an assessment o f  whether these adversities are 
related to psychosocial problems and quality o f life;
3) To describe the quantity, quality, and content o f  professional care in Dutch H PN  patients.
O utline o f the thesis
In this thesis, six studies are reported in seven chapters. In chapter 2, a literature review is presented. 
The aim o f this review was to describe the implications o f  home parenteral nutrition for the quality o f 
life as experienced by patients, as well as to describe the caregiver's reactions regarding these 
implications. Cinahl, Medline, and Psychlit databases were searched for the period 1965 to 2005, to 
answer these questions. A  total o f 26 studies were included. A  standardised record was used for data 
extraction, including study design, sample characteristics, HPN-related characteristics, data sources, 
outcome measures, recommendations, as well as strengths and methodological flaws o f a study. In 
chapters 3 and  4, a survey among 48 Dutch H PN  patients is described on patient problems 
experienced. C hapter 3 describes a questionnaire study, to arrive at answers to the question: To what 
extent do long-term H PN  patients experience problems? Questionnaires were based on results o f two 
group interviews: one with patients on H PN , and one with health care workers. Questionnaires 
covered subjects arising from these interviews and included the Checklist Individual Strength (fatigue), 
the Beck Depression Inventory (depression), Sickness Impact Profile (social impairment), the Utrecht 
Coping List (coping), the Health Locus o f  Control questionnaire (health belief), the Subjective Sleep 
Quality Scale (sleep), the State-Trait Anxiety Inventory (anxiety), and Cantril's ladder (Quality o f Life).
Complementary, interviews were held to explore which H PN  treatment-related problems had a 
negative influence on daily life. C hapter 4 describes this study. Data were collected during single 
interviews at the patients’ homes. An open approach was chosen for the interviews. In order to 
standardise the interviews, each patient was asked the same questions in the same order. They were 
asked to state the 3 problems that came with the heaviest burden in their daily life with H PN. Per 
problem, information was obtained about the meaning and content, severity, and cause according to 
all patients.
Based on the results o f the study in chapter 3, in which H PN  patients reported fatigue as the most 
bothersome problem in daily life, chapter 5 describes the course o f  fatigue and the predictors o f 
persistent fatigue. In this longitudinal study 75 H PN  patients were included. Patients completed 
questionnaires at baseline and follow up (12 months later). Measurements included fatigue, 
depression, functional impairment, social support, self-efficacy, coping, anxiety and acceptance. 
Relevant laboratory measures were obtained from the medical records. Descriptive statistics, 
correlations, and linear regression analysis were performed.
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C hapters 6 and 7 focused on venous access device-related complications and their association with 
psychosocial complaints. In chapter 6 blood stream infection (BSI) and occlusion incidence rates 
during central venous catheter and arteriovenous fistulae (AVF) use were compared. Surgically created 
arteriovenous fistulae are constructed in the forearm, or, less ideally, in the lower extremity. The 
population consisted o f  127 H PN  patients in whom 343 CVC and 194 AVF access years were used. 
Based on biological and clinical rationales, possible confounders in the relation between access type 
and complication rate were identified and reported for each access type. These included the frequency 
o f  H PN  administration, the underlying disease and relevant co-morbidities, the use o f immune- 
suppressive therapy or systemic anti-coagulants and the administration o f  nutrition (with or without 
lipids) versus solely fluids and electrolytes.
The aim o f C hapter 7 was to present an overview o f venous access device-related complications in 
the current population o f patients on long-term H PN  in the Netherlands and to assess whether these 
adversities are related to psychosocial problems and quality o f life. Information on venous access 
device-related complications was collected from medical records, and in addition a survey was 
performed to characterise psychosocial problems and assess their association with technique-related 
complications. The questionnaires addressed general as well as HPN-related characteristics, quality o f 
life, social impairment, depression, fatigue, physical complaints, coping, self-efficacy, social support, 
sexual disorders and anxiety. Pearson’s correlations were used to analyse associations between venous 
access device-related complications and psychosocial problems and quality o f life. To compare 
subjects with and without complications, t-tests or Mann Whitney U tests were used where 
appropriate.
C hapter 8 presents an overview o f  professional care in H PN  patients. A  survey among 51 H PN  
patients was performed, to assess contacts with professionals and possible shortcomings in care. 
Patients were on H PN  for at least 12 months. Nursing files were screened to collect information 
about all contacts between the patients and the H PN  nurse. Medical files were screened to check 
venous access device-complications and hospitalisations. H PN  nurses and (specialised) home care 
nurses were interviewed to assess care and bottlenecks experienced.
Finally, in chapter 9 the findings o f  the studies in this thesis, conclusions, methodological 
considerations, and implications for practice and future research are discussed.
The present thesis provides a solid overview o f the concurrent situation regarding venous access- 
related complications and psychosocial problems that are experienced in daily life in the context o f 
home parenteral nutrition, including their interrelation.
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Chapter 2
“Going out can only be for a few hours a day 
and at certain times o f the day.
I stay out for a maximum o f 3 to 4 hours. 
There is no spontaneity ond that is awful.”
The impact of home parenteral nutrition 
on daily life
A review
Clinical Nutrition 2007; 26: 275 288
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Sum m ary
BACKGROUND: Total parenteral nutrition (TPN) is a lifesaving therapy in patients with severe 
intestinal failure that can be administered at home. However, patients have to face complex 
technological nutritional support issues at home, which will influence their personal life.
OBJECTIVES: This review aims to describe the implications o f  home parenteral nutrition (HPN) on the 
quality o f  life, as experienced by patients, as well as to describe the caregivers’ reactions regarding 
these notions.
SEARCH STRATEGY: A  systematic review o f  the literature published between 1965 and 2005 was 
conducted. Cinahl, Medline, and Psychlit databases were searched. Systematic data extraction and 
narrative data synthesis were performed.
SELECTION CRITERIA: Papers were included if  they described original research published in a peer 
reviewed journal, with a focus on adult patients on H PN  and/or their family caregivers.
DATA COLLECTION ( a n d  a n a l y s i s ) :  A  standardised record was used for data extraction.
MAIN RESULTS: A  total o f  26 studies were included. The quality o f life reported by patients was 
moderate to good, but psychological problems, e.g. depression and anxiety, were common. Social life 
was disturbed due to the venous access device, the time schedule for H PN  administration, the inability 
to have normal oral intake, gastrointestinal mobility problems, and physical complaints. Frequently 
mentioned somatic problems included fatigue, diarrhoea, pain, polyuria during infusion and sleep 
disruption.
Despite social restrictions, depression and fatigue, caregivers reported their overall quality o f life as 
similar to the norms for healthy populations.
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Introduction
Parenteral nutrition is a lifesaving therapy in patients with severe intestinal failure. M ost frequently, 
this failure results from extensive resections o f  small bowel due to inflammatory bowel disease or 
mesenteric thrombosis, or it is caused by loss o f function because o f severe motility disorders.
Total parenteral nutrition (TPN) implies that a complete aqueous food formulation is administered 
intravenously. Generally, total parenteral nutrition is administered overnight for a period o f  12 hours. 
Patients feed two to seven times a week, depending on their remaining gut function. Importantly, 
these patients do not choose total parenteral nutrition out o f their own free will, but it is usually the 
ultimate remaining option to maintain or improve their nutritional status.
In patients with prolonged intestinal failure, parenteral nutrition may be administered in the home 
setting. Home parenteral nutrition (HPN) is nowadays a commonly used procedure in many 
developed countries.1 The patient population receiving H PN  is small, but growing steadily.
Moving parenteral nutrition support from the hospital to the domestic setting results in a significant 
gain in quality o f  life.2 However, patients have to face complex technological nutritional support issues 
at home, which will inevitably influence their personal life. H PN  administration is a time consuming 
and intrusive procedure that requires many adjustments. Besides, the underlying disease that led to 
intestinal failure may also cause a variety o f physical complaints, due to the presence o f  a stoma, 
altered body image, etc. These factors frequently impose restrictions on daily life regarding social, 
physical and psychological function. Understanding the difficulties that these patients experience is 
crucial in order to offer the right modalities o f  support. Besides, these notions may help patients as 
well as health care workers to anticipate to problems in the future.
The aim o f the present study was to identify the implications o f  H PN  on the quality o f life (QoL), 
including somatic, psychological, and social aspects o f  daily life, as experienced by patients, as well as 
to describe the caregivers' reactions regarding these notions.
M ethod
In c l u s io n  o f  s t u d ie s
A  systematic review o f the literature was conducted. The Cumulative Index to Nursing and Allied 
Health Literature (Cinahl), Medline and Psychlit databases were searched for relevant studies 
published in between 1965 and 2005. Subject-specific keywords used to describe patients relevant for 
this review were selected by using the databases’ thesaurus function. We used the following keywords: 
home parenteral nutrition, successively combined with: depression, anxiety, quality o f life, 
psychological, social, psychosocial, physical, pain, coping, sleeping, stress, mobility, activities o f  daily 
living, and limitations. The selected keywords were combined using the Boolean operator 'AND'. The 
search was also performed in free text. Additionally, the reference lists o f studies were searched to 
retrieve relevant studies not recovered using the search terms. Also, the proceedings o f  the European 
Society o f Parenteral and Enteral Nutrition (ESPEN ) congresses from 1992 to 2005 were screened. 
Because in some studies quality o f life was measured as a general parameter, while in others quality o f 
life was specified in somatic, psychological, and social aspects o f daily life all options were checked. 
Inclusion criteria o f this review were: the article had to describe original research published in a peer- 
reviewed journal, with a focus on adult patients on H PN  and/or their family caregivers.
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E x c l u s io n  o f  s t u d ie s
Articles in languages other than English or Dutch, or with a focus on T PN  in the context o f A ID S or 
cancer, or case reports, were excluded.
METHODS TO ANALYSE STUDIES
Two reviewers independently assessed the abstracts for fulfilment o f  inclusion criteria. In case o f  any 
doubts, consensus was achieved by discussion. After this first selection, the full papers were read by 
the first reviewer. A  standardised record was used for data extraction. A  second reviewer extracted 
data from two full papers for comparison. Data were compared and results showed consensus to a 
major extent.
Extracted information included study design, sample characteristics, HPN-related characteristics, data 
sources, outcome measures, recommendations, as well as strengths and methodological flaws o f  a 
study.
R esu lts
SELECTED STUDIES
The search o f Medline, PsycInfo, and Cinahl databases provided a total o f  661 hits (duplicates 
included). After selecting studies by reading the abstracts, 43 studies remained. Twenty-three o f  these 
were excluded because inclusion criteria were not met. Nine o f these did not describe original 
research, seven only reported on medical treatment and complications, two concerned patients with 
A ID S and cancer, one described hospital total parenteral nutrition patients, one discussed only 
appetite factors, one evaluated the hospital support team o f  H PN  patients, one was a case report, and 
one was published in two different journals. An additional six studies that met the inclusion criteria 
were identified by checking the references o f the relevant papers. Thus, a total o f  26 studies were 
available for this review (Table 1).
DESCRIPTION OF STUDIES
M ost o f  the included studies were conducted in the United States (n=15),3-17 and in Europe 
(n=10),1,18-26 only one study was performed in Canada.2 Seventeen studies had a quantitative design,1,3- 
9,12,18-24,26 six had a qualitative design,10,13,15-17,25 and three used both types o f design.2,11,14 The mean 
sample size o f H PN  dependent patients was 59±85 (range 5-347).
Studies were carried out at a single point in time (n=15)4,6-8,10,11,15,16,19-21,23,24,26,27 or over a longer period 
(n= 1 1).1,3,5,9,12-14,18,22,25,28 Data were gathered using one or more o f the following techniques: 
questionnaires (n=17),3-9,11,12,14,18-23,26 interviews (n=9),3,10,11,13-15,25,27,28 analyses o f medical and nursing 
files (n=8),2,3,6,19,22-24,26 unstructured monitoring during care (n=4),1,5,7,16 and monitoring sleep.9 Four 
studies gathered information from caregivers o f  HPN-dependent patients.10,11,25,28 Five studies used a 
control group: two compared H PN  patients with intestinal transplantation patients,4,5 and one 
compared H PN  patients with short bowel syndrome patients without H PN .21 One study compared 
H PN  patients with long-term medication use (opiates, benzodiazepines) with closely matched H PN  
patients, not dependent on these drugs.23
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Table 1 Search outcome
H P N  combined with Cinahl Medline PsycInfo
Hits Selected Included Hits Selected Included Hits Selected _Included
Psychosocial 0 0 0 16 6 4 2 2 1
Psychological 0 0 0 25 6 2 0 0 0
Physical 30 4 1 26 6 5 1 1 0
Social 36 13 4 58 16 10 2 2 1
Quality o f life 79 18 4 163 47 14 0 0 0
Depression 23 7 1 10 8 3 1 1 0
Anxiety 8 4 1 11 6 2 1 0 0
Pain 19 1 1 55 5 2 0 0 0
Coping 15 3 0 2 2 2 0 0 0
Sleeping 1 0 0 2 0 0 0 0 0
Stress 38 2 0 6 2 1 0 0 0
Mobility 1 0 0 3 0 0 0 0 0
Limitations 14 4 1 5 1 1 0 0 0
Activities o f dialy living 1 0 0 7 0 0 0 0 0
Total 265 56 13 389 501 46 7 6 2
Total per database
without duplicates 4 15 1
Total included Cinahl, Medline, PsycInfo: 61 
Total without duplicates: 20 
ESPEN: 0
Studies found in references: 6 
Total studies found: 26
One compared a group o f H PN  patients who were supported by an organisation with a group o f non­
supported patients.3 In three other studies, adult H PN  patients were part o f  the study population and 
were compared to enteral nutrition patients,6,12 and patients with nutritional therapy.19 One study 
gathered information from mothers o f  HPN-dependent children.28 Details o f  the studies are listed in 
Table 2.
The age o f  H PN  patients ranged from 17 to 87 years. Underlying diseases were Crohn's disease, 
mesenteric ischemia, pseudo-obstruction, radiation enteritis or other gastrointestinal failure. The 
duration o f  H PN  ranged from 1 month to almost 28 years; patients were on H PN  for 2—7 days a 
week, 7—24 h a day (Table 3).
M e t h o d o l o g i c a l  q u a l it y
Many o f the studies had methodological flaws. For example, in several quantitative studies the sample 
size was very small1,4,5,9,12,14,19,22 (<20), and in one study quality o f life o f  HPN-dependent patients was 
assessed by the author without any obvious structure.24 The response rate was only mentioned in 14
studies3-8,10,11,18-21,23,26 and varied from 30%7 to 100%.18,20
Questionnaires used were strongly heterogeneous, especially with regard to global measures o f  quality 
o f  life and health assessment.
Im p a c t  o n  d a il y  l i f e
We studied the impact o f H PN  on quality o f  life, somatic, psychological, and social aspects o f daily 
life. Table 2 gives a summary o f the results per study.
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Q u a l it y  o f  l i f e
Ten studies used a specific quality o f life questionnaire3-5,7,11,19,21-23,26 and 12 studies used other 
questionnaires or interviews to evaluate quality o f life.1,6,8,12,14-16,18,20,24,25,27 In five studies, quality o f life 
was seemed to be acceptable on average for H PN  patients.1,3,11,15,23 Some studies conclude that the 
majority, e.g. 70% o f the patients, had a reasonably good quality o f  life.2,7,8,25,26 A  low quality o f  life was 
found in six other studies.4,5,12,19-21
HPN patients experienced a lower quality of life compared to the healthy population.3,12,18 
They scored equal or lower than patients with other nutritional therapy6,12,19 and end stage 
renal disease (ESRD) patients.6,7,11,21 Herfindal et al.7 noticed that the difference with ESRD 
patients is that HPN patients tend to be isolated from other patients and health care providers. 
Patients suggest that health care providers should be sensitive to the psychological and 
technology needs of HPN patients.
Compared to intestinal transplantation patients quality of life was similar in both groups 5,26 
but in one study intestinal transplant patients experienced a significant higher quality of life.4 
HPN patients depending on opiates or benzodiazepines experienced a low quality of life, i.e. 
0.26 mean on a scale from 0 (worst possible quality of life) to 100 (best possible quality of 
life).23
An acceptable quality of life seems to depend on several factors such as primary disease, 
duration of HPN, contact with social worker, hospital admissions, presence of a stoma and 
employment status.7,18,20,23,25,26
P s y c h o l o g i c a l  a s p e c t s
Seven studies did not assess the psychological reactions of patients on HPN. In many of the 
remaining studies, depression was a common emotional response to the HPN procedure 
(n=12). Severity of depression ranged from mild to severe and was found in 10-80% of the 
HPN patients.3,13,14,26 Jeppessen et al.21 showed that the female HPN patients expressed more 
feelings of depression and discouragement and they appeared to be more tearful and upset 
than male HPN patients. In a sample of 216 HPN patients, Smith et al.3 found that the 
patients supported by an organisation had a mean score indicating none or mild depression, 
while the mean scores for the patients who were not supported indicated moderate 
depression. In the study of Richards and Irving23,depression was reported in 70% of the HPN 
patients depending on opiates or benzodiazepines, compared to only 10% of the non­
dependent closely matched HPN patients. Depression may have serious consequences as it 
might lead to less care with the aseptic technique regarding the catheter, resulting in an 
increase in line sepsis.14,15
By contrast, two studies showed little evidence that psychological health status was affected by 
HPN.6,12
Table 2 Characteristics of included studies (n=26)
Author
Year
Type of study 
design
Sample size Data sources Main Outcomes
Carlson GL 
et al.
1995 26
Quantitative 47 File analysis
Questionnaire : subjective QOL, the Nottingham 
Health Profile, SF 36
Good QOL, age and gender appeared to have little effect on QOL 
Many patients reported sexual and social dysfunction and most 
patients were unable to return to work. Almost half the patients 
had frequent feelings o f depression or anxiety.
Carls son E, 
et al.
2003 19
Quantitative 8 HPN,
20 nutritional 
therapy (SBS)
File analysis
Questionnaire : Visual Analogue Scale, SF-36, 
Rating Form of IBD patients concerns, Jalowiec 
Coping Scale
Low QOL and low perceived health in HPN group
The most intense concerns were being a burden, energy level,
having surgery, feeling alone, and loss o f sexual drive.
Detsky AS et Both 
al.
1986 27
73 analysis 
37 interview 
(van de 73)
Dossier analysis 
Structured interviews
QOL improved fast during the first year and then increased slowly. 
QOL specifically improved in patients who had experienced 
malnutrition prior to HPN
DiMartini A 
et al..
1998 4
Quantitative 19 :
10 HPN 
9 ITx
Questionnaire : Quality o f Life Instrument HPN patients reported significant worsening across many areas of 
QOL after becoming TPN dependent.
Intestinal transplant recipients experience a significant 
improvement in most areas o f QOL, compared to the period while 
on TPN.
Herfindal 
ET et al. 
1989 7
Quantitative 347 Questionnaire : Campbell’s Life Satisfaction 32, 
patient predictor’s, physiologic complaints, QOL, 
Affect Balance Scale
HPN patients appear to adapt to most aspects o f their treatment 
program.
Overall life satisfaction is lower than ESRD patients 
Patients have difficulties with the isolation from health care 
providers, the ability to travel and sleeping.
Jeppessen 
PB et al. 
1999 21
Quantitative 49 patients 
36 controls
Questionnaire : Visual Analogue Scale, Sickness 
Impact Profile, Inflammatory Bowel Disease 
Questionnaire
Reduced QOL according to those with short bowel without HPN 
and patients with chronic renal failure treated with dialyses.
HPN patients spent more time at home. They experience a large 
impact on their psychosocial activities, sleeping and emotional 
functioning.
Females scored worse on QOL.
Johnston JE 
198116
Qualitative Evaluating 36 
patients,
26 HPN participants
Monitoring: 3 years experience (36 patients), 
working with 26 HPN participants
Stresses introduced by HPN involve self-image, depression, fear, 
hopelessness, family life, job participation, social participation, 
financial situation and sexual activities.
Chronically ill patients adapted more easily to HPN than patients 
with acute gastrointestinal trauma..
Author
Year
Type of study 
design
Sample size Data sources Main Outcomes
Ladefoged K  Qualitative 
1981 25
13 patients 
10 partners
Structured interview (1st 13 patients 2nd 9 patients) 70% fair QOL, 30% poor QOL.
Patients were not able to work, experienced physical distress, and 
sexual activity had ceased completely in patients above 55 year. 
Leisure activity and social activities were restricted.
MacRitchie
KJ
1980 15
Qualitative
Survey
20 (2 subgroups with Open interview (once)
distinctive coping
styles)
Sudden loss o f bowel inevitably results in grief. Patients who 
already were chronically ill experience a smoother adaptation. 
Resultant body image alteration played an important role within the 
group, especially in woman.
Malone M 
2002 12
Quantitative 12 HPN 
5 HEN
Questionnaire : SF 36, symptoms, impact of 
nutrition on their lifestyle
Sleep, travel, and social activities were the most affected aspects of 
the patient’s lifestyle.
The general health scale showed that older patients had a better 
general health status score.
Mughal M & Quantitative 
Irving M 
1986 24
200 File analysis
QOL (self made instrument)
Most patients were fit and independent.
Those likely to do well tend to have a primary intestinal disorder. 
Patients with a poor QOL were older men whose mesenteric 
arterial occlusion is a manifestation o f generalised arteriopathy.
Perl M, et al. 
1980 14
Both
(quantitative and
qualitative)
Longitudinal
10 Semi-structured interview 
Observation and report by nurses 
Questionnaire : Life History Questionnaire, 
Structured mental status examination
Patients are gratified with the new life, but most patients were at 
least mild depressed as a result o f obvious and severe current life 
stresses.
Common problems: fear related to realistic dangers, 
embarrassment, problems with not being able to eat, social 
discomfort, sexual problems, financial difficulties.
Pironi L et 
al.
1993 1
Quantitative 18 Monitoring
QOL according to Mughal & Irving
HPN improved QOL by ameliorating the nutritional status, 
allowing social rehabilitation and reducing the hospital rate.
The outcome o f the patients on HPN is mainly determined by the 
underlying disease.
Pironi F et 
al.
2003 20
Quantitative 40 Questionnaire : SF 36, nutritional status, 
rehabilitation status according to Mughal & Irving, 
hospital réadmissions 
File analysis
QOL was lower than that o f the healthy population. Lower QOL 
in patients with pseudo-obstruction or those dependent on 
narcotics and sedatives.
During HPN, 58% o f the patients maintained the same 
occupational activity they had before HPN.
Pironi L et 
al.
2004 18
Quantitative 31 Questionnaire: SF 36, social demographic and 
general factor’s, disease factor’s, HPN factor’s, 
hospital stays, rehabilitation according to Mughal 
& Irving
SF 36 raw scores were worse compared with the standard 
population.
Lowest scores among older patients and those addicted to narcotic 
analgesics.
Higher scores among those who had been treated with HPN 
longer.
Author
Year
Type of study 
design
Sample size Data sources Main Outcomes
Price BS, 
Levine EL 
1979 13
Qualitative
Retrospective
19 In-depth open interviews Depression, social restrictions, sexual problems, anxiety and fear of 
the unknown, frustration, ambivalence and fatigue are common. 
Patients developed a ‘love-hate’ (life-death) relationship with the 
TPN apparatus.
Every patient misses and craves food.
The cosmetic effect o f multiple surgical procedures was a constant 
source o f concern.
Reddy P, Quantitative 
Malone M 
1998 6
22 HPN 
10 HEN
Questionnaire: SF 36, influence o f therapy on
lifestyle
Review charts
HPN had a significant negative impact on a patient's QOL and 
lifestyle domains like sleep, travel, exercise, and social life.
Richards 
DM et al.. 
1997 22
Quantitative 20: 10 dependent 10 
controls
Questionnaire: EuroQOL index, SF 36 Outcomes for opiate- and sedative-dependent patients are 
significantly worse than for other HPN patients (more depression, 
anxiety, complications). This is possibly due to a low morale, more 
pain, less energy, more anxiety and more central line sepsis
Richards 
DM Irving 
MH 
1997 23
Quantitative 51 patients 
64 case notes
Dossier analysis: demographic and clinical details 
Questionnaire: EuroQOL index, SF 36, self-rated 
health status, change in health over the past 12 
months
Fairly good QOL. No difference between patients with o f without 
a stoma.
Poorest scores in older patients and those dependent on narcotic 
drugs
Employment rate was low (5%)
Robb RA et 
al.
1983 8
Quantitative 42 Questionnaire (own development): patients 
predictor's, hospital admissions, physiological 
complaints, psychosocial interferences
Reasonable QOL; most patients believed that HPN had no effect 
on their self-image and a very positive effect on their overall life. 
Patients with chronic diarrhoea or a low annual income might be 
expected to have more medical and psychosocial problems
Rovera GM 
et al.
1998 5
Quantitative
(longitudinal)
20: 10 HPN 
10 ITx
Questionnaire: Quality o f Life Instrument Little difference in QOL between ITx recipients and HPN 
dependent patients
Improvement occurred over time in ITx recipients in domains 
related to sleep, anxiety, and impulsiveness/control.
Scolapio IS 
et al.
2002 9
Quantitative 5 Wrist activity data 
Polysomnography
Questionnaire: Epworth Sleepiness Scale
Reduced sleep quality in patients receiving HPN; total sleep time 
and sleep efficiency during HPN infusion was less than reported 
for controls.
Sleep quality does not seem to be negatively effected by cyclic HPN 
infusion.
Süver HI 
2004 28 '
Qualitative 9 HPN patients (6 
adults, 3 children)
3 mothers o f HPN 
patients
Structured interview (online) Improvements in the ability to function.
Fear o f death, fear o f complications, frustration, and anger were the 
most frequently expressed negative feelings.
Facing social situations with family and friends when food is 
present appeared to be anxiety-producing.
Author
Year
Type of study 
design
Sample size Data sources Main Outcomes
Smith CE 
1993 11
Both 178 patients 
178 caregivers
Telephone interview
Questionnaire: QOL index, Rosenberg's Self- 
Esteem Scale33, Cantril's self anchoring scale, 
Batson Emotion Index, Caregiving reaction 
assessment scale, Mutuality (quality o f relationship) 
Family Crisis Oriented Personal Evaluation Scale, 
Family Adaptability and Cohesion Evaluation 
Scale, Centre o f Epidemiologic Studies — 
Depression Scale
Low QOL was associated with increasing length o f time on HPN, 
fewer coping skills, and inability to get along income.
Depression and physical fatigue were reported as most problematic 
for both patient and caregivers. Self-esteem was comparable to that 
o f healthy individuals.
Patients and caregivers reported missing out on activities and 
worrying about infection frequent.
Smith CE et 
al.
1993 10
Qualitative 20 family caregivers Semistructured interviews Reactions to care giving were mainly positive.
Common problems: anxiety in managing the technology, 
depression, fatigue, less time for leisure.
Smith CE et 
al.
2002 3
Quantitative 95 large centres 
121 smaller centres 
(controls)
Telephone interviews 
File analysis
Questionnaire: Quality o f Life Index, Centre of 
Epidemiologic Studies — Depression Scale
Patients supported by an organization experienced a higher QOL, 
less reactive depression, and a lower incidence o f catheter-related 
sepsis.
SF 36 Short Form 36 health status questionnaire
IBD Inflammatory Bowel Disease
QOL Quality o f Life
HIVH Home intravenous hyperalimentation
ITx Intestinal Transplantation
Table 3 Patient characteristics
Author Mean age (range) Gender Employed Years on HPN  
mean (range)
Hours on H PN /  day Hospital admissions
Price BS, 39.6 (17-60) 47% F 15,8% FT, 36,8% PT - At night -
Levine EL
1979 13
Peri M, et al. 41.6 (24-66) 
1980 14
40% F 40% FT, 50% PT 1.8 (0.5-3.25) Generally 24 hours
MacRitchie 44.1 (18-66) 50% F - 1.5 (0.25-5) - -
KJ 1980 15
Ladefoged K  45.3 (24-62) 
1981 25
54% F 0% Median 32 mo (3- 
49 months)
7.1 hours mean Mean LOS 38.8 (0-120 days).
Johnston JE 
198116
(10-69) 27% F - - 10-12 hours overnight
Robb RA et 50.1 (22-78) 67% F 11.9% working 9.5% homemaker 3.6 (0.5-9.5) - Mean 1.6 (0-7 times),
al. 1983 8 (48% employable) 35% wasn't hospitalised last year. 
Only 36% o f admissions were 
attributed to HPN complications.
DetskyAS et 41.7 (19-75) 
al. 1986 27
53% F - (0.5-12) -
Mughal M & (0-80) 
Irving M 
1986 24
60% F Nearly 1/3 FT
22% PT or looking at family
(0.08-6) Usually 12 hours at night
Herfindal 45.8 58% F 11% FT, 6% PT, 28% retired, 15% 2.9 - 3 times last year due to HPN
ET et al. 
1989 7
homemaker, 50% disabled, 9% 
unemployed
complications (22.5 average length 
o f stay).
Pironi L et 45.5 (27-71) 44% F Some patients could maintain the 1.8 (0.08-5.8) 12-18 hours overnight 0.41 catheter related complications
al.
1993 1
employment (no percentage) /  patient-year
Catheter sepsis: 0.12 /patient-year, 
deep vein thrombosis: 0.1 /patient- 
year.
Smith CE 
1993 11
HPN 52 (19-85) Nearly
equally
divided
4.6 (0.08-20) 8-24 hours; majority 
during night time
Caregivers 
52.5 (21-87)
- - - -
Smith CE et HPN (32-78)
al. 1993 10 Caregivers - 30% FT , 30% PT, 30% retired, 10% 0.08-8 providing 1-24 hours a day
(30-76) unknown home care assistance (mean 9.95)
Author Mean age (range) Gender Employed Years on HPN  
mean (range)
Hours on H PN /  day Hospital admissions
Carlson GL 
et al. 1995 26
Median 50 (21-67) 51% F 11% FT, 3% PT, 59% unemployed, 15% 
retired, 11% carrying for home/fam.
4.6 (1-12.6) 3.0 /  year HPN: patients with a 
positive attitude towards ITx 
3.5 /  year HPN: patients with a 
negative attitude towards ITx
Richards 
DM Irving 
MH 1997 23
44.4 (17-70) 62.5% F 10% FT, 10% cope with housework, 80% 
too ill to work
Median 4 years 
(0.5-15)
98% noctural
Richards 
DM et al.
Dependent patients 
36.2 (19-45)
80% F 2.7 (1-12) - Mean 2.2 admissions the past year 
(mean 29 days)
1997 22 Non-dependent 39 
(24-55) C
80% F 3.3 (1-11) " Mean 0.2 admissions (mean LOS 8 
days)
DiMartini A 
et al. 1998 4
HPN 37.4 (22-73) 60% F 50% totally disabled, 20% pre-TPN 
working status, 30% housewives
4.2 (1.2-8) - -
ITx 26.6 67% F 22% totally disabled, 22% housewives, 
56% student
2.6 (0.25-8) - -
Rovera GM 
et al. 1998 s
HPN 36.4 (27-54) 70% F 20% working, 10% student 5.3 (0.5-15.8) Noctural basis -
ITx 34.2 (23-62) 50% F 0% working; 20% home maker, 20% 
student
2.4(0.25-8) HPN 
before ITx
- -
Reddy P, 
Malone M 
1998 6
56 median (25-74) 64% F 14.5% FT, 
4.5% PT
Median 6 (1-21)
leppessen 
PB et al.
HPN Median 45.4 
(25-75)
63% F 14% FT Median 5 (0.2- 
27.8)
Generally at night; 12% 
day and night
-
1999 21 SBS 50.0 (44.1-60.4 56% F
= 50%)
44% FT -
Smith CE et 
al. 2002 3
(30-70) More
woman
8 (2.9-16.9) - -
Scolapio IS 
et al. 2002 9
61.4 (40-73) 60% F 1.9 (0.4-5) 10 hours noctural -
Malone M 
2002 12
HPN 54.8 59% F 
(total
population)
35% working, 41% retired, 24% unable to 
work (n=17)
7.1 (1-18) (n=17) 1993-1996: none o f these patients 
were admitted to hospital as a result 
o f HPEN related complications
Pironi F et 
al. 2003 20
42.6 (17-66) (n=40) 55% F 
(n=40) 
60% F 
(n=17)
30% working/ student, 28% housewives, 3.74 (0.08-11.02) 
18% retired or temporary suspension, 24% (n=40) 
already uncapable due to the disease 
(n=40)
Overnight (n=40) Rehospitalisation's related to HPN: 
0.37 ±1.02 /year o f HPN (n=40, 
1986-2001)
Rehospitalisation related to HPN: 
0.33 ±0.66 /  year o f HPN (n=17, 
2001-2002)
Author Mean age (range) Gender Employed Years on HPN Hours on H PN /day Hospital admissions 
mean (range)
Carlsson E, 
et al. 2003 19
51 (37-57) (n=8) 50% F 
(n=8)
50% PT (not reduced since HPN), non 
workers stopped working due to disease
6.2 (4.75-17.42)
Pironi L et 
al. 2004 18
45.4 (18-74) 55% F - 4.2 (0.2-17.6)
Süver HI 
2004 28 '
38.7 50% F - 4.3 (2-8)
F Female
FT Full-time
PT Part-time
ITx Intestinal Transplantation
SBS Short Bowel Syndrome 
LOS Length o f Stay
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Another common reaction in HPN patients was anxiety and fear for the unknown; the future, 
the attitude of other persons, complications and death (n=10).4,5,13-16,21,25,26,28 
Carlson et al.26 reported that 41% of the patients had frequent feelings of anxiety or 
depression. Other studies did not report percentages of anxiety and fear, but gave descriptions 
as "there was a high degree of anxiety and fear for the unknown”,13 "most frequently 
mentioned was their fear of death" and "all subjects expressed fear of liver damage".17 
Anxiety and fear was related to realistic threats, such as catheter infection, pump malfunction, 
air metabolism, liver damage, etc.13,14,16,25,28 Perl et al.14 described fear was almost universal, 
especially in the early months of HPN. With the passage of time, patients became less fearful. 
As the level of fear became manageable, overall functioning and activity improved.
When HPN patients were compared to patients after small intestinal transplantation, anxiety 
levels were higher in the HPN patient group.4,5
Reduced physical mobility, lack of energy and optimism, fatigue, a sense of loss o f control, 
financial instability, marital disintegrations and inability to return to an appropriate work or 
social setting could lead to or aggravate symptoms of depression or anxiety in total parenteral 
nutrition patients.4,14-16
A constant source of concern for almost all patients was the cosmetic effect of multiple 
surgical procedures and the actual location of the catheter.13-16 Patients perceived themselves 
as unattractive or repulsive. MacRitchie15 showed that especially females experienced feelings 
of embarrassment and shame concerning disfigurement caused by scars, the catheter and 
weight loss. Unlike HPN patients, transplanted patients experienced a significant 
improvement in appearance.4 By contrast, in two studies patients believed that HPN had no 
effect on their self-image or self-esteem.8,11
Patients with chronic bowel disease seemed to cope more effectively than patients with acute 
gastrointestinal trauma.1,13,15,16,20,21,23,24 They were usually so grateful, that they showed a better 
compliance and adjustment to the HPN regime. Also, they were more emotionally prepared 
for HPN. These patients, suffering from a chronic disease, viewed HPN as a relief from 
frequent hospitalisations and abdominal discomfort. Patients with acute gastrointestinal 
problems found their new circumstances quite devastating, had enormous fears, and they 
grieved for the loss of functioning.13,15,16,23
Patients who had been able to maintain stability in their personal lives towards employment, 
family support and financial security, seemed to adjust better to HPN and had a more positive 
outlook on the future.16
Other psychological problems were changes in dependence (mostly loss of 
independence),13,16,21 frustration,13,28 anger,21,28 difficulty with concentration and memory,5,14 
some patients felt they were a nuisance or a burden to others,19,21 some felt lack of 
understanding from others,21 and some felt alone,19 tense,13 or annoyed.25
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S o c i a l  a s p e c t s
Freedom to choose and the power to make simple decisions of daily living were sharply 
reduced and social contact and interaction decreased because of the catheter, the schedule of 
HPN, mobility problems, and physical complaints.11-13,21 When statistics were reported, 35­
43% of the patients experienced social activities as a problem due to HPN.8,12,25 Sports, 
shopping, leisure, travelling, hobbies, and child care were domains where patients had to make 
adaptations.4,7,8,12,14,17,25
Depending on the underlying disease, HPN patients are either able to eat and drink normally, 
just a bit or not at all. Patients who can eat orally are encouraged to do so if they wish to 
minimise feelings of social alienation.16 When a HPN patient is not able to eat and/or drink, 
friends sometimes stopped asking them over for meals or celebrations that included food.10 
Some patients felt unable or unwilling to sit down to meals with the rest o f their family26 and 
some had a reduced appetite.21
In seven studies the impact of HPN on the sexual relationship was assessed.13-16,21,25,26 Sexual 
functioning reduced and this was a major concern in 27-60% of the HPN patients.14,21,26 
Lovemaking had to be timed,13 the enjoyment of sexual relations was reduced,14 and 
embarrassment and shame often led to impairment in sexual relationship.15,26 Reasons were an 
altered body image, feelings of embarrassment, discomfort with the bag and pump, and the 
partner’s fear of harming the patient. Sexual relations tended to improve after the first few 
months. Single patients may experience a more difficult time feeling uncomfortable in sexual 
situations because of their catheter. Younger patients seemed to have a more normal sex life.25 
Going on holiday or travelling required logistic attention. Patients had to carry along adequate 
supplies of nutrient fluid and equipment. Despite this, in one study patients frequently made 
road or air trips, having their supplies sent to their destination.14 Other studies reported 
travelling and going on holiday was negatively affected by HPN in 32-53% of the patients.7,11- 
13,26 In a sample of 347 HPN patients, Herfindal et al.7 found that the ability to travel was the 
activity most disturbed by HPN, but the longer the patients were on the HPN program, the 
less affected this ability was.
Patients mostly were encouraged to return to work as soon as their physical and emotional 
condition permitted. I f a patient worked a regular day, he had to learn to schedule his 
employment hours around being ’hooked up’ to feedings. This highly restrictive schedule left 
little time for any other family or leisure time activities. Because the solutions mostly run 
through the night and disrupt sleep, patients sometimes felt weak and tired during the day. In 
several studies percentages of full-time working patients were given, none of the patients in 
the study of Ladefoged25 felt capable of managing a job, related to a complexity of reasons: 
tiredness, pain, diarrhoea, frequent hospitalisation, and the time-consuming therapy of HPN. 
In several studies 10-20% of the patients worked full-time,4,6-8,23,26 and in other studies nearly 
30-40%.5,14,19,20,24 Furthermore, some patients were home makers, some were students, and
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some were retired. Richards and Irving23 reported that 80% of the patients were too ill to 
work. The reason for this low employment rate was unclear but might be a result o f illness- 
related financial benefits.
S o m a t i c  a s p e c t s
The most frequently mentioned general complaint in HPN patients was fatigue 
(n=8).4,10,11,13,14,19,21,22 Fatigue was seen as consistently interfering with daily activities like work, 
and leisure. In other studies weakness and/or tiredness was mentioned.7,8,13,14,25 Only three 
studies reported statistics, 23-54% of the HPN patients experienced this problem.
Another complaint, described in five studies, was diarrhoea, for which the reason was not 
always clear.4,8,11,12,21 Robb et al.8 found that patients who complained of diarrhoea had 
significantly more physiological complaints than the patients who did not have diarrhoea.
Five studies reported patients suffered from different sorts o f pain: bone and joint pain,1,8 
abdominal cramping or abdominal pain,8,21 and pain which was not specified.4,22 Four studies 
described skin rash in a small part (8-17%) of the HPN population.6-8,12
The most frequently mentioned physical complaint related to the fluid intake was polyuria 
during infusion, mostly at night. This problem was mentioned in eight studies and seemed to 
be an important reason for sleep disruption.4,6-8,12,13,18,28 Studies using percentages reported 
42-58% of the patients mentioned this problem.7,8,12
An overview of general and HPN-related problems that were mentioned in several studies is 
shown in Table 4.
C a r e g i v e r s  r e a c t i o n
Most of the caregivers were patients’ partners,10,11,25 but in two studies there were also some 
parents, children, sisters and a close relative who provided care to the HPN patient.10,11 Silver 
assessed the reaction of three mothers of HPN-dependent children.28
Caregivers reported their overall quality of life, self-esteem, life satisfaction, family cohesion 
and quality of the patient-caregiver relationship as similar to the norms that are published for 
other healthy populations. Reactions to care giving were mainly positive, although common 
problems like depression and fatigue were articulated.10,11 Low quality of life was associated 
with increased length of time on TPN, fewer coping skills, and inability to get along on 
income.11
All four studies mentioned social restrictions: caregivers were missing out on activities, friends 
had stopped visiting, or asking them over for meals or celebrations that included food.10,11,25,28 
Depression or other psychological feelings such as strain, frustration, anger, and difficulty 
watching the patient go through the illness, were also reported by caregivers in all
studies.10,11,25,28
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In three studies caregivers were anxious about infection, loss of venous access, liver damage, 
managing the technology, and death.10,11,28
Two studies mentioned that fatigue and tiredness consistently interfered with daily 
activities.10,11 Caregivers undertook more household duties,10,25 and more physical care.10,17 
Other problems mentioned in the studies were sexual problems,25 role reversal, and financial 
dependence on insurers because of the cost o f TPN.10
Table 4 Physical complaints
Reference Physical complaint % patients experiencing this problem (if reported)
4;10;11;13;14;19;21;22 Fatigue -
7;8;13;14;25 Weakness/tiredness 23 -  54%
4;8;11;12;21 Diarrhoea 25 -  26%
4;7;8;21;22 Pain -
4;6-8;12;13;18;28 Polyuria 42 -  58%
6-8;12 Skin rash 8 -17%
7;8 Decreased concentration 11 -26%
6-8;12 Ankle or feet swelling 17 -45%
8;12 Orthostatic hypotension 17 - 25%
6;8;12 Ageusia 52%
6;8;12;34 Nausea 25 -  37%
6;12 Thirst 42 -  58%
6;12 Constipation 0 -  9%
6;12 Gas 8 -  23%
6 Dry mouth 45%
6 Vomiting 9%
6 Hyper- or hypoglycaemia 27%
6 Sore throat 5%
8 Chest pounding 19%
12 Fluid retention 25 -  50%
7;8 Nervousness or sweating 33 -  38%
7;8 Cramps in hand or feet 40 -  62%
7;8 Hair loss 15 -  24%
7;8 Shortness o f breath during infusion 14 -18%
Discussion
The aim of this study was to identify the impact of HPN on daily life as described in literature. 
We found that, overall, HPN patients experience a moderate to good quality of life, but many 
suffer from depression and fatigue. HPN also limits social activities. Caregivers reported their 
overall quality of life as similar to the norms that are published for other healthy populations, 
but common problems like depression and fatigue were articulated.
This review was conducted in a systematic and meticulous manner. In order to reduce 
publication bias we also searched the proceedings of the ESPEN congresses from 1992 to 
2005 for studies that were presented but had not (yet) been published. Therefore, it is not 
likely that relevant studies were missed. However, the conclusions from this review should be 
treated with some caution, because of limitations in the data. Some included reports were 
difficult to compare because of the use of different instruments, scales, and lifestyle domains. 
Other studies used individually designed questionnaires that were not validated and therefore
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could be considered weak. Also, the methods used to conduct and interpret the interviews 
were not always clearly described. Another problem within the studies is selection bias. 
Satisfied patients may not have responded and responders may be less satisfied, or the other 
way around. Finally, it is sometimes difficult to evaluate whether the problems are a result of 
HPN use or the underlying disease. Despite these limitations most reports mention similar 
problems experienced by HPN patients.
While we found that overall HPN patients experience a reasonable quality of life, some issues 
need to be discussed. First, the interpretation of the outcome measures are quite variable 
between studies, both 0.51 and 0.73 on a scale from 0 to 1 were indicated as a reasonably good 
quality of life.2,23 Also, part o f the HPN patients is not capable to eat and/or drink normally. 
The value of food intake on social patterns, self-esteem, pleasure and enjoyment, and 
nutritional status is not considered in most generic or disease-specific quality of life tools.29 
Taking these items into account may result in a lower appreciation of quality of life.
There are some studies that yielded contradicting results in several ways. Depression is a 
complaint that was mentioned in 12 studies as a problem, but in two studies little or no 
evidence of impairment of the psychological health status was found.6,12 
Also, in most studies only 10-30% of the patients were capable to work part-time or full-time. 
In contrast, in the study of Perl et al.14 about 80% of the patients had a part-time or full-time 
job or retained family and homemaking activities. The reason for this difference is unclear, but 
it may be a result of illness-related financial benefits.
Finally, Perl et al.14 concluded that patients are extremely gratified with the new life afforded 
by HPN, and seem to put up with the inconveniences with a good sense of humour. But at 
the same time 80% of these patients experience at least mild depression, 30% experienced 
several suicidal episodes, and fear was almost universal in these patients.
Conclusion/recommendations
Both qualitative and quantitative studies provided information on symptoms experienced 
while receiving HPN. In general, it has become clear that HPN patients suffer from a broad 
range of problems, of which many are social or psychological in nature. Frequently expressed 
problems were depression, anxiety, limitations in social activities and travelling, sexual 
problems, fatigue, and diarrhoea.
To minimise the impact of HPN, patients could be supported in coping with these problems 
from the time patients start with HPN. In order to be maintained as an active outpatient on 
HPN, Perl et al.14 stated it is necessary that emotional needs be understood and that the 
psychological problems be handled as enthusiastically and competently as the physical 
problems. An annual assessment of psychological-, social-, and physical functioning might 
provide insight into experienced problems and the necessity to start with interventions. It is 
recommended to involve partners and family of HPN patients in this process.
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Recently, Baxter et al.30 carried out a review of the quality of life of adult patients on HPN. 
There are however several differences with this review. Baxter et al. included cancer patients 
while we did not, and they did not limit the study design, whereas we only included original 
research published in peer reviewed journals. Also, we included caregivers’ experiences in our 
review, while they did not.
We agree with Baxter that both HPN and the underlying disease may affect quality of life, and 
that there is a need for a standardised, scientifically validated, treatment-specific instrument to 
measure quality of life in HPN patients.
In the literature Smith et al.31,32 have published on interventions in HPN patients. The first 
study31 demonstrated that Interactive and Videotaped Educational Interventions were 
associated with a reduction in reactive depression, catheter-related bloodstream infections, and 
hospitalisations because of infections. Writing in checklists and diaries, and using step-by-step 
problem-solving engaged subjects, prompted use of self-monitoring, activated professional 
partnerships for problem management, and ultimately helped maintain their satisfactory 
quality of life. The partnership problem solving intervention was shown to be a logical, 
stepwise approach for identifying problems and emotional reactions and encouraging specific 
communication with professionals. The second study32 demonstrated that journal writing was 
acceptable to participants, effective and specific for reactive depression, and low in costs. The 
intervention stimulated writing and prompted mood-evaluating activities, resulting in a 
positive effect on patient and caregiver depression.
A specific questionnaire to evaluate the value of food intake on daily life is not available and 
therefore should be developed.
It is recommendable to develop, evaluate, and implement interventions which go into negative 
moods, anxiety, limitations in social activities and travelling, sexual problems, fatigue, and 
diarrhoea.
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A bstract
BACKGROUND a n d  A im s: Home parenteral nutrition (HPN) is a therapy that changes life radically 
and often means lifelong dependence on parenteral feeding. The aim o f  this study was to gain insight 
into problems experienced by adult patients who were dependent on long-term HPN.
METHODS: A  survey was performed on all patients at the ambulatory care clinics o f  two university 
centres. We used two techniques: written questionnaires and interviews. The questionnaires addressed 
fatigue (CIS), quality o f  sleep, anxiety, depression (BDI), social impairment (subscale SIP68), and 
sexual functioning. Data were analysed descriptively. Structured interviews inquired about the negative 
influence o f H PN  dependence on daily life. These data were quantified by content analysis.
RESULTS: The response rate was 76% (n =  48). Questionnaire results: all the respondents had multiple 
physical symptoms, which they attributed to the underlying disease. Furthermore, severe fatigue 
(63%), sleeping disorders, (severe) depression (65%), social impairment (55%), and sexual disorders 
(33%) were present.
Quality o f life (QoL) correlated with fatigue, sleeping disorders, anxiety, depression, and social 
impairment (P<0.02). Interview results: psychosocial problems were the main complaints in daily life 
due to H PN  dependence, e.g. negative changes in moods and feelings (including anxiety), lack o f 
freedom, limitations in social life and being dependent.
CONCLUSIONS: Although many somatic symptoms were present, HPN-dependent patients reported 
primarily psychosocial problems in daily life. To improve quality o f life, H P N  teams should assess 
somatic as well as psychosocial aspects standard. Given the large proportion o f  patients with 
depressive disorders, therapies such as antidepressant medication, psychosocial support and cognitive 
training, should be offered.
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Introduction
Home parenteral nutrition (HPN) is a life-saving therapy for patients with very serious intestinal 
problems. It is impossible for these patients to absorb sufficient amounts o f  food, even with extra 
enteral feeding. Inevitably, intravenous supplementation o f  nutrition becomes necessary. Indications 
for H PN  are mainly the short bowel syndrome (SBS) and motility disorders. In 2003, 80—90 patients 
were dependent on long-term H P N  in the Netherlands, which is a prevalence o f 5 per 106. In Europe, 
the mean prevalence o f  H PN  is 3 per 106.1 H PN  is a therapy that changes life radically. The technique 
consists o f administering intravenous nutrient solution via a pump. In general, H PN  is given 
intermittently, during a 10—14 hours overnight period. Depending on the underlying disease, patients 
may tolerate a normal quantity o f  oral food, or a restricted quantity in the case o f  motility disorders. 
Thus, the frequency o f  H PN  can vary from 2 to 7 times a week. H PN  treatment often means lifelong 
dependence on parenteral feeding.
Despite the heavy impact that H PN  has on a patient's life, research has mainly focused on the physical 
consequences, i.e. health status and complications such as liver disease and line problems.2,3 Some 
studies examined the impact o f long-term H PN  on daily life. These studies showed that quality o f  life 
in patients on long-term H PN  is lower than that in the general population,4-9 and lower than quality o f 
life in closely related patient groups, e.g. non-HPN-dependent groups with severe malnutrition due to 
SBS,7,10 small bowel transplant recipients,10,11 and kidney transplant patients with end stage renal 
disease.12 A  few studies described problems related to H PN  at home in more depth. These included 
problems o f  frequent depressive episodes, disturbed sleep, difficulty with travelling, exercise and
i • 7,8,12-15leisure.
Patients also reported complications that may be caused by metabolic problems, such as cramp in 
hands and feet, swelling o f  the ankles or feet, weakness and joint pain.12,13 However, most o f  the 
studies are relatively old, they were often based on small populations, and nowadays nutritional 
regimes comprise all-in-one bags. We were interested to find out what problems were being 
experienced by long-term HPN-dependent patients. The aim o f this study was to gain insight into the 
impact o f  H P N  on daily life in adult H P N  patients as input to improve treatment and increase quality 
o f  life. Therefore, the nutrition support team at our hospital initiated a study that addressed the 
following questions:
(1) To what extent do long-term H PN  patients experience problems?
(2) Which HPN-treatment-related problems have a negative influence on daily life?
M aterials and  m ethods
D e s i g n
A  survey was carried out in the spring o f 2003. We used written questionnaires to address research 
question (1) and structured open-ended interviews to address research question (2).
P a r t ic ip a n t s
All adult patients monitored by the nutrition support teams at the University Centres in Amsterdam 
and Nijmegen were invited to participate in the study (n=63). We estimate that these patients
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represent 80% o f all the patients receiving long-term H PN  in the Netherlands. Patients gave informed 
consent.
N u t r it io n  s u p p o r t  t e a m s
In the Netherlands, H PN  is mainly carried out at two university centres that both have a 
multidisciplinary nutrition support team. Main participants are a gastroenterologist, an internist, an 
H PN  nurse and a dietician. A  24 h telephone service is included. Main objectives o f the teams are to 
assist the patient to gain an optimal physical condition, to prevent and treat complications, and to 
educate patients to master the technology and become independent. All the patients were using all-in- 
one bags. Professional assistance is only given when patients report severe psychosocial problems.
Q u e s t io n n a ir e s
We initiated a pilot study to draw up a set o f  questionnaires to address research question 1. We 
planned two group interviews: one with the patients on long-term H PN  and one with the health care 
workers. The subject o f  discussion was: 'What type o f problems do HPN-dependent patients 
encounter in somatic, psychological, social or other areas o f daily life?'. The procedure for 
participation in the group interviews was planned meticulously. Patients as well as their care providers 
were selected explicitly on different characteristics, e.g. patients with SBS as well as with motility 
disorders. The eight m ost important subjects which emerged from the interviews were: bowel 
disturbances and metabolic complications, fatigue, sleeping disorders, anxiety, depressive disorders, 
social impairment, sexual functioning disorders, and care provider burden. We then looked for 
questionnaires to cover each o f these subjects (with the exception o f care provider burden) thus 
creating a set o f  questionnaires to measure the extent o f HPN-treatment-related problems (Table 1). 
The feasibility o f the questionnaire set was tested in two patients. These data were not included in the 
study. Based on the outcome, changes were made to the layout, introduction, and sequence o f 
questions.
INTERVIEWS
To address research question 2, all the respondents were interviewed at home. They were invited to 
describe in their own words any problems they were encountering due to H PN  dependence, with a 
maximum o f three. A  problem was defined as an 'unwanted negative influence on daily life'.
D a t a  c o l l e c t io n
The written questionnaires were sent by mail to all the participants 10 days before the interview. 
Completion o f  the set took 45-75 min. The interviewer collected the responses during the interview at 
home. Data verification against the medical records was only conducted to check the medical 
diagnoses. Two research assistants carried out the interviews.
D a t a  a n a l y s is
Data from the questionnaires were analysed descriptively. Correlations were calculated between 
patient characteristics and the presence o f  problems. Pearson's correlation, Spearman, t-test or M ann-
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Whitney were used where appropriate. Correlations were considered to be statistically significant at a 
cut-point o f  0.05.
Content analysis, a procedure to quantify communication material, was used to analyse the interviews. 
The problems reported by the respondents were listed in categories and quantified.
Table 1 Set of questionnaires
Topic Instrument +  references Information
Patient characteristics
General characteristics - 12 items
HPN-related - 6 items
characteristics
Quality o f life Cantril's Ladder: 16 - 1-item questionnaire on a visual analogue scale
Health related Sickness Impact Profile (SIP68): 17-18 - 48 dichotomous questions, 6 subscales
functioning - validated in various populations
Coping strategy Utrecht’s Coping List (UCL): 19-20 - assesses the coping strategy when problems are met 
in daily life
- 47 item questionnaire, 7 subscales
- validated in various populations
Health Locus o f control Multidimensional health locus of - measures the extent to which individuals believe that
control scale: 21-22 their health is the result o f their own actions 
(internally oriented), the medical doctor, or o f 
chance or fate 
- 9 items
Extent of problems
Bowel disturbances and - 18 items
metabolic complications
Fatigue Fatigue Severity, subscale o f the - 8 items, score 8-56
Checklist Individual Strength (CIS): - clinically severe fatigue present when score >  35
23-25 - validated in various populations
Quality o f sleep Subjective Sleep Quality Scale 
(SSQS): 26
- 15 dichotomous items, score 0-15
Anxiety State-Trait Anxiety Inventory - consists o f two subscales:
(STAI): 27-28 - anxiety state refers to the state o f anxiety at the time 
o f the test
- anxiety trait reflects the predisposition o f a person 
towards anxiety as a more stable line o f anxious 
feelings in general
- both scales comprise 20 items; score 20-80
- the STAI was tested in various groups and reliability 
is high
Depression Beck Depression Inventory-21 - focuses on a negative attitude o f a patient towards
(BDI): 29 him or herself
- only the 14 psychological items; score 0-42
- a total score o f 0 to 3 represents no depression, 4 to 
13 represents depression, 14 to 42 represents severe 
depression
Social Impairment Social Behaviour, subscale o f the 
sickness impact profile (SIP68): 17-18
- 12 items, dichotomous
Sexual disorders - 3 items
R esu lts
The response rate was 76% (n=48). N o differences in gender, age, duration o f  H PN  therapy and the 
indication for H PN  were found between the respondents and the patients who refused to participate.
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Q u e s t io n n a ir e : p a t ie n t  c h a r a c t e r is t ic s
General patient characteristics are presented in Table 2. Mean age was 52 years, about 2 /3  o f  the 
patients were women, 19% were employed, 29% had a stoma, 27% could 'eat and drink just a little', 
and 46% had one or more comorbid diseases besides the indication for H PN  treatment. The 
respondents’ mean Quality o f  life was 6.2% and 35% o f the group scored below 6.
Table 2 General patient characteristics (n=48)
Characteristics
Mean age, years 52
- Range, years 29-82
Women, % 65
Married/cohabiting, % 83
Mean quality o f life 1 6.2
- below 6, % 35
Education, in %:
- Primary education 31
- Secondary education 52
- Higher education 17
Employed, % 19
Underlying disease, %:
- Mesenteric thrombosis 38
- Crohn's disease 25
- Adhesions 10
- Neuropathology 8
- Radiation enteritis 8
- Volvulus 4
- CIIP* 2
- Others 5
Disease history before HPN:
% acute (versus % chronic) 48
Comorbidity, % 2) 46
Stoma, % 29
Able to eat and drink ‘just a little’, % 3) 27
Medication, in %:
- Acid suppression 65
- Analgesics 38
- Diarrhoea inhibitors 33
- Sedative drugs 31
- Antidepressive drugs 8
1) Score 0-10, where 10 represents best possible quality o f life.
2) Percentage o f patients who have other types o f disease besides the indication for HPN.
3) Patients were asked whether they were able to eat and drink normal quantities or just a little.
* CIIP =  chronic ideopatic intestinal pseudo-obstruction
The mean number o f years on H PN  treatment was 4.6, with a mean frequency o f 5 days a week and a 
mean o f  12.4 hours a day (Table 3). On average, the respondents had been admitted to hospital due to 
catheter problems 1.6 times in the past year; 38% o f the patients had not been admitted at all.
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Table 3 HPN-related characteristics (n=48)
Characteristics
Years on HPN*, mean (range) 4.6 (0.1-19.0)
Hours HPN*/day, mean (range) 12.4 (4-24)
Days on HPN*/week, mean (range) 5 (2-7)
Type o f catheter:
Port-a-cath(PAC), % 43
Long line(LL), % 34
Shunt (in combination with LL or PAC), % 23
Indication HPN: SBS*(vs motility disorder), % 71
Hospital admission due to catheter problems in the past year:
Number o f admissions, mean (range) 1.6 (0-7)
No admissions in the past year, % 38
If admitted (n=30): number o f days, mode (range) 16 (1-240)
* SBS= Short Bowel Syndrome
Table 4 shows the health status o f the patients (SIP-68). Raised levels were found on the subscales 
Social Behaviour and Emotional Stability, which were comparable with cerebrovascular accident 
(CVA) patients.18 Coping strategies are presented in Table 4: when faced with a problem in daily life, 
the H PN  group was less active in solving problems than the healthy Dutch population. However, the 
H PN  group was less absorbed by a problem, generated more optimistic thoughts when meeting a 
problem in daily life, and sought more comfort and understanding from other people.19 The results on 
the health locus o f  control scale did not indicate any specific orientation towards own strength, 
medical doctor or chance or fate (Table 4).21
Table 4 Health-related functioning, coping strategy and locus of control (n=48)
mean sd
Health-related functioning (range) 1)
Somatic autonomy (0-17) 1.5 3.1
Mobility control (0-12) 3.3 3.3
Psychological autonomy and communication (0-11) 1.5 2.2
Social behaviour (0-12) 5.5 3.2
Emotional stability (0-6) 1.4 1.6
Mobility range (0-10) 2.2 2.5
Sumscore (0-68) 15.3 11.3
Coping strategy (range) 2)
Active (7-28) 17.5 4.7
Palliative (18-32) 17.1 3.3
Avoiding (18-32) 15.9 4.1
Social (6-24) 12.4 4.2
Passive (7-28) 11.7 3.6
Expressive (3-12) 6.2 1.7
Encouraging (5-20) 13.0 3.0
Health locus of control/H LC (range) 3)
Internally-oriented (1-5) 3.5 0.9
Medical-doctor-oriented (1-5) 3.2 0.7
Fate-oriented (1-5) 3.1 1.1
1) higher scores indicates more health-related problems.
2) Higher scores indicate more inclination to cope in this particular way.
3) More belief in one type o f orientation corresponds with lower scores.
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Q u e s t io n n a ir e : e x t e n t  o f  p r o b l e m s
Responses to the set o f  questionnaires showed a multitude o f  problems related to bowel disturbances 
and metabolic complications (Table 5).
Table 5 Bowel disturbances and metabolic complications (n=48)
Presence (%) Severity 1) Due to H P N  2) (%)
Fatigue 90 2.5 21
Diarrhoea 90 2.9 0
Feeling cold 85 1.5 17
Dry mouth 75 0.8 27
Cramp in hands/feet 73 0.8 31
Nocturia 63 1.7 77
Sleeping disorders 60 1.7 31
Abdominal cramp 60 1,4 13
Feeling warm/hot 56 2.5 33
Nausea 54 1,4 35
Bad smell (faeces) 54 1,6 27
Vomiting 50 1,1 13
Flatulence 46 1.0 5
Palpitations 40 1.4 32
Bad taste 40 2.1 37
Bad smell (nutrition fluid) 38 0.8 95
Faecal incontinence 38 0.7 6
Headaches 33 1.0 19
1) Range 0-4, 0 indicates no problems and 4 indicates severe problems.
2) When a symptom was present, respondents could indicate whether this symptom was due to the Home Parenteral
Nutrition (HPN), the underlying disease or both. Only scores due to HPN are given.
Several symptoms were present simultaneously, e.g. fatigue (90%), diarrhoea (90%), feeling cold 
(85%), having a dry mouth (75%), and cramp in hand and feet (73%). Diarrhoea and fatigue were 
reported to be the m ost disturbing symptoms in daily life. Patients mostly attributed the symptoms to 
the underlying disease; only about 15—35% o f the symptoms were side effects o f the H PN  treatment. 
Severe tiredness was reported by 63% o f the respondents (Table 6). The mean fatigue score o f  39.6 
(on a scale from 8 to 56; SD  =  16:1) was higher than that in healthy subjects or patients with 
Functional Bowel Disorder or CVA and corresponded with tiredness in patients with Multiple 
Sclerosis.22,23 o n  average, more sleeping disorders (Table 6) were present than in the general Dutch 
population.24 Surprisingly, anxiety levels in the H PN  group (Table 6) matched those in the general 
Dutch population.26 N o depressive disorders were present in 35% o f the group; 65% had depressive 
disorders, 17% o f which were severe (Table 6). Only 1/3  o f the patients whose score indicated severe 
depression were using anti-depressant drugs. One-third o f  the group stated that their sexual activities 
had decreased due to H PN  (Table 6). About half o f  the respondents experienced social impairment in 
various social activities (Table 6).
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Table 6 Fatigue, sleep, depression, sleeping disorders, and sexual impairment (n=48)
Questionnaire
Fatigue Severity/CIS* %
No or mild fatigue 37
Severe fatigue 63
Sleeping d isorders/SSQ S* (range) 1) mean sd *
Quality o f sleep (1-15) 8.0 4.3
A nxiety/STA I* (range) 2) mean sd *
Anxiety at present (state) (20-80) 40.4 12.0
Anxiety in general (trait) (20-80) 39.3 10.8
Depressive d isorders/B D I* %
No depression 35
Depression 48
Severe depression 17
Social behaviour/SIP* %
Impairment in social behaviour 55
Sexual disorders %
Diminished sexual interest 31
Not possible to relax due to HPN* 13
Sexual functioning has decreased due to HPN* 31
1 Lower scores indicate more severe sleeping disorders.
2) Higher scores indicate greater anxiety.
*  CIS =  Checklist Individual Strength; sd =  standard deviation; SSQS =  Subjective Sleep Quality Scale; STAI =  State-Trait 
Anxiety Inventory; BDI =  Beck Depression Inventory; SIP =  Sickness Impact Profile-68 
HPN =  Home Parenteral Nutrition
We also analysed the relationship between the problems encountered and patient characteristics. Low 
quality o f life was strongly related (P<0.02) with greater fatigue (r=-0.52), more frequent sleeping 
disorders (r=-0.35), higher anxiety (anxiety state r=-0.43), anxiety trait r=-0.63), more severe 
depression (r=-0.58), and greater social impairment (r=-0.3). More tiredness was statistically 
significantly related with passive coping strategies (r=0.5) and believing that good health is determined 
by fate (r=-0.7). More frequent sleeping disorders were related with gender (the women slept less well 
than the men: mean 10.5 versus 6.7). Higher anxiety was also related to gender (the women were more 
anxious than the men) and to younger age (r=-0.3), higher education, believing that good health is 
determined by the medical doctor (r=-0.4) or by fate (r=-0.3), and passive coping strategies (r=-0.4). 
Coping in an active way was statistically significantly related to less anxiety (r=-0.5). More severe 
depressive feelings were statistically significantly correlated with younger age (r=-0.3), higher 
education, the opinion that good health is determined by fate (r=-0.3), coping in an active way 
(r=-0.5), and passive coping strategies (r=-0.4).
INTERVIEWS: p r o b le m s  in  d a i l y  l i f e
In the interviews, we asked the respondents which (three) problems they experienced due to H PN  
treatment. A  total o f  125 problems were reported: 74 problems had a psychosocial character, 30 had a 
somatic character and 21 were o f another type (Table 7). At least one psychosocial problem was 
reported by 92% o f the respondents, while 50% reported at least one somatic problem. Negative 
moods or feelings were mentioned most often among the psychosocial problems (46% o f all the 
respondents), in particular anxiety with regard to medical complications (31%). Other negative feelings 
(27%) were loneliness, anger, uselessness, incapability, lack o f understanding from others, and feeling
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ill. Furthermore, lack o f freedom was reported frequently (29%), especially being bound to the pump 
and housebound. Limitations in social life (21%), being dependent on others and the H PN  (19%) 
were also reported.
The two most frequently reported somatic symptoms were fatigue (17%) and not being able to eat and 
drink like other people (13%). Strictly speaking, the latter symptom was not due to the H PN  
treatment, but due to the underlying disease.
Table 7 Problems due to H P N  reported in the interviews (n=48)
number of 
problems
%
respondents 1)
type of problem 2)
Negative moods & feelings 22 46 One or more o f these psychosocial
- e.g.: anxiety 15 31 problems: 92% o f the respondents (n=44)
Lack of freedom 14 29
Social limitations 10 21
Being dependent 9 19
Problems related to holidays 5 10
Unable to work 4 8
Medical ambience at home 4 8
Subtotal 74
Fatigue 8 17 One or more o f these somatic problems:
Unable to eat or drink3) 6 13 50% o f the respondents (n=24)
Metabolic symptoms 4 8
Problems with mobility 4 8
Diarrhoea 3 6
General malaise 3 6
Sleeping disorders 2 4
Subtotal 30
Problems with care providers 8 17 One or more o f those other types of
Connecting the HPN infusion bag 4 8 problem: 33% o f the respondents (n=16)
Problems related to the pump 3 6
Financial limitations 2 4
Others 4 8
Subtotal 21
Total 125
1) Respondents formulated a maximum of 3 problems in their own words.
2) Afterwards, the problems were classified into one o f the three types o f problem.
3) This type o f problem was not due to HPN, but to the underlying disease.
D iscu ssio n
In the interviews, the respondents primarily reported psychosocial problems due to H P N  dependence, 
such as negative changes in moods and feelings (including anxiety for serious medical complications), 
lack o f  freedom, limitations in social life and being dependent. The questionnaire set showed multiple 
physical symptoms, which the patients believed were mostly due to the underlying disease. The 
respondents were severely fatigued (63%), had sleeping disorders, were (severely) depressed (65%), 
were socially impaired (55%), and had sexual disorders (33%). Low quality o f life was related with 
fatigue, sleeping disorders, anxiety, depression, and social impairment (P<0.02).
In our study, many more psychosocial problems were reported than in the literature. This was most 
probably due to our meticulous data collection method. Firstly, we conducted a pilot study in which 
we identified the important themes and secondly, we combined the techniques o f  questionnaires and
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interviews. This combination enabled us to form a more complete impression o f the H PN  group than 
previous studies. Particularly, the fact that this was the first study that used open interviews in this 
patient group may explain our results. Given the fairly high response rate and the non-selective non­
response, we think that the results o f  our study can be generalised to all HPN-dependent patients in 
the Netherlands. When generalising the results from our study to the American and European 
situation, it should be kept in mind that in the Netherlands, H PN  is not indicated for cachexia 
secondary to cancer or A ID S as it is in some other countries.1
In comparing our results to the results o f  Van G ossum  et al.,30 a difference is found in the percentage 
o f  patients that have a full-time or part-time job. The European survey shows an employment 
percentage o f 68%, while we found a percentage o f 19%. As the populations in the studies do not 
differ on factors that may influence employment, e.g. age, underlying disease and duration o f HPN, 
this large difference can only be explained by two differences between the Netherlands and other 
European countries. Firstly, the percentage o f women with a full-time or part-time job is low in the 
Netherlands, compared to other European countries. As 65% o f our population is female, this will 
result in a relatively high percentage o f unemployment, regardless o f H PN  dependence. Secondly, the 
social security system in the Netherlands is comprehensive. In the past, people who were ill and only 
capable o f  a partial appointment, were declared unfit for work and received a disability pension much 
more often than in other European countries.
Two limitations are apparent in our study. First, due to our cross-sectional design, we cannot draw any 
conclusions about the causality between quality o f life and psychosocial problems. Secondly, we did 
not focus on positive factors to explain how problems were managed in the past. Prior to developing 
interventions, it may be relevant to interview patients on how to cope successfully with a far reaching 
treatment such as HPN.
Nutrition support teams face great challenges to address the above-described psychosocial problems 
in HPN-dependent patients. A  specific psychosocial assessment tool is needed that can unravel the 
association between somatic and psychosocial aspects, because different types o f intervention might 
be necessary. An example is the lack o f  freedom experienced by patients caused by shortcomings o f 
the pump, embarrassment towards showing up with a pump, or incomprehension o f acquaintances. It 
was noteworthy that no relation was found between psychosocial problems and the number o f 
admissions to hospital. Therefore, we can conclude that patients who are not admitted regularly are 
suffering to the same extent, which implies that all patients should be assessed. It was also noteworthy 
that no relation was found between psychosocial problems and the duration o f  H PN  treatment. 
Consequently, psychosocial assessment is necessary at regular intervals throughout the years.
To improve quality o f life it is important to focus on fatigue, sleeping disorders, anxiety, depression, 
and social impairment. In our H PN  group, the anxiety levels measured by the questionnaire matched 
those in the general Dutch population. Conversely, one-third o f  the group mentioned anxiety as the 
main problem in the interviews, especially anxiety about the risk o f serious medical complications. 
Apparently, the State-Trait Anxiety Inventory was not sensitive enough to measure this type o f 
anxiety. It can be concluded that reducing medical complications will help to prevent anxiety. An 
impressive proportion o f two-third o f  our H PN  group had depressive disorders according to the 14 
psychological items o f  the Beck Depression Inventory (BDI), 17% o f which were severe. However,
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overestimation is a serious validation problem when using the BDI in a patient group that may have 
depression associated with the medical illness. Kathol et al.31 concluded that the BDI only screens 
patients at risk for major depression, but does not diagnose depression. In the interviews, depression 
was not reported as such, but statements were made by almost half o f the HPN group that 
demonstrated the respondent's negative attitude towards him or herself (Table 7). Therefore, we 
believe that depression is a major risk in HPN patients and should be studied in more detail by 
individual assessment. Various therapies, such as anti-depressant medication, psychosocial support 
and cognitive training, could be offered and the results monitored over time. In the study of Smith et 
al.14 it was interesting that interactive and videotaped educational interventions successfully reduced 
infection, rehospitalisation and reactive depression.
In conclusion, despite the fact that HPN-dependent patients experience many somatic symptoms, 
psychosocial problems were primarily reported as having the greatest impact on daily life. Therefore, 
to improve quality o f life, HPN teams should assess somatic as well as psychosocial aspects standard. 
Moreover, given the large proportion of patients with depressive disorders, therapies such as anti­
depressant medication, psychosocial support and cognitive training, should be offered.
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Abstract
BACKGROUND: Home parenteral nutrition (HPN) is offered to patients who are unable to absorb 
sufficient nourishment from normal oral food intake or tube feeding. Major causes include severe 
motility disorders and limited resorption surface in the small intestine. HPN is a lifesaving therapy but 
has severe consequences on daily life. The aim o f this study was to make an inventory of the problems 
experienced by patients receiving HPN.
METHODS: Open interviews were held with 48 patients from the 2 major centres for HPN in the 
Netherlands, centred around the question: Which 3 HPN problems have the most severe impact on 
your daily life? Data were analysed using content analysis.
RESULTS: The respondents mentioned 7 central problems: negative emotions, physical problems, 
social limitations, dependence on others, incapability, complications, and "patient-care provider 
problems. In addition, practical problems were mentioned: sleeping problems, financial problems, and 
the "hospital atmosphere" at home. The latter issues formed less o f a problem for the patients. 
CONCLUSION: The main underlying elements in the lives o f many HPN patients appeared to be loss, 
longing, and grief. In contrast, a smaller proportion o f the patients expressed that they had clearly 
adapted to life with HPN. By means of the HPN, they were still alive and enjoying all the things they 
could still do.
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Introduction
Home parenteral nutrition (HPN) is a lifesaving therapy. Since 1968, it has developed from a rare and 
complicated clinical treatment into a routine therapy that can be applied at all hospitals and even at 
home. The patient group receiving HPN is small but growing steadily. In the Netherlands, this 
concerns about 100 patients in a country o f 17 million inhabitants.
HPN is indicated in the case of gastrointestinal failure due to either loss o f absorption area or motility 
disorders. Generally, HPN is administered at night over a period o f about 12 hours. Patients feed 
themselves 2—7 times per week, depending on their nutrition needs. A proportion o f patients can also 
cope with oral nutrition, but they are unable to derive sufficient quantities o f nutrients from it.
HPN involves a heavy physical and mental burden on the patient, and it also may have considerable 
consequences on daily life.1 In the literature on the influence of HPN on daily life, attention has 
mainly focused on the administration system and potential metabolic and septic complications. Until 
now, few qualitative studies about the consequences o f HPN are carried out.
A small number of studies used a questionnaire to investigate the influence of HPN on daily life. The 
results showed that HPN patients had a lower quality o f life than dialysis patients and patients with 
short bowel syndrome without indications for HPN. HPN patients had anxiety, depression, pain, 
stress, anger, negative self-image, low self-confidence, loss o f control, mobility problems, low vitality, 
and sleeping problems.1-4
Van Reeuwijk-Werkhorst5 discovered a bottleneck in the psychosocial care o f HPN patients: too little 
attention is paid to the fact that a proportion o f the patients cannot eat solid food. This has serious 
consequences on social activities like leisure, vacation, and hobbies. These problems are also 
recognised by Dutch care providers. In the Netherlands, 2 university medical centres have nutrition 
teams who provide support for HPN patients: Radboud University Nijmegen Medical Centre and the 
Academic Medical Centre Amsterdam. Major tasks for the nutrition teams include keeping the patient 
in optimal physical condition, prevention and treatment o f complications, and instructing the patient. 
Despite the fact that attention is given to psychosocial problems, patients mention serious problems in 
this field.
It can be concluded, therefore, that the literature and daily practice show clear indications o f problems 
in HPN patients. Until now, these problems have been insufficiently mapped, which means that no 
structural therapeutic measures can be taken.
The aim of this study was to gain insight into the problems experienced by HPN patients. Therefore, 
we conducted open structured interviews with the following central study question: What is the nature 
and context o f the problems experienced by patients as a result o f receiving HPN in the home 
situation?
M ethods
Interviews were held to obtain data for this inventorial study. Our questions were open ended, but 
there was structure in the conversation line. The interviews were centred around the problems 
experienced by patients in their daily lives as a result o f having to live with HPN.
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St u d y  p o p u l a t io n / in t e r v ie w e e s
The study population comprised adult patients who were receiving HPN at home in the period from 
February to July 2003. Patients under supervision o f the Radboud University Nijmegen Medical 
Centre or the Academic Medical Centre Amsterdam were invited to participate. At the time o f this 
study, 68 patients were under treatment at the 2 hospitals. This represented about 75% o f all the adult 
patients receiving HPN in the Netherlands. We excluded 5 patients with insufficient knowledge of the 
Dutch language and patients younger than 18 years; children receiving HPN will experience different 
problems.
Therefore, we invited 63 patients to participate, and 48 of them agreed to be interviewed (76%). No 
differences in gender, age, duration of HPN, and underlying disease (acute or chronic) were found 
between the groups o f responders and nonresponders.6 Table 1 shows the patient characteristics.
The Medical Ethics Committee of the Radboud University Nijmegen Medical Centre gave permission 
to conduct this study. Patients received a written invitation to participate, and the respondents signed 
an informed consent form.
Table 1 Patient characteristics
Total (n=48)
Mean age in y (range) 52 (29-82)
Percentage o f women 65
Married or living together, % 83
Patients with paid employment, % 19
Underlying disease, %
Mesenteric thrombosis 38
Crohn’s disease 25
Adhesions 10
N europ athology 8
Radiation enteritis 8
Volvulus 4
Chronic intestinal idiopathic pseudo-obstruction (CIIP) 2
other 5
Mean duration o f HPN, years (range) 4.6 (0.1-19.0)
Mean number o f days o f HPN per week (range) 5 (2-7)
Mean hours receiving HPN/day (range) 12.4 (4-24)
No. o f patients who could not eat and drink or could only manage a few swallows o f fluid, % 27
Type o f infusion line
Port-a-Cath (PAC), % 43
Central venous catheter (CVC), % 34
Shunt, % 23
Percentage o f patients hospitalised in past year due to line problems 62
Mean number o f admissions in past year (range) 1.6 (0-7)
D a t a  c o l l e c t io n
Data were collected during single interviews at the patients’ homes. An open design was chosen for 
the interviews.
Two interviewers were involved in this study. Each patient was interviewed by 1 interviewer, and 
mean interview duration was 1 hour. In order to standardise the interviews, each patient was asked the 
same questions in the same order (Table 2). They were asked to state which 3 problems formed the 
heaviest burden in their daily life with HPN. Per problem, information was obtained about the
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meaning and content, severity, and cause according to all patients. Moreover, to develop a comparable 
and consistent interview style, at 6 out o f the 48 interviews, the second interviewer was present and 
these interviews were evaluated.
Table 2 Interview questions 
Questions
Which 3 problems form the heaviest burden in your daily life with HPN?
Can you tell me what the meaning and content o f these problems are?
Can you tell me what the severity o f these problems is?
Can you tell me what the cause o f these problems is?
RELIABILITY AND VALIDITY
To increase the reliability o f the data, questions were asked during the interviews. In addition, 
summaries or rephrasing of the patient’s words were read back to the patient for confirmation at 
various intervals.7 The notes taken by the interviewer were also read back to the patient to confirm 
their accuracy. Additionally, tape recordings were made o f 2 interviews per interviewer (n=4). A third 
researcher evaluated these tape recordings, and good agreement was found between the notes taken 
by the 2 interviewers and the patients' words. To increase reliability in terms o f checking back, we 
aimed to adhere as closely as possible to the patients’ words in the reports, for example, by quoting 
their exact words in this article. To verify the quality of the interpretations, use was made of peer 
debriefing (i.e., interpretations were checked by colleague researchers).
Validity within a research project firstly concerns the soundness o f the data that have been collected.8 
The positive reactions of the respondents contributed to the validity o f the data obtained. During the 
interviews, the patients were able to talk about themselves, and they were listened to very closely. A 
number o f respondents mentioned explicitly that they had found this very pleasant.
To help achieve internal validity, 2 measures were taken. First, methodological memos were made 
about methodological qualities, doubts, ideas, and interpretations to support memories and the 
analyses. Second, we used peer examination (i.e., the quality o f the data analysis and preliminary results 
were evaluated critically by an independent researcher, and the same conclusions were drawn).
The participation rate in this study was high and covered about two-third of all the patients receiving 
HPN in the Netherlands.
A n a l y s is  o f  t h e  in t e r v ie w s
Content analysis was performed on the data obtained during the interviews. This technique allows 
statements to be made about communicative messages according to objective and systematic analysis.8 
In this way, the answers to the open questions gained structure.9 The notes made by the interviewers 
were typed out in full. The text was then divided into segments, and each segment was given a code. 
To assign a code, we adhered as closely as possible to the literal words o f the respondent. Two 
researchers checked the codes o f 15 interviews. Codes were then grouped to derive central notions. 
These central notions were worked out further, and we explored whether there were underlying 
relationships between these notions. The computer programme Atlas.ti 4.2 (Technical University, 
Berlin, Germany) was used for data management and analysis o f the textual data.
58 Chapter 4
Furthermore, frequencies o f the central notions were counted with the programme Microsoft Excel to 
give percentages o f respondents who mentioned each particular central notion.
Results
The results o f this study are presented in light o f the main problems that emerged during content 
analysis o f the interview data. The main problems are described in sequence of severity experienced by 
the patients. Each problem is accompanied by a table that lists all the relevant quotations. In addition, 
we describe underlying relationships between the problems.
N e g a t i v e  e m o t io n s
A negative emotion mentioned by one-third of the respondents was anxiety. In general, the 
respondents experienced this as a very severe problem (Table 3). In many cases, there was anxiety 
about the complications that can occur with the HPN. On one side, there was anxiety about 
complications related to the administration system, such as infections or obstruction of the catheter. 
Sometimes a new catheter had to be inserted, and this could also lead to complications. On the other 
side, there was anxiety about the complications related to the nutrition fluid itself, such as liver 
damage. Respondents were sometimes anxious about the need for venous puncture to administer the 
HPN.
Some respondents always stayed at home when they were receiving HPN because they were afraid of 
potential complications. This also affected holidays.
The future held uncertainty and anxiety. Some o f the respondents mentioned that they were afraid of 
dying.
Other negative emotions that were experienced by almost half o f the respondents varied widely. 
However, these were regarded as moderately severe problems. Some respondents remarked that they 
felt as if they were on their own, despite the help they were receiving. They had to deal with 
disappointments, lack o f understanding from other people, and a shortage o f friends. This often led to 
grief and anger.
Some o f the respondents mentioned that they felt "like nothing", they had frustrations about their 
appearance, and one person said that his ego was suffering.
A number o f respondents sometimes felt left out or that they no longer counted. They were 
confronted by people who did all sorts o f things, and that was difficult.
A number of respondents had problems with the strongly compelling nature of their situation (e.g., 
"must" endure drip feeding because they would not survive without HPN). For many respondents, 
being compelled to "hook up" was unpleasant and a daily routine.
Respondents saw a connection between emotions and dependence. They expressed finding it terrible 
to be dependent, and they did not want to be a burden on others. Some of the respondents were 
anxious about becoming dependent. Respondents also saw a connection between emotions and social 
limitations. Some of them mentioned that they could no longer join socially; they felt locked up, and 
that caused them grief.
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T ab le  3 Q uotations
Main problems
Negative emotions 
1
2
3
4
6
Physical problems 
7
Social limitations 
10
11
12
Dependence
13
14
15
16
Incapability
17
18
Complications
19
Problems with care 
providers
20
Every day I'm afraid that the IV line will become blocked or that I'll get an infection or thrombosis. 
I've had so many new lines.
HPN causes liver damage. But I also need HPN. I have to be careful not to see the HPN as my 
enemy. Without HPN I can't survive, but I won’t survive either with liver damage.
I am frightened o f the needle in my body.
I am afraid o f complications with the catheter. I am afraid that I will be left on my own. Afraid that 
one day it will be the end; I am afraid o f dying.
It is an awful letdown when I look in the mirror. My battered body means that I am frustrated about 
how I look. There are so many clothes I can’t wear: I can’t wear a skirt any more, and I have to wear 
something with a high collar.
I have less confidence in myself, forget lots more things. I tend to cry more easily and become angry 
at people around me. I find that terrible for others.
You get up and straight away feel that you want to lie down again. The tiredness ruins your whole life. 
I don't have any puff for anything; I am living like a potted plant. I am willing, but unable. Even the 
slightest things tire me out.
I feel like I have the flu. For years and years, day and night. Flu and tiredness is about the size o f it. I 
just feel more and more tired. In the summer and on holiday, you feel it the most. On days like that 
I’m quieter.
I have to feed for 18 hours at a time, and the nutrition bag is very heavy. This stops me moving 
around. I could hang the nutrition bag on the infusion pole, but it's really so big I can't walk around in 
the sitting room properly. I feel trapped in my own house.
I don't go anywhere anymore; I don't go out shopping or visit people. That's because I'm tired and 
too ill. On good days I sometimes go outside for a while. It's a piece o f life lost.
Going out can only be for a few hours a day and at certain times o f the day. I stay out for a maximum 
o f 3 to 4 hours. I plan everything and I can't do a lot; there is no spontaneity and that is awful.
In the beginning the problem was enormous, but I have got used to it now. Besides, I only have HPN
5 times a week at present instead o f 7, which means I have some evenings off.
Life revolves around the HPN, around me. You can't go one day without HPN; that is a scary feeling. 
Without the HPN, I am no one.
Being dependent, you can't do anything any more. I always have to be home by four o'clock in the 
afternoon. It is no longer possible to make plans.
"Must" is the problem. Must hook up to the HPN; must get up in the morning to unhook even 
though you're tired. I want to be the one who decides when I get out o f bed, not the nutrition bag.
I would like to be able to do everything myself, but I can't manage. That makes me so sad. I find it 
awful to be a burden on others, but I also feel bad that I can't do it myself any longer. I can't accept it.
I feel so useless. I would like to go out to work, to do something I'm good at, receive appreciation. I 
would also like to have more to offer my partner.
No longer being able to eat really gets me down. I miss the taste, the smell, and the enjoyment; it feels 
like an empty space. My social contacts are becoming less and less because I can't eat.
It's always serious and unexpected. They admit me to hospital and sometimes I get a new IV line. 
Then I have to regain confidence in the new line.
other problems 
21
It's always a different surgeon who places the intravenous line; they underestimate it. I think that's 
why I have so many infections. They make me wait ages for a new line, which means that I lose a lot 
o f weight and then that makes me ill.
I often have problems with the feeding pump. Time and time again the battery is flat, although it's 
been charged, and the ordinary batteries are often flat too. It makes me mad. The new pump is 
difficult to operate. On holiday, the pump broke down; that was a serious problem.
5
8
9
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PHYSICAL problems
Almost half o f the respondents remarked that physical complaints and limitations formed a problem 
(Table 4). In the majority o f cases, these problems were experienced as large and serious (Table 3).
The physical problems varied widely and were related to HPN or the underlying disease. In their 
heads, the respondents were capable o f a great deal, but not physically.
Table 4 Physical complaints and limitation of the H P N  patients
Physical Complaints Physical Limitations
Diarrhoea Mobility limitations caused by being hooked up to the nutrition bag, the
Fatigue heavy bag pack, the infusion pole, or difficulty with walking
Vomiting Limited strength
Nausea Physical limitations caused by fatigue and feeling ill
Tiredness
Urine incontinence
Cramp, particularly in the hands
General malaise
Respondents saw a connection between the physical problems and "being incapable" (e.g., no longer 
being able to cope with housekeeping due to mobility problems or fatigue) and also with 
complications that can occur during HPN ("feeling ill when the HPN is running in").
S o c ia l  l im it a t io n s
Almost half o f the respondents mentioned social limitations as one of their problems. A proportion of 
them experienced this as a very severe problem (Table 3).
Respondents felt that they were tied to the house when they were receiving HPN. They had to be 
home on time to hook up to the HPN, and afterwards they did not go out again. HPN took a long 
time, sometimes > 14 hours per day, and many o f the respondents had to hook up 5 times a week or 
more. Consequently, they missed all sorts o f social activities. They had not joined a club because they 
could not always keep appointments, and some of them paid fewer visits to their family or friends. 
Social contacts gradually diminished; respondents had fewer visits from family and friends.
As mentioned above, respondents saw a connection between physical problems and social limitations. 
There was also a connection with dependence. In some patients, the administration time of the HPN 
was long, or they were dependent on others to assist with the HPN, which limited the patients' social 
activities. Furthermore, respondents saw a connection between social limitations and no longer being 
capable of doing things; for example, not being able to eat, especially in patients with motility 
disorders o f the gut, meant limitations socially: they could not go out for a meal and were reluctant to 
invite other people. Respondents did not join clubs, because o f their physical limitations.
D e p e n d e n c e
Over one-fifth of the respondents remarked that they experienced their dependence as a problem 
(Table 3).
The respondents felt dependent in a number o f respects. First, they felt dependent on the HPN: 
without it they would not survive. Second, the respondents felt dependent on others. In many cases,
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this was the partner who had to help with the housekeeping or sometimes assist with the HPN. A 
proportion o f the respondents also required aid from third parties, such as (specialised) home help, 
nursing, or household help. Third, some of the respondents felt dependent in a practical respect. For 
example, they felt dependent on the pharmacy (respondents were "stuck at home all day when a 
delivery was due").
The dependence o f the respondents was experienced as a severe problem by the majority o f them. It 
was difficult to accept dependency. People wanted to "have their own hands on the reins". 
Respondents saw a connection between dependence, social limitations, and emotions. This 
connection is described in the corresponding notions.
INCAPABILITY
Incapability can be described as "not being able to do anything". One-third o f the respondents 
mentioned that they were experiencing this incapability, in their own words, "no longer being 
capable", as a problem (Table 3). The severity o f this problem varied between respondents. Several o f 
them said that the fact that they could no longer do a number o f things (such as eat or go to work) 
was really terrible.
In their heads, the respondents could still do many things, but in reality, they were incapable due to 
physical problems. These issues comprised working, social activities, housekeeping, and managing the 
HPN procedure.
Going on holiday was also a problem sometimes. Respondents could not always spend their holidays 
in the way they wanted. Some of them never went away, because o f the risk o f complications and 
because many care providers are not trained in HPN. When the respondents did go on holiday, this 
always required enormous organisation.
A small proportion o f the patients we interviewed were not able to eat and drink, and this was a 
serious problem. No longer being able to eat led to frustration. It was a difficult fact to live with. In 
addition to being a basic need, eating and drinking also are a social activity.
A proportion o f the respondents mentioned that after some time, they had been able to accept the 
fact that there were some things that they could no longer do. They were enjoying the things they 
were still able to do; they were adjusting their boundaries and indicated that they were pleased with the 
HPN because, without it, they would die.
As mentioned above, respondents saw a connection between incapability and physical problems. 
There was also a connection between incapability and social limitations, as described previously.
C o m p l ic a t io n s
One-fifth of the respondents said that the complications associated with HPN were a problem. In the 
majority o f patients, this was a moderate to severe problem (Table 3).
These problems included complications with HPN administration. Infections were relatively 
frequent,10 and one patient told us that he had received 3 new infusion lines within 5 months. Other 
complications mentioned by the respondents were liver disturbances, feeling unwell while the HPN 
was running in, and cramping in the hands.
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Complications were strongly related with the physical problems that the respondents had. In addition, 
complications were related with anxiety; respondents were afraid of having complications, sometimes 
due to their own knowledge and experience.
P r o b l e m s  w it h  c a r e  p r o v id e r s
A small proportion of the respondents mentioned problems with the care providers. These problems 
were regarded as being moderate to severe. This applied to a range o f care providers (Table 3).
For example, the site o f entry sometimes went wrong (e.g., on the chest just beneath the nipple), and 
the respondents indicated that the experience of the surgeon might play a role.
Sometimes respondents had to wait a long time for a new central venous line. Also, they were not 
always satisfied with the communication between doctors or hospitals. In some cases, the general 
practitioner lacked knowledge about HPN and showed little interest in it.
OTHER PROBLEMS
Other problems mentioned during the interviews included the medical atmosphere at home, financial 
problems, and sleeping problems, but these were not considered to be serious (Table 3).
Conclusions
Patients who were receiving HPN at home experienced many problems. These problems mainly had a 
psychosocial nature.
Seven problems played a central role in the daily lives o f HPN patients: negative emotions, physical 
problems, social limitations, dependence, incapability, complications and problems with care
providers. Problems like anxiety, fatigue, physical and social limitations are also seen in haemodialysis
11patients.
Patients had an ambivalent attitude toward the HPN treatment. On the one hand, life without HPN 
was impossible. They were pleased that HPN exists and that it was keeping them alive. On the other 
hand, living with HPN was difficult. It put a considerable burden on everyday life. Life with HPN 
meant limitations in physical, psychological, and social areas. Prospects for improvement or progress 
were usually absent.
A small proportion of the respondents said clearly that they had adapted to a life with HPN. They 
were particularly pleased that it was keeping them alive. Also, they were well aware of the limitations it 
was causing, but they had learned to enjoy the things they could still do.
The results o f this study partly confirm our study using a questionnaire in the same population.6 The 
results o f the written questionnaire showed clearly that patients receiving HPN have problems in 
physical, social, and emotional areas. Our verbal interviews with open questions provided insight into 
which problems were experienced as the heaviest burden. For example, in the written questionnaire 
study, many o f the patients complained of fatigue. The interviews demonstrated that the majority of 
patients did not experience fatigue as one of the largest problems in daily life. Also, the written 
questionnaire study found that the level o f anxiety in HPN patients was no higher than that in healthy 
Dutch people,12 whereas one-third o f the HPN patients told us during the interviews that anxiety was 
a severe problem. Apparently, the State-Trait Anxiety Inventory (STAI) was not sensitive enough to
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measure this type o f anxiety in the questionnaire.6 Last, it was clear from the written questionnaire 
study that many HPN patients had needed to give up work. In the interviews, only a small group of 
patients mentioned this as a problem. A possible explanation for this difference could be the fact that 
patients had to give up work because of the underlying disease and not just because of HPN.
The combination of questionnaires and interviews in this patient group gave a more complete picture 
than that obtained in previous studies and therefore seems to be a more valuable approach.
Our results also support those of Jeppesen et al.,1 who reported that HPN patients were experiencing 
many physical and psychological problems. Compared with patients with the short bowel syndrome 
without HPN and compared with kidney dialysis patients, HPN patients experience even more 
problems.
Problems that have been documented in other questionnaire surveys in HPN patients were anxiety, 
depression, pain, stress, urinary problems, loss o f control, decreased mobility, decreased energy, 
sleeping problems, financial problems, not being able to work, and problems with self-image and self- 
confidence.4,13 These problems were also mentioned by the respondents in our study.
In view of the high response rate, we assume that the results o f this study can be generalised to the 
total group o f HPN patients in the Netherlands.
By our method, we obtained a clear broad overview o f the problems experienced by patients receiving 
HPN. The underlying notions that came forward in the interviews were, in our opinion, loss, longing, 
and grief. These notions formed the main threads in the problems of the respondents. However, as 
we did not conduct deep-level interviews, we cannot be sure about the latter. More research is 
necessary to confirm these underlying notions.
Once care providers have gained greater insight into the problems experienced by HPN patients, they 
can improve their psychosocial care. Our interviews showed clearly that patients were experiencing 
many problems in their lives with HPN. The chronic nature of the underlying disease and the negative 
influence o f the treatment with HPN on daily life mean that professionals need to pay structural 
attention to the problems. Support to cope with these problems might lead to improvements in the 
situation. This support could comprise extensive periodical anamnesis by the HPN nurse, more 
coaching and guidance from an HPN nurse in cooperation with a psychologist or psychiatrist if this is 
indicated. Insight into the world o f the individual patient can contribute to meeting their existing 
needs.
Several studies describe interventions in chronically ill patients.14-18 An example of an intervention for 
HPN patients is interactive schooling, as described by Smith et al.14 They showed that by means of 
interactive schooling, depressive reactions can be prevented and the patient’s own capacity to solve 
problems is promoted. This intervention can also lead to fewer admissions to the hospital and a higher 
quality of life.14 The positive effect o f psychosocial interventions on quality of life is described in other 
studies, and these are most effective when incorporated into medical care.15-17 Most powerful and 
lasting psychosocial interventions are combinations o f education, coping skills like behavioural 
training and stress management, and emotional support required from trained health professionals, as 
well as family and friends.18
Research is necessary to develop psychosocial interventions for HPN patients and evaluate their 
effects.
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Abstract
BACKGROUND &  A im s : T h e  success o f  h om e parenteral nutrition (H P N ) program s is com p rom ised  
by com plication s o f  central ven ou s catheters (C V C s), such  as occlusions and b loo d stream  infections. 
W e p erfo rm ed  a retrospective analysis o f  com plication  rates o f  arteriovenous fistulae versus C V C s in 
patients on  long-term  H P N .
METHODS: D a ta  w ere collected fro m  127 consecutive patients w h o received H P N  betw een Jan u ary  
2000  and O cto b er  2006, com prisin g  344 access years o f  C V C s and 194 access years o f  arteriovenous 
fistulae. W e evaluated access-related  b lo o d stream  infection  and occlu sion  incidence rates (num ber o f  
com plication s per access year) u sin g  P o isso n -n o rm al regression  analysis. C om plication  incidence rate 
ratios w ere calculated by dividing com plication  incidence rates o f  C V C s by th ose  o f  arteriovenous 
fistulae, ad ju stin g  fo r  H P N  frequency, m edication  use , in fu sion  fluid com p ositio n , and underlying 
diseases.
RESULTS: B lo o d stream  infection  incidence rates w ere 0 .0 3 /y e ar  fo r arteriovenous fistulae, 1 .37 /y ear 
fo r  long-term  C V C s (Port-a-Caths and tunnelled catheters), and 3 .1 2 /y ear  fo r  short-term  C V C s 
(nontunnelled catheters). O cclu sion  incidence rates w ere 0 .6 0 /y e ar  fo r  arteriovenous fistulae, 
0 .3 5 /y e ar  fo r long-term  C V C s, and 0 .9 3 /y e ar  fo r  shortterm  C V C s. A d ju sted  incidence rate ratios o f  
long-term  C V C s over arteriovenous fistulae w ere 47 (95%  confidence interval, 19—117) fo r 
b loo d stream  infections and 0.53 (95%  confidence interval, 0 .31—0.89) fo r  occlusions.
CONCLUSIONS: T h e  occlu sion  incidence rate w as h igher fo r  arteriovenous fistulae than fo r  certain 
types o f  C V C s. T h e  incidence rate o f  the m o st serious access-related  com plication  (bloodstream  
infections) w as m uch  low er fo r  arteriovenous fistulae than fo r  all types o f  C V C s. T h u s, arteriovenous 
fistulae are safe  and valuable alternatives to C V C s fo r  patients requiring long-term  H P N .
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Introduction
In patients on long-term home parenteral nutrition (HPN), frequently occurring vascular access- 
related complications continue to result in multiple hospital admissions and, in the end, these 
problems pose the foremost threat to continuation of therapy. Surgically created arteriovenous fistulae 
were the first intravenous access to be used for the administration o f parenteral nutrition. However, 
with the development o f intravenous catheters in the 1970s, the use of arteriovenous fistulae for HPN 
administration became rare. Ever since, it has remained common practice worldwide to administer 
HPN by means o f central venous catheter (CVC) devices such as implantable subcutaneous ports 
(Port-a-Cath II [PAC], Smiths Medical MD, St Paul, MN) or externally (subcutaneously) tunnelled 
catheters. In addition, nontunnelled catheters are used for short-term total parenteral nutrition (TPN) 
administration, mostly during a hospital stay. The most frequent CVC-related complications are 
(potentially) life-threatening bloodstream infections and occlusions, both o f the catheter and o f the 
vessels wherein the catheter is located. O f note, the use of CVCs for total parenteral nutrition 
purposes has been recognised as an additional independent risk factor for the occurrence of catheter- 
related bloodstream infections.1-4 Therefore, when long-term HPN is required, a reliable vascular 
access with a low complication profile is mandatory.
From the start o f our HPN programme in the early 1970s, in addition to CVCs, we have used 
surgically created arteriovenous fistulae for vascular access in HPN care on a regular basis. Similar to 
the situation in patients on haemodialysis, this has mostly concerned arteriovenous fistulae 
constructed in the forearm or, less ideally, in the lower extremity. After a maturation period of 6 
weeks, these fistulae are usually available for self-puncture by the patient or his or her partner. Apart 
from a straightforward arteriovenous anastomosis, the fistulae may be created by the interposition of 
autologous venous, xenologous venous, or prosthetic material (arteriovenous graft). In 1983, our 
group reported on a series o f 7 patients using an arteriovenous fistula and concluded that these 
fistulae might be valuable alternatives for CVCs.5 However, the information in the literature on the 
use o f arteriovenous fistulae for this indication has remained anecdotal in the latest decades and solely 
concerns case reports or case series, with the largest series comprising only 17 patients.6-11 Recently, 
we have described our oldest patient who has been using HPN over an arteriovenous fistula for 32 
years without major complications in the last decades.12 Our impression that patients using 
arteriovenous fistulae for HPN administration do very well, in combination with the paucity of 
information from other sources, inspired us to re-evaluate the feasibility o f arteriovenous fistulae for 
long-term HPN administration and to perform a comprehensive retrospective analysis o f all our data 
on access-related bloodstream infection and occlusion incidence rates in our own long-term HPN 
population.
Patients and M ethods
P a t i e n t s
In the present investigation, we included all consecutive patients who were on long-term HPN 
between January 1st, 2000, and October 1st, 2006 (n=127), which comprises about 50% of all patients 
treated with HPN since the start o f our programme in the 1970s until October 2006. Our HPN team 
was reorganised in 2000, and from that time a focused team of HPN nurses started to document our
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HPN population in detail. Electronic patient files were also then introduced, enabling us to create a 
comprehensive database o f our HPN population. We did not include patients after October 2006, 
because then we started a successful trial evaluating antibiotic catheter lock therapy with taurolidine as 
an alternative to heparin.13 Including patients after 2006 would therefore induce bias because this new 
lock therapy was designed to counter complications.
O f the 127 included patients, 36 (28%) were already on HPN before January 2000. Excluding these 36 
patients or the accesses they used before the year 2000 would have introduced a considerable source 
o f selection bias. Therefore, and because all the necessary data for this study before January 2000 were 
available, we included these patients and all their accesses in our investigation.
Two independent reviewers reviewed the medical records o f all patients. In each patient, all vascular 
accesses placed for HPN purposes between the start o f HPN and October 1st, 2006, were analysed for 
complications. All data were entered in a database (Microsoft Access 2000; Microsoft Corp, 
Redmond, WA). In accordance with the European Society for Clinical Nutrition and Metabolism 
guidelines for parenteral nutrition, long-term HPN was defined as a requirement for TPN and/or 
intravenous fluid support for more than 3 months used in the home setting.
A c c e s s  c l e a n in g  p r o t o c o l s
In general, we pay much attention to aseptic procedures during our 1- to 2-week inpatient training 
period. Our access cleaning protocols are described in the following text in more detail.
For tunnelled and nontunnelled catheters, the catheter exit site is covered with a Tegaderm pad (3M 
Health Care, Neuss, Germany), which is replaced every 96 hours. The exit site is disinfected by 
circular movements from the exit site to the outer circumference. Every circle is disinfected with a 
new sterile swab. The first 10 cm o f the catheter is disinfected with a sterile swab and chlorhexidine in 
ethanol. After drying, the exit site is covered with a new Tegaderm pad. After 3 weeks, the catheter 
cuff o f tunnelled catheters has grown in the surrounding tissues and sutures for line fixation are 
removed. From then on, the exit site o f tunnelled catheters is no longer covered with a Tegaderm pad 
and is cleaned by daily washing with water and soap and drying with a clean towel. The nontunnelled 
catheters remain fixed with a suture and covered with a Tegaderm pad, which is replaced every 96 
hours, during the complete period of their use. Before TPN administration, the opening o f the 
infusion bag as well as the (non)tunnelled catheter hub is disinfected with chlorhexidine in ethanol. 
After drying, the infusion system is connected to the catheter hub.
For PACs and arteriovenous fistulae, after placement, the wound is covered with sterile compresses if 
necessary. Before HPN administration, the skin overlying the subcutaneous port is cleaned with 
chlorhexidine by the described circular movement method. After HPN administration, the puncture 
site is covered with a sterile compress for a few minutes until (minor) bleeding ends.
Independent of the access type, the patient's/caregiver's hands are washed and subsequently 
disinfected with chlorhexidine in ethanol before TPN administration or cleaning of the exit site or 
skin.
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A s s e s s m e n t  o f  v a s c u l a r  a c c e s s - r e l a t e d  b l o o d s t r e a m  i n f e c t i o n s  a n d  o c c l u s i o n s  
Vascular access-related bloodstream infections were defined by the presence o f symptoms (fever, 
chills) associated with positive blood cultures in the absence o f other evident infectious foci that likely 
could explain the bloodstream infection. Episodes with fever and/or chills without positive blood 
cultures were considered a bloodstream infection in case blood samples were drawn under antibiotic 
treatment or in case patients were showing signs o f sepsis (fever with cold chills, low blood pressure 
requiring intravenous fluid support, or oliguria) and other infectious foci that could explain the 
symptoms were excluded. If information could only be extracted from medical letters from referring 
hospitals, the vascular access was defined as being infected according to the criteria o f the referring 
hospital.
Concerning the occlusions, the time span of development (i.e., slowly [mainly due to precipitation of 
infused substrates] versus acute [mainly due to thrombus formation]) was frequently undocumented 
and ultrasonography or contrast venography was not always performed. In this retrospective study 
design, it was therefore impossible to distinguish thrombotic from nonthrombotic occlusions. For this 
reason, and in accordance with a large investigation on CVC-related complications performed by 
Bozetti et al.,14 we report overall occlusion rates.
Bloodstream infection and occlusion incidence rates (number of complications per access year) were 
calculated. Vascular accesses that were in situ but not used and therefore not likely at risk for 
complications, CVCs of which the exact type ([non]tunnelled or PAC) was not reported (defined as 
"unspecified CVCs"), and accesses with missing data concerning the precise utilisation period or the 
exact number o f complications during use were excluded from the analysis.
STATISTICAL ANALYSIS
We analysed the bloodstream infection and occlusion incidence rates using random effects models 
with Poisson distributions for counts. The random effects for patients were incorporated in the 
modelling process to account for repeated vascular access periods in patients. Based on biological and 
clinical rationales, possible confounders in the relation between access type and complication rate 
were identified and reported for each access (Table 1). Complication incidence rate ratios for CVCs 
over arteriovenous fistulae (i.e., the complication incidence rate that occurred with CVCs divided by 
those with arteriovenous fistulae) were calculated and adjusted for all these confounders using 
Poisson-normal regression analysis. The N LM IXED  procedure of SAS System for Windows version 
8.2 was used (SAS Institute Inc, Cary, NC). Statistical significance was accepted if the probability o f a 
type I error did not exceed 5%. To provide information about statistical significance, we reported 95% 
confidence intervals (CIs) where appropriate. We performed available case analysis because the 
number o f missing data was limited and the missing process could be considered to be at random.
Results
D e s c r ip t io n  o f  t h e  s t u d y  p o p u l a t io n
The studied HPN population comprised 127 consecutive patients (123 adults; 46 men). The mean (± 
SD) age at the start o f HPN was 46 (±15) years (range, 0.05-80 years). Sixty-three patients terminated 
HPN between 2000 and 2006 because of resumption of enteral feeding (n=35), small bowel
70 Chapter 5
transplantation (n=2), progressive liver failure (n=1), death (n=24; one following catheter sepsis and 
23 due to progression of the underlying diseases or other non-HPN-related causes), or unknown 
reasons (n=1). The median duration of HPN use, counted from the start o f HPN to termination or 
October 1st, 2006 (the end of the study period), was 2.1 years (range, 0.25-30.2 years).
Table 1 Overview of Confounders, Specified per Access Type
Tunnelled 
catheters (n=374)
PACs
(n=166)
Arteriovenous 
fistulae (n=62)
Nontunnelled 
catheters (n= 83)
Immune suppressive use
Yes 58 (16) 27 (16) 8 (13) 14 (17)
No 316 (84) 139 (84) 54 (87) 69 (83)
Anticoagulant use
Yes 204 (55) 98 (59) 58 (94) 59 (71)
No 169 (45) 68 (41) 4 (6) 23 (28)
Partly 1 (0.3) — — —
Unknown — — — 1 (1)
Underlying diseases
Possible coagulative state 47 (13) 56 (34) 17 (27) 29 (35)
Inflammatory 92 (24) 38 (23) 11 (18) 8 (10)
Other 235 (63) 72 (43) 34 (55) 46 (55)
Composition o f infusional fluid
Nutrition with fat 328 (88) 139 (84) 55 (89) 68 (82)
Fat-free nutrition 26 (7) 8 (5) 1 (2) 7 (8)
Nutrition with/without fat (both partly) 7 (2) 4 (2) — 1 (1)
Only fluids and electrolytes 13 (3) 15 (9) 6 (10) 6 (7)
Unknown — — — 1 (1)
HPN frequency (times/week)
1 3 (1) 4 (2) — 3 (4)
2 4 (1) 2 (1) 2 (3) —
3 18 (5) 22 (13) 16 (26) 2 (2)
4 31 (8) 19 (11) 6 (10) 3 (4)
5 32 (9) 21 (13) 11 (18) 3 (4)
6 32 (9) 19 (11) 5 (8) 5 (6)
7 251 (67) 76 (46) 22 (35) 64 (77)
Unknown 3 (1) 3 (2) — 3 (4)
NOTE. Distribution o f relevant confounders adjusted for in the analysis, presented as absolute number (%) o f accesses 
with a certain confounder status. Relevant confounders included medication use (immune suppressives or systemic 
anticoagulants), underlying disease and relevant comorbidities, the administration of nutrition (with or without lipids) 
versus solely fluids/electrolytes, and the frequency o f HPN administration (i.e., the frequency o f access puncture or use 
per week). Underlying diseases and comorbidities were divided into 3 categories: inflammatory diseases (mostly Crohn's 
disease and ulcerative colitis), diseases related to a possible procoagulative state (mesenteric thrombosis and patients with 
>2 pulmonary emboli and/or deep venous thromboses not directly related to CVC use), and "other" diseases (mostly 
patients with motility disorders, pancreatitis, enterocutaneous fistulae, and so on). PACs, Port-a-Cath II.
Indications for HPN in our population mainly were motility disorders (31%) and short-bowel 
syndrome (46%), the latter mostly related to inflammatory bowel disease or mesenteric thrombosis 
(Table 2).
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Table 2 Indications for long-term H PN
Indication__________________________________________________N=127
Motility disorder 39
Chronic Idiopathic Intestinal Pseudo-obstruction 9
Multiple adhesions 3
Sclerosing peritonitis 2
Sclerodermia 3
Slow transit obstipation 4
Neurogenic 3
Cause unknown 5
Other 10
H igh output stoma 11
Crohn’s disease 6
Ulcerative colitis 2
Resection; multiple adhesions 1
Resection; intestinal wall perforation 1
Mesenterial thrombosis 1
Short bowel 60
Mesenterial thrombosis 25
Crohn's disease 12
Other vascular/ischemia 9
Malignancy 3
Volvulus 4
Other 7
Inadequately absorbing intestinal surface 4
B-cell non-Hodgkin lymphoma 1
Amyloidosis 1
Radiation enteritis 2
Other 13
(high output) Enterocutaneous fistulae 5
Pancreatitis 5
Other 3
V a s c u l a r  a c c e s s e s
Complication rate analysis was performed with 194 arteriovenous fistulae access years and 344 CVC 
access years, represented by 62 arteriovenous fistulae and 623 CVCs. Table 3 presents the 836 vascular 
accesses that were created to administer HPN in our 127 patients (i.e., a median o f 5 accesses per 
patient [range, 1—24]) and the reasons to exclude some accesses from incidence rate analysis. 
Arteriovenous fistulae
Fifty-eight patients (46%) had at least one arteriovenous fistula created at some point during their 
HPN treatment. During maturation o f the fistula, these patients used a CVC. The median number of 
created arteriovenous fistulae in these 58 patients was 2 (range, 1—7). In each patient, usually multiple 
factors steer the decision to create an arteriovenous fistula for HPN administration. Clinically, the 
most important factor is whether intestinal failure is expected to be permanent and at least longer than 
1 year. Additionally, patient preference is essential and usually varies over time. From the perspective 
o f the patient, complications associated with CVC use are often critical. In 42 patients (72%), prior 
CVC-related complications occurred and importantly contributed to the decision for arteriovenous
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fistula creation. In 16 patients, fistula creation was performed independent of CVC-related 
complications. The median duration from the start o f HPN to the creation o f the first fistula was 10 
months (range, 0.0 —10.6 years).
In total, 120 arteriovenous fistulae were created (Table 3). O f these, 75 (63%) became functional; 6 
failed during their creation (4 immediate occlusions and 2 because of inappropriate vasculature) and 
39 failed during maturation (resulting from occlusion [32], inadequate maturation [2], wound infection 
[2], vascular steal phenomenon [1], or unspecified reasons [2]). We excluded 16 functional fistulae; 11 
fistulae were never used (because o f pain during puncturing [2], a preference to continue using a CVC 
after adequate maturing of the fistula [5], fistula maturing at the time o f analysis [1], and nonspecified 
reasons [3]) and for 5 arteriovenous fistulae the complication rate could not be fully ascertained. O f 
the 62 fistulae that were included in the incidence analysis, 32 were straightforward arteriovenous 
anastomoses and 30 were arteriovenous grafts (20 with autologous grafts, 2 with bovine grafts, and 8 
with Gore-Tex [Goremedical, Flagstaff, AZ] grafts).
Central venous catheters
Overall, 716 CVCs were placed. In total, 671 CVCs (94%) became functional (Table 3), which is a 
significantly higher proportion when compared with the arteriovenous fistulae (P<.001); the insertion 
o f 45 CVCs failed (due to vascular occlusion [24], malpositioning [8], failed punctures [6], and 
unspecified reasons [7]). O f these functional CVCs, 620 could be used to analyse bloodstream 
infection incidence rates and 623 could be used to analyze occlusion rates. Twenty-five and 23 CVCs 
were excluded because bloodstream infection or occlusion incidence rates, respectively, could not be 
fully ascertained and 26 were excluded because the exact CVC type was not reported (defined as 
"unspecified CVC" in Table 3). As a rule, catheters were single lumen and exclusively used for the 
administration o f parenteral nutrition. In rare cases (i.e., if multiple ports were essential for the 
management of the patient), multiple-lumen catheters were used. The catheter tips were mainly placed 
in the superior (86%) or inferior vena cava (9.6%) via insertion through the subclavian, internal 
jugular, axillary, cephalic, femoral, or greater saphenous veins. Incidentally, the CVC was even placed 
in an uncommon vein such as the vena ovarica (1 CVC) or directly in the right atrium via sternotomy 
(2 CVCs). In 4% o f the CVCs, the exact vessel used was not documented.
B l o o d s t r e a m  i n f e c t io n  a n d  o c c l u s io n  i n c i d e n c e  r a t e s
Table 4 presents the complication incidence rates. In total, 507 vascular access-related bloodstream 
infection episodes occurred. In 473 episodes (93%), blood cultures were positive. Eighteen episodes 
(4%) were counted based on information from referring hospitals without information about the 
results o f the blood cultures (11 episodes in tunnelled CVCs, 3 in PACs, 1 in arteriovenous fistulae, 
and 3 in nontunnelled CVCs). In 16 episodes (3%), blood cultures were negative but the episode was 
defined to be an access-related bloodstream infection because cultures were drawn under antibiotic 
treatment (6 in tunnelled CVCs, 2 in PACs, and 1 in nontunnelled CVCs) or patients were showing 
evident signs o f sepsis and other infectious foci that likely could explain the symptoms were excluded 
(3 episodes in tunnelled CVCs, 2 in PACs, and 2 in arteriovenous fistulae).
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Bloodstream infection incidence rates (number/access year) were 0.03/year for arteriovenous fistulae, 
1.79/year for tunnelled catheters, and 0.84/year for PACs (i.e., 1.37/ year for overall long-term 
CVCs).
Table 3 Created and analysed vascular accesses, per type of access in 127 patients on long-term HPN.
No. of 
patients1
Created 
access per 
type of 
access2
Failed creation/ 
maturation3
Functional
accesses, 
n (%) 4
Used5 Missing data 
exact number 
BSI/O C C 6
Missing data 
exact duration 
of use6
Included in 
BSI/OCC 
incidence 
analysis7
Access years 
analysed for 
BSI/OCC
AVF 58 120 6 / 3 9 75 (63) 64 0/0 2 62/62 194/194
Overall CVC 127 716 45/N A 671 (94) 671 14/8 31 620/623 343/344
Tunnelled catheter 109 412 30/NA 382 (93) 382 1/0 8 373/374 184/185
PAC 62 182 9/NA 173 (95) 173 3/3 7 166/166 151/151
Nontunnelled catheter 62 92 2/N A 90 (98) 90 5/3 7 81/83 8/8
Unspecified CVC8 19 30 4/N A 26 (87) 26 5/2 9 0/0 0/0
Total 127 836 90 746 735 14/8 33 682/685 537/538
PAC; Porth a Cath; BSI; blood stream infections; OCC; access or vascular occlusions; NA, not applicable.
1 Number o f patients with at least one created access per type o f access.
2 Includes failed creations/maturations.
3 Failed accesses per type o f access; a more detailed description o f failure reasons is presented in the text.
4 All created accesses that were technically usable for HPN administration.
5 Eleven functional arteriovenous fistulae were not used because o f reasons explained in the text.
6 Excluded accesses per type o f access due to incomplete follow-up data.
7 Remaining number o f accesses after exclusion o f accesses with missing data concerning the exact number o f complications and/or the exact utilisation interval.
8 Unspecified CVCs are CVCs o f which the exact type ([non-]tunnelled or PAQ was not reported.
Table 4 Bloodstream infection 
administration of TPN
and occlusion incidence rates and incidence rate ratio’s in CVCs compared with arteriovenous fistulae used for the
BSI
incidence ratea
Adjusted IRR 
CVCs/AVFb
Occlusion 
incidence ratea
Adjusted IRR 
CVCs/AVFb
Long-term TPN accesses
AVF 0.03 (0.01-0.06) 0.60 (0.43-0.84)
Overall long-term CVC 1.37 (1.14-1.66) 47 (19-117) 0.35 (1.27-0.47) 0.53 (0.31-0.89)
Tunnelled CVC 1.79 (1.47-2.18) 61 (25-150) 0.26 (0.24-0.37) 0.37 (0.21-0.67)
PAC 0.84 (0.64-1.09) 29 (12-73) 0.50 (0.36-0.70) 0.81 (0.45-1.45)
Short-term TPN access
Non tunnelled CVC 3.12 (2.04-4.78) 89 (33-237) 0.93 (0.48-1.80) 1.27 (0.55-2.94)
Bloodstream infection (BSI) and occlusion incidence rates (unadjusted for confounders) o f arteriovenous fistulae (AVF) and central venous catheters (CVCs) presented as
number o f BSI or occlusions per access year (95% Cl). 
b Bloodstream infection and occlusion incidence rate ratio’s (IRR) o f CVCs over arteriovenous fistulae adjusted for the confounders presented in table 1. 
Overall long-term CVCs indicate tunnelled catheters and PACs combined.
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For short-term CVCs (i.e., nontunnelled catheters), bloodstream infection rates were highest 
(3.12/year). The bloodstream infection incidence rate ratio, adjusted for confounders, o f overall long­
term CVCs over arteriovenous fistulae was 47 (95% CI, 19—117). Gore-Tex grafts were applied in 
13% of analyzed arteriovenous fistulae but 33% of the fistulae-related bloodstream infections (2 o f the 
6) occurred in Gore-Tex grafts, suggesting that the use o f artificial grafts is a risk factor for 
arteriovenous fistula-related bloodstream infections.
Organisms responsible for the CVC-related bloodstream infections were mainly gram-positive 
organisms (mainly Staphylococcus epidermidis and Staphylococcus aureus; 51% in tunnelled CVCs, 
68% in PACs, and 93% in nontunnelled CVCs). Less frequently, gram-negative organisms (40% in 
tunnelled CVCs, 28% in PACs, and 4% in nontunnelled CVCs) and fungi (9% in tunnelled CVCs, 4% 
in PACs, and 4% in nontunnelled CVCs) were cultured. In arteriovenous fistula-related bloodstream 
infections, 3 organisms were cultured (2 Staphylococcus aureus and 1 Candida albicans).
Occlusion rates were slightly lower in tunnelled CVCs (0.26/year) than in arteriovenous fistulae 
(0.60/year). Occlusion rates in PACs (0.50/year) did not significantly differ from arteriovenous 
fistula-related occlusion rates. In short-term (nontunnelled) CVCs, occlusion rates were highest 
(0.93/year). For overall long-term CVCs (tunnelled CVCs and PACs), the adjusted occlusion 
incidence rate ratio with respect to arteriovenous fistulae was 0.53 (95% CI, 0.31- 0.89).
D iscussion
Vascular access-related complications remain a major problem in patients on long-term HPN. In our 
patients, the incidence rate o f vascular access-related bloodstream infections was much lower during 
arteriovenous fistula use than during CVC use. The occlusion rate was slightly higher in arteriovenous 
fistulae, but only compared with certain types o f CVCs.
Our centre is the larger o f the 2 HPN centres in The Netherlands, and we take care of 60%-70% of 
the nationwide HPN population, which currently approximates 130 patients. The main indications for 
long-term HPN in our 127 analysed patients are in accordance with other studies. 15,16 The present 
study is by far the largest to evaluate the use o f surgically created arteriovenous fistulae as an 
alternative to CVCs in patients on long-term HPN.
The observed bloodstream infection rates in CVCs correspond with the rates reported in other 
studies, ranging from 0.17 to 2.19 episodes per year.1,17-22 In our study population, the arteriovenous 
fistula-related bloodstream infection rate was 0.03/year, which even in comparison with the lowest 
CVC-related bloodstream infection incidence rate reported in the literature constitutes a clinically 
relevant reduction. Therefore, also in other populations with lower bloodstream infection incidence 
rates, the conclusions and recommendations o f our study would remain unchanged. The lower 
bloodstream infection rate (up to 61 times lower) in arteriovenous fistulae in comparison with long­
term CVCs (PACs and tunnelled catheters) is in line with case reports or small case series that even 
describe a complete absence of infections related to arteriovenous fistula use in patients treated with 
HPN.8,10,11 The considerably lower bloodstream infection rate observed during arteriovenous fistula 
use is o f major importance because, in patients treated with HPN, bloodstream infection is the most 
frequent and most life-threatening catheter-related complication. In fact, 20%-50% of the causes o f 
death directly related to HPN are represented by catheter-related infections.19,23 In our population, the
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death of 1 patient was directly related to HPN treatment and was caused by an episode o f catheter 
sepsis. It can be argued that the incidence rate o f arteriovenous fistula-related bloodstream infection 
benefits from the fact that patients who have been using (multiple) CVCs before arteriovenous fistula 
creation have been better trained in aseptic techniques. However, all our patients who require long­
term HPN receive in-hospital training on aseptic vascular access care and proper HPN administration 
for 1-2 weeks. They are allowed to administer TPN at home only if they can satisfactorily care for 
their access. We therefore do not believe that a more extended access-care experience has skewed our 
results in that patients with an arteriovenous fistula have a better aseptic technique. We consider it 
more likely that the patients who eventually end up using an arteriovenous fistula represent a selection 
o f patients who are more vulnerable to infections. Improper access care, which more likely is a trait o f 
character that improbably will change with a switch to a fistula, might in fact be a factor that 
contributes to this risk.
Although based on a low number of arteriovenous fistula-related bloodstream infections (n=6), we 
observed a relatively high bloodstream infection rate with artificial Gore-Tex grafts; 33% of the 
arteriovenous fistula-related bloodstream infections occurred in Gore-Tex grafts, while only 13% of 
the arteriovenous fistulae were Gore-Tex grafts. Higher bloodstream infection rates in artificial grafts 
compared with autologous grafts have also been shown in patients on hemodialysis.24 Therefore, we 
propose that the artificial grafts, such as those constructed from Gore-Tex, might be more susceptible 
to bloodstream infections than the autologous grafts and that arteriovenous fistula-related 
bloodstream infection rates in patients receiving HPN can be decreased even further if only 
autologous grafts are used.
The main problem in arteriovenous fistulae is the risk of fistula occlusion. In our patients, 4 fistulae 
could not be created because o f immediate occlusion during surgery and 32 fistulae never matured 
because of early occlusion. However, once adequately matured, the occlusion incidence rate in the 
arteriovenous fistulae was only slightly higher than in tunnelled catheters, while it was not significantly 
different from the occlusion rate in PACs. In our study population, arteriovenous fistulae were mainly 
used in patients in whom CVCs repeatedly proved ineffective; in 72% o f the patients, prior CVC 
related complications decisively contributed to the decision for fistula creation. This might have 
contributed to the higher occlusion rates in arteriovenous fistulae with respect to CVCs because the 
prior insertion of multiple CVCs may damage the proximal vasculature and make fistula creation 
impossible or increase fistula occlusion rates due to an already compromised blood flow. This latter 
hypothesis can, however, only be proven in a prospective study in which detailed data on thrombotic 
clot localisation are correlated to prior catheter placements in the exact same vessels. Nevertheless, we 
propose that arteriovenous fistulae should be considered early, if not immediately, after the decision to 
start long-term HPN. Alternatively, we promote the use o f jugular instead o f subclavian veins to place 
CVCs, thus minimising the risk of obliteration of the venous circulation, which might be required for 
future creation o f an arteriovenous fistula.
The retrospective study design confers favourable as well as less favourable aspects. It caused a limited 
number of incomplete data concerning access use, the occurrence o f complications, and covariates. It 
is highly unlikely, however, that bias due to incomplete data has coloured our conclusions. We 
reviewed both the surgical and gastroenterological records as well as all letters from referring
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hospitals. In addition, to further increase the reliability o f data collection, 2 independent reviewers 
reviewed all medical records and differences in interpretation were evaluated until consensus could be 
reached. Eventually only a very small and in all likelihood random number o f accesses could not be 
included in the analysis due to lacking data (3% of arteriovenous fistulae and 7% o f CVCs). The 
retrospective study design of a study period of over 30 years was favourable because it enabled us to 
evaluate access-related complication incidences during more than 500 access years and to include a 
large cohort o f unselected patients on long-term HPN. We propose that no apparent bias was 
introduced by the relatively long study period because medical and surgical procedures, as well as 
complication prevention protocols, have not changed dramatically in the studied decades. As 
previously mentioned, arteriovenous fistulae have been used by a selected group of our patients, 
mainly patients in whom CVCs (repeatedly) proved ineffective. In the present population, it is 
impossible to correct for this apparent selection bias, but in the absence of likely other causes, most 
likely these patients are more vulnerable to complications. Therefore, the arteriovenous fistula-related 
complication rates are probably more overestimated than underestimated. This strengthens our 
conclusion that arteriovenous fistulae are safe alternatives for CVCs. In our opinion, complication rate 
analysis o f all accesses created in our entire HPN population best represents complication rates that 
occur in daily practice. It has been argued that in each patient only the first access should be included 
because inclusion of accesses that were placed in patients with prior access-related complications 
might bias the results.14 However, in clinical practice, patients on long-term HPN mostly need 
multiple accesses, so only comparing the first accesses would probably result in decreased 
generalisability for a complete study population over the total duration o f HPN. Therefore, instead of 
only 127 first accesses, we decided to include all 685 accesses in our analysis. We used a Poisson- 
normal regression model with account for repeated measurements to control for overrepresentation 
o f some patients.
In conclusion, in our patients on long-term HPN, the occlusion incidence rate was higher in 
arteriovenous fistulae compared with some types o f CVCs. The incidence rate o f potentially life- 
threatening bloodstream infections, however, was extremely low in arteriovenous fistulae compared 
with CVCs, independent of CVC type. These data suggest that arteriovenous fistulae are safe and 
valuable alternatives for CVCs in patients in whom (life-)long-term dependency on HPN can be 
expected. Finally, within the limitations of a retrospective study design, we propose that the risk of 
arteriovenous fistula-related bloodstream infections and occlusions can probably be further decreased 
if only autologous grafts are used and if arteriovenous fistula creation is performed before (multiple) 
catheter placement(s).
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Abstract
BACKGROUND: Venous access device (VAD)-related complications remain the foremost drawback of 
home parenteral nutrition (HPN) support. In addition to technical issues, patients also experience 
significant psychosocial problems.
The aim o f this study is to present an overview of VAD-related complications in patients on long­
term HPN and to assess whether these adversities are related to experienced psychosocial problems 
and quality of life (QoL).
METHODS: Information on VAD-related complications was collected from the medical charts o f all 
110 adult HPN patients who were followed by the two major referral centres in The Netherlands, in 
Nijmegen (n=64) and Amsterdam (n=46).
In addition, a survey was performed to characterise psychosocial problems and assess their association 
with technique-related complications. 75 patients (75/110, 68%) responded.
RESULTS: The majority o f patients (76%) had already developed one or more episodes o f catheter- 
sepsis at some point during their HPN treatment course. The overall incidence o f access-related blood 
stream infection (BSI) was 3 per 1000 venous access days. Incidence of venous access device 
occlusion was 0.8 per 1000 venous access days.
There was a highly significant association between the incidence o f VAD-related complications and 
the occurrence of psychosocial complaints, in the form o f depression, fatigue , social impairment, and 
quality o f life.
CONCLUSION: Psychosocial complaints are associated with previously experienced VAD-related 
complications in patients on HPN. Although only an association, and not a causal relation is 
demonstrated by these findings, our results underscore the need for preventive and therapeutic 
measures regarding both types o f problems in these patients.
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Introduction
Parenteral nutrition has been used for nearly four decades now to prevent or correct malnutrition in 
patients with severe intestinal failure. In case o f chronic intestinal failure, patients may administer 
parenteral nutrition in the home situation (home parenteral nutrition, HPN). In The Netherlands, 
HPN patients, whenever possible, are trained in the two academic referral centres in Nijmegen and 
Amsterdam in order to become autonomous with regard to their HPN practices and allow them to 
live in their own social environment.
HPN is most frequently delivered by means o f a venous access device (VAD), such as a tunnelled 
catheter or a subcutaneous port, which is positioned in a large-bore central vessel, mostly the 
subclavian or internal jugular vein. Despite substantial clinical experience, VAD-related complications 
remain the most serious threat for both the patient as well as HPN survival as a technique.1-3 Catheter- 
related blood stream infection (CRBSI) is the most common complication. For instance, Howard & 
Ashley4 reported that adult HPN patients in the USA experience catheter-related BSI on average once 
every 2 to 3 years (0.34 episodes per catheter year). Other studies mentioned BSI rates in central 
venous catheter's (CVC) ranging from 0.17—2.19 episodes per year.2,3,5-7 CRBSI could be responsible 
for the loss o f a precious central venous access or even serious septic complications, therefore 
increasing morbidity and costs, or, in the most severe cases, leading to death. Additionally, in HPN 
patients, the loss o f a VAD may complicate the clinical status in those patients for which parenteral 
nutrition constitutes the unique route for nutrient delivery.6 Therefore, prevention o f CRBSI is very 
important. A summary o f our protocols for CRBSI and occlusions are given in box 1 and 2. Recently, 
we published an in-depth analysis o f all venous access related complications o f the HPN population in 
Nijmegen showing that the use of arteriovenous fistulae for the administration o f HPN is feasible, 
with a significantly decreased infectious complication rate when compared with central venous 
catheter (Hickman-type or subcutaneous ports).8
As reported previously by our group, HPN patients also experience a wide range o f psychosocial and 
physical problems in daily life besides VAD-related complications.9,10 For instance, anxiety and fear are 
common reactions in HPN patients and these have been shown to be associated with realistic threats, 
such as catheter infection, thrombosis, air embolism and liver damage.9,11 Anger, negative self-image, 
being dependent, and diarrhoea are other frequently reported problems.4,9,12-14
Box 1 Criteria for defining and treatment of infections
In both Dutch HPN centres, patients who are suspected o f having catheter sepsis are evaluated in the clinical setting:
• Blood cultures are taken from the venous access device as well as from peripheral sites.
• TPN administration is aborted and only restarted after a period o f 24 hours without fever.
• Treatment is started with broad spectrum antibiotic infusion through the catheter (i.e. flucloxacillin in 
hemodynamically stable patients, ceftriaxone and gentamycin in hemodynamically unstable patients).
• The therapeutic regimen thereafter is tailored according to culture results.
• In addition, in Nijmegen, patients are treated by the instillation o f the fibrinolytic agent urokinase into the catheter 
(5.000E/2.5ml) before antibiotics are given.
• Catheters are only immediately removed in case o f septic shock, with fungal infections, or with treatment failure, as 
evidenced by culturing the same organism from the access device within 6 weeks after antibiotic discontinuation. 
VAD-devices are also removed in case o f tunnel- or persistent exit site infections.
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Box 2 Criteria for defining and treatment of occlusion
Apart from infections, catheter- or AVF occlusion is the most common VAD-related problem, often necessitating catheter 
removal or AVF surgery or -angioplasty. These latter events interrupt HPN treatment and also expose the patient to the 
risks associated with catheter replacement as well as the loss o f valuable access sites.
Occlusion o f CVCs can be caused by thrombus formation, lipid deposition or drug precipitation. Thrombosis o f CVCs 
generally results from disruption o f the vein and development o f a fibrin sheath around the catheter. If catheter 
thrombosis is unrecognised and untreated, it may lead to the need for catheter removal and long-term loss o f a venous 
access site.
Treatment:
• In case o f suspected lipid deposition or drug precipitation, patients are treated by means of sodium hydroxide 
(0.1mol/l, 25 mL) infusion.
• Catheter thrombosis may be treated by means o f urokinase.
• If treatment is unsuccessful, removal o f the catheter is necessary.
• AVF occlusion may occur during episodes o f dehydration or in case of an underlying prothrombotic disease, but 
mostly is related to the occurrence o f stenosis o f the vascular anastomosis. The latter problem mostly develops 
gradually over time and can be suspected in case o f an increased pitch o f the murmur that can be heard over the AVF. 
Patients are therefore trained to check their AVF by means o f a stethoscope. In addition, periodic ultrasonography is 
performed to detect any abnormalities.
Fatigue, depression, and social impairment are the most common problems and have a major impact 
on daily life. Typical for HPN patients, fatigue may result from a lack of sleep 15 because of the sound 
o f the infuser pump or because of repeatedly disrupted sleep episodes as a consequence of frequent 
urination at night associated with fluid infusion.16 In our previous study fatigue was the most 
frequently reported general complaint in HPN patients. Fatigue was seen as consistently interfering 
with daily activities such as work and leisure.16
An important underlying question that sparked the present investigation was whether the occurrence 
o f psychosocial problems is associated with VAD-related complications, which are essentially 
preventable, or rather with the underlying disease that leads to intestinal failure, which mostly cannot 
be prevented. This is relevant, since such a notion would further bolster the indication for preventive 
measures in this respect.
The aim of the present study was (1) to provide an assessment and characterisation o f VAD-related 
complications in patients on HPN in the Netherlands, and (2) to relate these complications to 
experienced psychosocial complaints.
M aterials and m ethods
We included all long-term adult HPN patients who were treated in the two Dutch specialised 
university centres for at least 3 months, in December 2006. Their medical charts were retrospectively 
reviewed by two reviewers, independently. Whenever data from medical charts were unclear, nursing 
files were screened as well. In each patient, all vascular accesses placed for HPN purposes between the 
start o f HPN and December 2006 were analysed for complications. Vascular access device-related 
bloodstream infections were defined by the presence of symptoms (fever, chills) associated with 
positive blood cultures in the absence o f other evident infectious foci that likely could explain the 
bloodstream infection. Episodes with fever and/or chills without positive blood cultures were 
considered a bloodstream infection in case blood samples were drawn under antibiotic treatment or in 
case patients were showing signs o f sepsis (fever with cold chills, low blood pressure requiring
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intravenous fluid support, or oliguria) and other infectious foci that could explain the symptoms were 
excluded. Concerning the occlusions, the time span o f development (i.e., slowly and partial, with a 
spontaneous flow of less than 100 drops/min [considered to be mainly due to precipitation of infused 
substrates] versus acute [(nearly) complete obstruction, mainly due to thrombus formation]) was 
frequently undocumented and ultrasonography or contrast venography was not always performed. In 
this study, it was therefore impossible to distinguish thrombotic from nonthrombotic occlusions. For 
this reason, and in accordance with other studies on CVC-related complications8,17, we report overall 
occlusion rates.
Catheters are only used for administration of parenteral nutrition or fluids for hydration.
A standardised record was used for data extraction. Extracted information included: age, sex, 
underlying disease, indication for HPN, years on HPN, type o f CVC (external tunnelled vs. implanted 
port vs. AVF), co-morbidity, type of complications (infection, occlusion, others) and their treatment. 
For each patient, all vascular accesses placed for HPN purposes between the start o f HPN and 
December 2006 were analysed for complications. Vascular accesses that were in situ but not used, and 
therefore not likely at risk for complications (n=8), and accesses with missing data concerning the 
precise utilisation-period or the exact number o f complications during use (n=4) were excluded from 
the analysis.
With regard to the second aim of this investigation, a single survey was performed in October 2006, 
using questionnaires that were based on our previous survey in 2003.10 All adult patients monitored by 
the nutrition support teams at the University Centres in Nijmegen and Amsterdam in October 2006 
were invited to participate in the study (n=110). Based on previous reports, we estimate that these 
patients represented 85% of all the patients receiving long-term HPN in the Netherlands during that 
period (n= ±  130).18 The Medical Ethics Committee o f the Radboud University Nijmegen Medical 
Centre approved the study protocol. All patients gave their written informed consent before inclusion 
in the study.
The questionnaires addressed general as well as HPN-related characteristics, medication use, quality of 
life, social impairment, depression, fatigue, physical complaints, coping, self-efficacy, social support, 
sexual disorders and anxiety (Table 1). To assess a possible relation between experienced psychosocial 
problems (in October 2006) and VAD-related complications, we included complications that occurred 
between January 1st 2005 and September 30th 2006.
Completion o f the survey took 45 to 75 minutes and was accomplished by 75 of 110 patients who 
were addressed for this part o f the study.
Fatigue Severity, a subscale o f the Checklist Individual Strength (CIS-fatigue) was used to measure 
fatigue.19,20 The Beck Depression Inventory—Primary Care (BDI-PC) was used for measuring the 
severity of depression21, and the subscale ‘Social Behaviour’ o f the SIP 68 (Sickness Impact Profile) 
was used to evaluate social impairment.22,23
Quality of Life (QoL) was measured with the Cantril ladder of life, a 1-item questionnaire, based on a 
visual analogue scale from 0 to 10, where 0 stands for the worst possible QoL and 10 for the best 
QoL.24 Cantril's ladder has acceptable psychometric characteristics. Both reliability and validity were 
found to be reasonable.25
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Information on hospital admissions is provided from 2002 to 2006 because o f the highly improved 
computer registration o f patient data in this period.
HPN patients who experienced VAD-related complications between January 1st 2005 and September 
30th 2006, were compared with those who did not have VAD-related complications in this period.
Table 1 Set of questionnaires
Topic Instrument +  references Information
Patient characteristics
General Own development 9  items
characteristics
HPN-related Own development 13 items
characteristics
Quality o f  life Cantril's Ladder 70 1-item questionnaire on a visual analogue scale. Cantril's ladder has 
acceptable psychometric characteristics. Both reliability and validity 
were found to be reasonable. 25
Extent of problems
Fatigue Fatigue Severity, subscale 8 items, score 8-56
o f  the Checklist Individual Clinically severe fatigue present when score >  35
Strength (CIS) 71-73 validated in various populations. The internal consistency o f  the C IS is 
good: Cronbach's a  for 'fatigue severity' was 0.88. Convergent validity is 
satisfactory.
D epression Beck D epression The BC I-PC  is a 7 item questionnaire with each item rated on a 4 point
Inventory-Primary Care scale (0-3). It is scored by sum m ing ratings for each item (range 0-21).
(BDI-PC)45;74 Items are sym ptom s o f  sadness, pessim ism , past failure, loss o f  
pleasure, se lf dislike, se lf criticalness, and suicidal thoughts and wishes. 
Patients were asked to describe their symptoms for the 'past two weeks 
including today'. A  cu to ff score o f  > 4  is given a diagnosis o f  m ajor 
depressive disorder. The internal consistency is high (a =  0.86). With 
regard to the convergent validity, the B D I-P C  was positively associated 
with the diagnosis o f  m ajor depressive disorders (r =  0.66, p<0.001).
Social Impairment Social Behaviour, subscale 12 items, dichotomous. The internal consistency o f  the SIP 68 is high,
o f  the Sickness Im pact Cronbach's a  =  0.92.
Profile (SIP68) 75;76
S t a t i s t i c a l  a n a l y s i s
Descriptive statistics were computed for all variables. These included means, medians, and standard 
deviations. Pearson's correlations were used to analyse associations between VAD complications and 
psychosocial problems and quality o f life. To compare subjects with and without complications ,t-tests 
or Mann Whitney U tests were used where appropriate. ANOVA was used to analyse differences 
between VAD type. A p value < 0.05 was considered significant in all analyses. All statistical tests 
were performed using SPSS version 16.0.
Results
In total, 110 medical charts could be retrieved for review (i.e. there were no missing records). Patients 
recruited were treated at the Radboud University Medical Centre Nijmegen (n=64) or at the Academic 
Medical Centre Amsterdam (n=46) in the Netherlands. In October 2006 sixty-six percent o f these 
were female, mean age was 51 years (sd 12.4; range 18-81) (Table 2). The cumulative duration o f HPN 
treatment in these 110 patients was 567 years, i.e. 206.955 VAD days, with a mean o f 5.1 years (sd 5.6; 
range 3 months to 30 years). Three patients (4%) only used fluids for hydration, all other patients
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(n—72) used parenteral nutrition, from which 37 patients used parenteral nutrition combined with 
fluids. Two patients used antidepressants.
Table 2 Characteristics of H P N  patients
N  =  110
Mean age (years) 51 (sd 12.4)
Women N 72 (65%)
Underlying disease N (%)
- Mesenteric thrombosis 39 (35%)
- Crohn's disease 19 (17%)
- Radiation Enteritis 7 (6%)
- CIIP* 10 (9%)
- Others 35 (32%)
Indication HPN: short bowel syndrome (versus motility disorders) (%) 57 (52%)
Comorbity N (%) 38 (35%)
Years on HPN, mean (range) 5.7 (sd 5.6)
Type o f venous access at start HPN
- Central Venous Catheter (CVC) % 47 (43%)
- Port-a-Cath (PAC) % 35 (32%)
- Arterio Venous Fistulae (AVF) % 17 (15%)
- Other 11 (10%)
* CIIP, Chronic Idiopathic Intestinal Pseudo-obstruction
The majority o f patients (76%, n—84) had experienced infectious complications at some point during
their HPN treatment (n—391). The overall incidence o f access related BSI was 3 per 1000 venous
access days (3/1000). Access-related BSI were mainly caused by Gram-positive bacteria (54%, mostly
Staphylococcus sp.). Gram-negative bacteria, mostly Escherichia coli or Klebsiella sp., were found in
25%. Fungi, mostly Candida sp., were responsible for access--related BSI less often (5%) (Table 3).
Table 3 Pathogenesis of infections
Pathogens n %
Gram positive bacteria 194 50
Gram negative bacteria 82 21
Gram positive bacteria and gram negative bacteria 20 5
Fungi 14 4
Gram positive bacteria and fungi 6 2
Gram negative bacteria and fungi 3 1
Unknown 72 16
Total 391 100
In 54% (n—211) o f all catheter infections urokinase was used as part o f the treatment protocol, with 
the intention o f eliminating a potential thrombus. Ninety-five percent o f all episodes (n—371) had 
been treated with antibiotics, and in 5% the catheter was removed immediately (n—20). In 57% of all 
infections (n—223), the VAD was eventually replaced.
Access device occlusions occurred in 42% o f patients (n—46/110) and the overall incidence o f access 
device occlusions was 0.8 per 1000 venous access days (0.8/1000) Eighty-four percent o f these access 
occlusions (n—176) were treated by infusion of a caustic solution (0,1M sodium hydroxide, NaOH)26
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(Box 2). In 44% o f all catheter occlusion episodes (n=92), this strategy failed to open the catheter and 
a new catheter had to be placed.
Almost one third of all patients (n=34/110) experienced a range o f other complications, such as 
accidental removed (n=12) and tearing of the catheter (n=9). These latter complications occurred 0.65 
per 1000 venous access days (0.65/1000). In 69% of these cases (n=84), placement o f a new catheter 
or AVF was mandatory.
Table 4 shows our data on hospital admissions due to venous access-related complications. The mean 
length of stay in days per patient per year in the hospital significantly decreased over these years from 
21.5 (sd 34.9) to 8.9 (sd 17.5) (p<0.001).
Table 4 Hospital admissions 2002 to 2006
2002 2003 2004 2005 2006
Num ber of patients under treatment n=46 n=53 n=64 n=81 n=110
Mean no. o f admissions per patient per year (sd) 
Total no. o f admissions per year 
Mean length o f stay in days per patient per year (sd) 
Total length o f stay in days per year
1.61 (1.5) 
74
21.5 (34.9) 
987
.77 (1.2) 
41
9.5 (22.1) 
505
1.05 (1.4) 
68
10.1 (17.0) 
656
1.0 (1.5) 
83
10.9 (19.3) 
879
.71 (1.1) 
79
8.9 (17.5) 
986
P r o b l e m s  e x p e r i e n c e d
The response rate in our survey was 68% (n=75/110). No evidence for selection bias, as suggested by 
differences in gender, age, duration of HPN therapy and the indication for HPN, was found in 
respondents or patients who refused to participate.
Severe fatigue was reported by 66% o f all respondents (Table 5). There was a significant association 
between the severity of fatigue and the occurrence of VAD-related complications (r = 0.30, p = 
0.009). Fatigue severity was not associated with the number o f hospital admissions.
Table 5 Problems experienced by H P N  patients
Mean (sd) Range
CIS-Fatigue 39.61 (13.30) 9-56
BDI-PC 3.65 (3.32) 0-18
SIP-Social Impairment 5.68 (3.48) 0-12
Quality of life 5.70 (1.72) 1-10
According to the BDI-PC, almost 57% percent o f the HPN patients had depressive disorders (Table 
5). There was a significant association between depressive disorders and the number o f experienced 
VAD-related problems (r = 0.30, p = 0.011). In addition, depression was clearly associated with the 
number o f hospital admissions due to VAD-related problems (r = 0.43, p = 0.002).
The results o f the SIP 68 questionnaire showed raised levels on the subscales Social Behaviour (Table 
5). There was a highly significant association between social behaviour and VAD-related 
complications (r = 0.34, p = 0.003). We also found an association between social impairment and the 
number o f hospital admissions due to VAD-related complications (r = 0.31, p = 0.026).
For quality o f life, patients scored a 5.7 on average (sd 1.72). Forty-three percent o f the patients 
scored below 6. Quality of life was clearly associated with the number of VAD-related problems (r
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= -0.38, p = 0.001) and the number of hospital admissions due to these problems (r = -0.41, p = 
0.002). In case o f more VAD-related problems and related admissions, patients reported a lower 
quality of life. A low quality of life was also strongly related (p < 0.02) with more intense fatigue (r =- 
0.59), more severe depression (r = - 0.68) and greater social impairment (r =-0.45).
The length of hospital stay did not show a significant relation with quality o f life or experienced 
problems, except with social impairment (r = 0.04, p = 0.291).
There were no significant correlations between the type o f venous access (AVF vs. implanted port vs. 
CVC) and quality of life, depression, fatigue, and social impairment.
Patients without VAD-related complications between January 1st 2005 and September 30th 2006 
(n=29) experienced significantly less psychosocial problems and reported a better quality o f life 
compared to those who did have VAD-related complications in this period (n=46) (Table 6).
Table 6 Comparison VAD-related complications vs. no complications
October 2006
VAD-related complications between 
Jan  1st 2005 -  Sept 30th 2006 
Yes (n=46) N o (n=29) Mean (sd) t-test p-value
Quality of life Yes 5.4 (1.7) -2.22 0.029
No 6.2 (1.7)
BDI-PC Yes 4.4 (3.6) 2.59 0.012
No 2.4 (2.5)
CIS-Fatigue Yes 43.1 (11.8) 2.991 0.004
No 34.1 (13.9)
SIP-Social impairment Yes 6.6 (3.0) 2.994 0.004
No 4.2 (3.8)
D iscussion
To our knowledge this is the first study that shows that in a substantial (70%) proportion of HPN 
patients, at least in the Dutch situation, the number o f access-related complications and hospital 
admissions due to these complications is strongly associated with an impaired quality o f life and the 
presence o f depression, fatigue, and social impairment.
In our opinion these data underscore the need for adequate measures to prevent access-related 
problems and, if possible, treat psychosocial problems. We also confirm that venous access device­
related complications are being experienced at some point by the vast majority of these patients 
despite the fact that all these patients or their caregivers in the home setting have been trained to 
perform HPN administration in accordance with current practice guidelines.
In our two major Dutch HPN referral centres, specialised TPN nurses teach all patients to work in an 
aseptic manner and also to recognise relevant symptoms o f all vascular access related complications in 
an early stage, thus enabling adequate treatment in an early stage o f any problem. Patients can contact 
their total parenteral nutrition centre on a 24/7 basis. The CRBSI rates in our HPN population are 
comparable with those in some recent studies showing incidence rates between 0.44—6 per 1000 
venous access days2,3,5-7 Occlusion rates in other studies are also comparable with our finding of 
0.9/1000 catheter days.26-28
Evidence indicates that the risk o f CRBSI is reduced for example by the use of tunnelled and 
implanted catheters, proper education and specific training o f the staff, an adequate policy of hand
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washing, and regular change o f administration sets.29 Recently, the use of an antibiotic lock solution 
containing 2% taurolidine was compared to our previous standard practice and has been shown to 
dramatically (>90%) reduce the recurrence of CRBSI.30 In due time we will evaluate whether this 
policy translates into an improved quality o f life as well as psychosocial outcome measures.
Several implications of our findings for clinical practice can be noted. Apart from measures to 
decrease access-related complications, other therapeutic options to improve quality of life are at hand. 
For instance with respect to fatigue. Fatigue is a major problem in HPN dependent patients to a 
degree that is similar to the level seen in patients on haemodialysis and Multiple Sclerosis31, and higher 
compared to fatigue in patients with Functional Bowel Disorder or Cerebrovascular Accident 
patients.20 Anti-fatigue therapy should be the standard care for most chronic conditions associated 
with fatigue.15 Yurtkuran et al.32 evaluated the effects o f a yoga-based exercise program on sleep 
disturbance and fatigue in haemodialysis patients. They concluded that a modified yoga-based exercise 
regimen for half an hour twice a week improves sleep disturbance and fatigue amongst other things. 
Liu33 reported that there were two significant predictors for fatigue in haemodialysis patients; 
depression and age. Findings suggest that identifying the existence of depression routinely as 
suggested by Wuerth et al.34 and providing adequate treatment for depression might be an effective 
strategy for decreasing levels o f fatigue.33 O'Sullivan concluded that as physical functioning increased 
fatigue decreased.31 The results from this study highlight the importance of focusing nursing care on 
fatigue and physical functioning ability in practice. To our knowledge, studies looking at the effect o f 
psychosocial interventions on clinical outcomes in HPN dependent patients were not previously 
performed.
Social impairment has a major impact on the daily life o f HPN patients. In our previous study, 35 to 
43% o f the HPN patients experienced social impairment as a problem due to HPN.16 HPN 
administration takes a long time, sometimes more than 14 hours per day, and many o f the 
respondents had to hook up 5 times a week or more. Freedom to choose and the ability to make 
simple daily life decisions were sharply reduced and social contact and interaction decreased because 
o f the catheter, the schedule o f HPN, mobility problems, and physical complaints.16 Skerrett et al.35 
has shown that the ways in which patients interpret and respond to their symptoms as part o f their 
underlying disease (coping style), have a significant impact on the level o f social impairment. Most 
important correlates o f social adjustment were embarrassment cognitions and avoidance/resting 
behaviours (for example "when I experience symptoms, I rest") To compare these results with ours, 
continued investigation in our HPN patients is needed. Skerrett et al. 35 also found that depression 
explained a moderate amount of the variance in social impairment levels as well as fatigue.
Depression also can have a marked impact on many aspects o f life. Depression is often accompanied 
by impairment in one's functional capacity to work and in role functioning in non-work domains as 
well.36 Our previous review showed that depression was a common emotional response to HPN 
treatment in many studies.16 Severity of depression ranged from mild to severe and was observed in 
10-80% of the HPN patients.
Limitations o f the present investigation have to be considered. The retrospective character o f the 
study carries a risk for misinterpretation of documented relevant data. We tried to overcome this by 
using two reviewers independently, both with a medical background and with expertise in this field.
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Given the design used, we cannot be sure that psychosocial problems truly resulted from 
complications. Firstly, data on psychosocial problems were collected following the collection o f data 
on VAD complications. While this suggests a favourable time order, complications could have been 
resolved at the time of data collection. Furthermore, part o f these psychosocial problems may be due 
to the underlying disease. However, Carlsson et al.12 showed that short bowel syndrome patients on 
HPN experience a lower quality o f life compared to short bowel syndrome patients without HPN, and 
HPN patients worry more about fatigue and feeling alone. In this study, patients without venous 
access device-related complications also experienced significantly less psychosocial problems and 
reported a better quality of life compared to those who did have venous access device-related 
complications. Although not allowing firm conclusions on causal relationships in this study, the results 
support our hypothesis that venous access device-related complications do contribute to psychosocial 
problems.
Another limitation is the small patient population. Therefore, subgroup analyses were sometimes not 
feasible. Despite this small patient population, a strength o f this study is the high response rate in the 
survey. Therefore, we assume that the results o f this study can be generalised to the total group of 
HPN patients in the Netherlands. Another strength is that several validated scales were used to assess 
psychosocial problems. Future research should include new HPN patients to determine whether 
psychosocial complaints are mainly caused by the underlying disease, or, as we think, are deteriorated 
by access-related complications.
Taking the limitations o f our studies into account and given the before mentioned questions regarding 
the interpretation o f our data, the correlations identified in our data still stand. Taken together, the 
results from the present study show that in patients on HPN, depression, fatigue, social impairment, 
and the experienced quality of life is closely related to previously experienced venous access device­
related complications. This notion should bolster our efforts to prevent such adversities and further 
optimise the quality o f HPN care.
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Abstract
OBJECTIVE: Home Parenteral Nutrition (HPN) is a life-saving therapy for patients with diseases that 
preclude adequate oral or enteral food intake. HPN has a large impact on daily life. Many patients 
suffer from fatigue and depression, and they experience limits in social activities. This all contributes 
to a lower Quality o f Life (QoL). Fatigue is the most frequently mentioned problem in Dutch HPN 
patients. Therefore, we studied the prevalence, course, and predictors o f fatigue in these patients. 
METHODS: All HPN patients treated at the two Dutch HPN centres were asked to participate. 
Patients completed questionnaires at baseline and follow-up (12 months later). Measurements 
included fatigue, depression, functional impairment, social support, self-efficacy, coping, anxiety and 
acceptance. Laboratory measures, including total bilirubin, creatinine, albumin, and haemoglobin 
levels, were obtained from the medical records. Descriptive statistics, correlations, and linear 
regression analysis were performed.
RESULTS: The response rate was 71% (n=75). Sixty-five percent o f the patients were severely fatigued 
(n=49). Eighty-nine percent experienced persistent fatigue. Baseline fatigue predicted 57% of the 
variance o f fatigue at follow-up, and avoidance was responsible for 3% o f the variance. No significant 
correlations between fatigue and laboratory measures were found. A cross-sectional analysis showed 
that 46% o f the variance o f fatigue was explained by functional impairment, self-efficacy, and 
depression.
CONCLUSION: Severe fatigue is a persistent problem for HPN patients. Baseline fatigue was the 
strongest predictor o f fatigue at follow-up. Functional impairment, self-efficacy, and depression are 
strongly related to fatigue. Early recognition and treatment of fatigue are important.
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Introduction
Home Parenteral Nutrition (HPN) has been used for the management o f intestinal failure since the 
late sixties o f the previous century. This treatment modality is life-saving for patients with an 
inadequate oral or enteral food intake o f nutrients and fluids. Most patients suffer from intestinal 
failure due to short bowel syndrome, or motility disorders.1 HPN is used alone or in conjunction with 
oral feeds. The support o f patients on HPN requires a dedicated multidisciplinary team. This team 
should be available for instructions to patients, advice and treatment of complications on a 24/7 basis. 
During their training period, patients who are fit to perform HPN administration become know- 
ledged and skilled in the performance of aseptic techniques, catheter care, and the intravenous 
administration of nutrients. Also importantly, these patients are trained to contact their treatment 
centre in case o f suspected catheter infection or - occlusion or other problems due to the therapy.2 
Several studies describe that HPN is associated with medical complications.3-5 These complications 
may be related to the central venous catheter or to the nutrition formula.6;7 However, HPN also has a 
major impact on daily life and many patients suffer from fatigue and depression.8-13 Not unexpectedly, 
HPN also limits social activities and impairs quality of life.10;11
A Dutch study showed that fatigue is the foremost and most frequently mentioned problem in HPN 
patients. Sixty percent o f the HPN patients were severely fatigued, and fatigue was reported by 90% of 
these patients as a main problem in daily life (n=43).11 It was found that HPN patients were more 
fatigued when compared with patients suffering from functional bowel disorder or cerebro vascular 
accident and fatigue scores corresponded with those seen in patients with multiple sclerosis. More 
specifically, a higher level o f fatigue was related to the presence of passive coping strategies and 
believing that good health is determined by fate. Depressive symptoms were present in 65% o f 48 
HPN patients, 17% of whom experienced severe depressive symptoms.11 Social impairment also was a 
commonly reported problem. Almost half o f the respondents mentioned social limitations as a 
problem in daily life. Increased social impairment was strongly related to a lower quality o f life. Social 
impairment was more often reported when compared to patients on haemodialysis, cancer patients, 
and patients suffering from rheumatoid arthritis.14
Fatigue is a common symptom in various chronic diseases. It has mostly been studied in patients with 
chronic fatigue syndrome, cancer, multiple sclerosis, Parkinson's disease, renal disease, and after 
stroke.15-20 Physical as well as psychosocial predictors have been reported in the literature. Vercoulen et 
al.19 found that 85% o f included patients suffering from multiple sclerosis, and 100% of Chronic 
Fatigue Syndrome patients felt fatigued at least once a week. In the same study only 13% o f the 
healthy individuals experienced fatigue at least once a week. Several studies show that persistent 
fatigue is predicted by the presence of fatigue at the baseline measurement.21-23 Vercoulen et al. (1994) 
developed a multidimensional assessment method for Chronic Fatigue Syndrome (CFS) and other 
chronic disorders.19;24 Nine relatively independent dimensions o f CFS were identified, namely 
psychological well-being, functional impairment in daily life, sleep disturbance, concentration 
problems, physical activity, social functioning, social support, causal attributions and self-efficacy.
In CFS patients, fatigue severity was related to impairment in daily life and low sense o f control. Other 
predictors o f fatigue in chronic diseases are depression and anxiety18;25;26, psychological general well-
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being, high impairment in role functioning, disability, acceptance, self efficacy, and problematic social
18;22;26-29support.
Besides psychosocial factors, physiological factors may be related to fatigue. For example McCann and 
Boore (2000)15 found that malnutrition causes fatigue in renal failure patients. Srivastava 30 and Piper 
et al. 31 found that anaemia affects the reported levels o f fatigue. Other studies however, did not find
these associations.15;32-35
So far, longitudinal studies regarding fatigue in patients on long-term HPN are lacking. The current 
study presents the longitudinal data o f a cohort o f HPN patients during a 12-month period. Based on 
the literature in other chronic patient groups, fatigue in HPN patients might be predicted by the 
presence or absence o f disease activity, depression, self-efficacy, coping, acceptance, anxiety, 
functional impairment and social support. The aims of this study were 1) to describe the prevalence 
and course of fatigue, and 2) to evaluate baseline fatigue and the fore mentioned set o f psychosocial 
and physiological factors in the prediction of fatigue.
M ethod
PATIENTS
All 106 HPN patients treated at the Radboud University Nijmegen Medical Centre or the Academic 
Medical Centre in Amsterdam at the start o f the study in October 2007 were asked to participate in 
this study. These patients represent about 90% of all patients receiving long-term HPN in the 
Netherlands. Patients had to be on HPN for at least three months at T1 (baseline). We excluded 
patients younger than 18 years. The regional committee on Research Involving Human Subjects 
waived the need for review of the study because we used questionnaires and medical records only. 
Patients received a written invitation to participate.
PROCEDURE
After obtaining written informed consent, questionnaires were sent to the patients (T1). Participants 
were asked to complete the questionnaires within two weeks and return them in a prepaid envelop to 
the hospital. After one year, a second questionnaire was sent by mail (follow-up, T2). Only fatigue was 
measured. In case of missing data, patients were contacted by telephone to complete the 
questionnaires. Patients who had discontinued HPN at follow-up still were asked to fill in a 
questionnaire. Results o f these patients were analysed separately. Laboratory measures (taken during 
regular check-ups at the outpatient clinic) were obtained from the medical records at T1 and T2.
M e a s u r e m e n t s
The questionnaire addressed general and HPN related characteristics.
Fatigue
The subscale 'Fatigue Severity' from the Checklist Individual Strength (CIS) is an 8-item 
questionnaire and measures fatigue during the previous 2 weeks.36 Each item was scored on a 
seven-point Likert scale. High scores indicate a high level o f experienced fatigue. Severe
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fatigue was defined as a CIS-fatigue score equal to or higher than 35.24 A score between 27 
and 34 indicates high experience of fatigue. In this study a score of 35 or above at baseline as 
well as at follow-up was seen as indicating 'persistent severe fatigue'. The CIS has been tested 
thoroughly among patients with different chronic diseases and healthy controls.19;24;36 The 
internal consistency of the CIS is good: Cronbach's a for the total CIS was 0.90, and for the 
subscale 'fatigue severity' 0.88. Convergent validity was satisfactory.37
Depression
The Beck Depression Inventory for Primary Care (BDI-PC) was used to assess depression. 
The BDI-PC, does not contain questions concerning physical aspects of fatigue and the 
somatic symptoms of depression.38;39 The BDI-PC has seven items and consists of cognitive 
and affective symptoms. Each item is rated on a 4-point scale ranging from 0 to 3. A score of 
4 or more indicates clinical depression. This score was found to correctly classify patients as 
being diagnosed with or without major depressive disorders (MDD) according to DSM-IV. 
The internal consistency is high (a =  0.86). With regard to the convergent validity, the BDI- 
PC was positively associated with the diagnosis of MDD (r =  0.66, p <  0.001).39
Functional impairment
The Sickness Impact Profile short form 68 (SIP-68) was included in our study as it is a widely 
used measure of the impact of disease on an individual's physical and psychosocial 
functioning.40 Patients are required to read through a list o f conceivable difficulties and to 
identify which of these apply to them using a yes/no response format. Scores range between 0 
and 68, a higher score indicates more functional impairment. The internal consistency is high, 
Cronbach's a =  0.92.40;41
Social support
The Van Sonderen Social Support Inventory (SSL) was used to assess social support.42 Total 
scores of the SSL-I (amount of social interactions) range from 34 to 136, a higher score 
meaning more social support. Subscales are emotional interactions, emotional support 
problems, esteem support, instrumental interactions, social companionship, and informational 
support. The SSL has good reliability (Cronbach's a =  0.93 for SSL-I) and content validity.43
Self-Efficacy
Self-efficacy, a sense o f control over fatigue symptoms, was measured with a Self-Efficacy Fatigue 
Questionnaire. Seven items measured sense o f control with respect to fatigue. Total scores range from 
7 to 28, a higher score meaning a patient experiences more sense of control with respect to fatigue.20 
Cronbach's a reliability coefficients range from 0.70 to 0.77.21;44
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Coping
The subscales avoidance and problem-focused coping o f the UCL (Utrechtse Coping List) were used 
to assess coping.45 A high score on a subscale means that the individual uses that coping style often. 
The internal consistency is moderate to high (a = 0.66 for avoidance, a =  0.78 for problem focused 
coping).46
Anxiety
In a previous study9 the State-Trait Anxiety Inventory47;48 was not sensitive enough to measure specific 
anxiety in HPN patients. Therefore, a specific questionnaire was used to measure anxiety. Based on 
interviews in a 2003 study, six questions specific for anxiety in HPN patients were developed. These 
items were scored on a 4-point scale ('not at all' to 'almost always'). Total scores ranged from 6 to 24, a 
higher score meaning a patient experiences more anxiety with respect to HPN complications or 
hospitalisations, future or even death.
Acceptance
Acceptance was measured with a subscale o f the Illness Cognition Questionnaire (ICQ). This 
questionnaire measures different cognitions about the way patients think about and give meaning to 
their chronic illness. The items are rated on a 4-point scale (1, not at all, to 4, completely), a higher 
score meaning better acceptance. The reliability (Cronbach's a =  0.90, test-retest reliability 0.76) and 
validity o f acceptance were found to be high.49
Laboratory measures
Relevant laboratory measures were obtained from the medical records. We evaluated liver function 
(total bilirubin), renal function (creatinine), inflammation (albumin), and haemoglobin levels (Hb).
St a t is t ic a l  a n a l y s is
Data analyses were performed using the Statistical Package for Social Sciences for Windows version 
16.0. Variables were normally distributed, and therefore, parametric tests were performed. Descriptive 
statistics as mean, standard deviation and range were used to describe the participants and to evaluate 
laboratory measurement outcomes. Paired sample t-tests were performed to analyse differences 
between baseline and follow-up scores. P-values < 0.05 were considered statistically significant. 
Associations between potentially predictive variables at baseline and fatigue at follow-up were 
examined by calculating the Pearson’s correlation coefficient. Pearson’s correlation coefficient was 
also used to analyse relations between the predictive variables at baseline to identify possible multi- 
collinearity.
We performed a longitudinal linear regression analysis in which we entered variables which possibly 
are connected to fatigue at follow-up as independent variables, and fatigue at follow-up as dependent 
variable (model 1). Subsequently, we performed a cross-sectional backward stepwise linear regression 
analysis with fatigue at baseline as dependent variable, and potentially predictive variables for fatigue 
from baseline as independent variables (model 2). This second model was added because o f the risk 
that persistent fatigue is predicted by the presence of fatigue at baseline alone.26 Therefore, model 2
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might give information on other important variables explaining fatigue. Predictive variables were 
removed from the model when they met the removal criterion o f P > 0.05.
Results
P a t i e n t  c h a r a c t e r is t ic s
The response rate at baseline was 71% (i.e. 75 out o f 106 patients). No differences in gender, age, 
duration of HPN therapy or the indication for HPN were found between the respondents and the 
patients who refused to participate. At follow-up, 68 out o f 75 patients were able to fill out the 
questionnaire again (Figure 1). Eight patients discontinued HPN, but filled out the questionnaire at 
follow-up. The reason for discontinuing HPN in all patients was being able to eat sufficiently again 
due to adaptation o f the remaining small intestinal mucosa. All follow-up analyses pertain to the 60 
patients still on HPN. The 8 patients who discontinued HPN were analysed separately.
Figure 1 Patient flow chart
At baseline, patients’ median age was 56 (range 19 to 81), 63% were women, 80% were married or 
cohabiting, and merely 20% was employed. Indications for HPN were short bowel syndrome, mostly 
related to inflammatory bowel disease or mesenteric thrombosis (n=41, 55%) and motility disorders 
(n=34, 45%), Table 1. Patients were on HPN for median 2 years (range 3 months to 30 years). Almost 
75% was able to use solid or liquid food to some extent.
Serum haemoglobin, creatinine, albumin and bilirubin were in accordance with the reference ranges 
(Table 1), and therefore did not indicate the occurrence of fatigue in the patient population. These 
laboratory measures were not included in our analysis because they did not correlate significantly with 
fatigue.
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Questionnaires that were completed by patients were checked, and in case of missing data, patients 
were contacted to complete the questionnaires. Because o f no missing values, all 60 cases were 
included in the analysis.
Table 1 Patient characteristics
57=N
Mean age (years) 53.1 (sd 12.8)
Women N 47 (63%)
Indication HPN: short bowel syndrome (versus motility disorders) 41 (55%)
Years on HPN
T1
5.0 (sd 6.2) 
T2
Haemoglobin Mean (sd) 7.4 7.4
Percentiles 25 - 75 7.1 - 8.0 7.0 - 7.9
Albumin Mean (sd) 35.8 (4.9) 36.9 (4.9)
Percentiles 25 - 75 36.5 - 41.0 34.0 - 40.0
Total bilirubin Mean (sd) 10.5 (10.9) 8.6 (6.7)
Percentiles 25 - 75 5.0 - 12.0 4.0 - 12.0
Creatinine Mean (sd) 77.8 85.2
Percentiles 25 - 75 58.8 - 87.0 62.0 - 91.5
Reference ranges (from included hospitals): Haemoglobin 7.5 — 10.0, Albumin 35-50, 
Total bilirubin <17, Creatinine 65-95
P r e v a l e n c e  a n d  c o u r s e  o f  f a t ig u e
The baseline fatigue score was 37.9 ±  13.6 (mean, sd), and 62% of all patients scored 35 or higher. At 
follow-up the mean fatigue score was 38.8 ±  13.2 (difference 0.9, p = 0.45), 63% of the patients 
scored 35 or higher. The correlation between baseline and follow-up CIS-fatigue scores is 0.75 (p < 
0.001). Eighty-nine percent o f the patients that were identified as severely fatigued at baseline were 
also severely fatigued at follow-up (Table 2).
Patients who discontinued HPN at follow-up (n=8) had a mean age of 44 ±  12 (median 47), 5 o f 
them were women, 5 were married or cohabiting, and 5 o f them were employed. They showed a mean 
fatigue score o f 43.1 ±  10.0 at follow-up. This did not differ from their baseline fatigue score (mean 
43.8, ±  10.3, p = <0.001). Five of these were identified as severely fatigued at baseline and follow-up.
Table 2 Course of fatigue
' ---- ----T2 Severe fatigue at Heightened fatigue N o fatigue at follow-
T1 ----- ---- ---- _ follow-up at follow-up up
Severe fatigue at baseline (n=37) 33 (89%) 2 (5,5%) 2 (5,5%)
Heightened fatigue at baseline (n=8) 3 (37,5) 2 (25) 3 (37,5)
No fatigue at baseline (n=15) 2 (13,3) 5 (33,3) 8 (53,3)
The course o f fatigue: numbers and percentages o f patients that were classified as severely, heightened or not fatigued at 
follow-up, on basis o f their classification as severely, heightened or not fatigued at baseline
P r e d ic t o r s  o f  f a t ig u e
The correlations between the predictive variables and fatigue at follow-up are presented in Table 3. 
There was multi-collinearity between depression and acceptance (r = -0.651) and between depression 
and anxiety (r = 0.628). Based on these results, acceptance and anxiety were excluded, and avoidance,
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social companionship, functional impairment, self-efficacy, and depression were included in the 
regression analysis.
Table 3 Pearson Correlations between possible continuous predictors at baseline and fatigue at follow-up
Fatigue
Coping
Active problem solving -.098
Avoidance .330**
Health cognitions
Acceptance -.369**
SSL-I (amount o f social interactions)
Total -.157
Emotional interactions -.214
Emotional support problems -.022
Esteem support -.185
A  A O
Instrumental interactions .048
Social companionship -.257*
-.166
Informational support
SSL-N (negative interactions) .230
SIP -T otal .511**
Self-efficacy fatigue -.443**
Anxiety .369**
BDI-PC
CIS — Fatigue .745**
Laboratory measures
Haemoglobin .086
Albumin -.139
Total bilirubin -.242
Creatinine -.036
*p=<0.05 **p=<0.01
The longitudinal analysis with fatigue at follow-up as dependent variable and fatigue, depression, self- 
efficacy, avoidance, functional impairment and social companionship at baseline as independent 
variables showed that 60% of the variance of fatigue was predicted by fatigue and avoidance. Fatigue 
was responsible for 57%, and avoidance was responsible for 3% of the variance (Table 4, model 1).
Tabel 4 Linear Regression of complete model and final model
Model 1
Complete model B S E B ß P-value
Constant 13.926 11.333 .224
Fatigue baseline .653 .106 .659 .000
Social companionship .262 .371 0.65 .483
Avoidance .537 .309 .149 .087
Functional impairment .110 .502 .088 .400
Depression -.245 .502 -.053 .627
Self-efficacy -.704 .394 -.167 .079
Final model B S E B ß P-value
Constant 1.777 5.231 .735
Fatigue baseline .714 .082 .720 .000
Avoidance .597 .298 .165 .049
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Cross-sectional, the analysis with baseline fatigue as dependent variable and depression, self-efficacy, 
avoidance, functional impairment and social companionship at baseline as independent variables 
showed that 46% o f fatigue was explained by functional impairment, self-efficacy, and depression. 
Functional impairment was responsible for 31% o f the variance, self-efficacy for 11%, and depression 
was responsible for 4% (Table 4, model 2).
Model 2
Complete model B SE  B ß P-value
Constant 50.408 10.833 .000
Social compagnionship -.158 .425 -.038 .711
Avoidance .040 .355 .011 .911
Functional impairment .463 .138 .364 .001
Depression 1.041 .568 .218 .071
Self-efficacy -1.062 .402 -.269 .010
Final model B SE  B ß P-value
Constant 49.472 7.742 .000
Functional impairment .465 .136 .366 .001
Depression 1.102 .535 .230 .043
Self-efficacy -1.100 .385 -.279 .006
D iscussion/conclusion
We found that severe fatigue is a persistent problem in daily life o f HPN patients. This finding has 
also been reported in other patient categories, such as (disease-free) breast cancer patients26, chronic 
peritoneal dialysis patients16, and patients suffering from rheumatoid arthritis.50 For HPN patients, no 
predictors o f fatigue were available from the literature. Our first longitudinal analysis showed that 
fatigue is the most important predictor for persistent fatigue. This result has also been found by 
Servaes et al. in disease-free breast cancer patients.26 Our second cross-sectional analysis, showed that 
functional impairment, self-efficacy, and depression explain a considerable part o f fatigue at baseline. 
While fatigue is a frequent symptom in HPN patients, it has received no attention in research. As 
HPN patients may suffer from anaemia, problems with fluid intake/diarrhoea, renal disease or liver 
disease, it is reasonable to assume that fatigue is related to somatic problems. However, our results 
show no correlations between relevant laboratory measures and fatigue. This is in accordance with 
several studies in patients on haemodialysis and in patients with primary biliary cirrhosis, where no 
association was found between anaemia, albumin- , creatinine-, and bilirubin levels and fatigue.15;32-35 
As in our study, other studies in patients suffering from rheumatoid arthritis show that the 
relationships between psychosocial variables are often much stronger than ‘objective’ measures o f 
disease severity or inflammatory markers, like laboratory values, swollen joints or deformities.51-53 
Riemsma et al.28 showed that laboratory measurements like haemoglobin concentration and 
erythrocyte sedimentation rate are not significantly related to fatigue, while psychosocial aspects like 
self-efficacy and problematic social support are the most important variables in explaining fatigue.
With regard to the results for functional impairment, it can be concluded that HPN patients 
experiencing more functional impairment have higher levels o f fatigue. Regarding self-efficacy, a lower 
sense o f control with respect to fatigue complaints is associated with an increase in experienced 
fatigue. Both these findings are consistent with results o f studies with chronic fatigue syndrome
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patients, multiple sclerosis patients, and patients with rheumatoid arthritis.20;28 In these patient 
populations, a negative self-efficacy was found to have a direct negative causal effect on fatigue 
severity. It is known that improving self-efficacy can be enhanced by self-management courses and it 
may thus be possible to decrease symptoms of fatigue.28 Self-efficacy is also an important aspect o f 
cognitive behaviour therapy in CFS patients. Prins et al.44 found that patients with a greater sense of 
control at baseline had a larger decrease in fatigue severity after cognitive behaviour therapy, than 
patients with lower sense of control.
For CFS patients, cognitive behaviour therapy (CBT) has proven to be successful in reducing fatigue 
complaints.44;54-56 Besides reducing fatigue severity, CBT also had a positive effect on functional 
impairment.44 A systematic review of Neill et al.57 showed the effectiveness o f non-pharmacological 
interventions for fatigue in chronic diseases. Exercise appears to be an effective, appropriate and 
feasible non-pharmacological intervention for reducing fatigue in people with MS, RA, and Systemic 
Lupus Erythematosus (SLE). This is consistent with recommendations for cancer-related fatigue and 
chronic fatigue syndrome. In addition, a range of behavioural interventions, like energy conservation, 
may be helpful in reducing fatigue in MS, RA, and SLE.58-60 Educational interventions also produced 
statistically significant reductions in fatigue.
The finding that depression partly explains fatigue is also confirmed by other studies on fatigue. 
Leserman et al.61 showed that depression results directly in fatigue. Lui 25 found that depression was 
the most important predictor o f fatigue in haemodialysis patients. Although this remains to be proven 
in future research, in our opinion the adequate identification and treatment for depression might also 
prove to be an effective strategy for decreasing levels o f fatigue.25;62 In HPN patients, a study by Smith 
et al. 63 showed that by means o f interactive education, depressive reactions can be prevented and the 
patient's own capacity to solve problems is promoted. This intervention also led to a higher health 
related quality of life.
Surprisingly, fatigue also was a main problem in patients who discontinued HPN. Their fatigue scores 
were higher compared to patients still on HPN. This can possibly be explained by having less energy 
because of their nutritional status. These patients have to eat often during the day, to maintain their 
body weight.
Importantly, we included about 70% o f all Dutch HPN patients who were treated according to very 
similar protocols. The 30% not included did not differ in gender, age, duration or indication o f HPN. 
Therefore, the sample seems representative of the whole population of HPN patients in the 
Netherlands. Unfortunately, reasons for not participating are unknown. We used validated 
questionnaires. Another strength of our present study is that there were no missing data. With 
exception of the patients who died, there was no loss to follow-up in 2007. A weakness o f this study is 
that, although we included about 70% of the Dutch HPN population, the sample size as a whole 
remains relatively small. Due to this problem, we could only include the total SIP-68 score in our 
analysis, instead o f different subscales. Based on these notions, an additional longitudinal, and ideally 
multicentre international study, including these factors is recommended.
The importance of identifying modifiable factors to predict fatigue is that these can help in the 
prevention and treatment o f this problem.
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Abstract
BACKGROUND: Home parenteral nutrition (HPN) is a lifesaving treatment for patients who cannot eat 
or cannot eat sufficiently, due to serious chronic intestinal failure. Very little is known about follow-up 
care after initial instructions during a hospital stay. Yet this is an important aspect o f care as patients, 
although well trained, must cope with high-tech skills at home. Also, complications, and psychosocial 
complaints can occur.
OBJECTIVES: The aim of this study is to describe the quality, quantity, and content o f care given to 
HPN dependent patients by various professionals in the Netherlands, and to detect potential 
shortcomings.
DESIGN: A descriptive survey.
PARTICIPANTS: Adult patients from the largest HPN centre in the Netherlands, who had been on 
parenteral nutrition in the home-setting for at least one year.
METHODS: A survey was performed, using a patient questionnaire to assess contacts with 
professionals and possible shortcomings in care. Nursing files from HPN nurses were reviewed for 
information from all contact moments. HPN nurses and (specialised) home care teams were 
interviewed to assess nursing care and to detect whether they experienced bottlenecks in daily care. 
RESULTS: HPN patients visit several professionals. The nutrition support team, at our centre 
comprising a gastroenterologist, dieticians and HPN nurses, was primarily responsible for the HPN 
care. In daily practice, HPN nurses were contacted most frequently. Physical complaints like 
abdominal pain or nausea, and venous access problems like fever were discussed most often. Patients 
were satisfied about the nutrition support team, but both the patients as well as the HPN nurses 
reported that relatively little attention was paid to psychosocial problems. Furthermore, the included 
patients visited their General Practitioner (GP) 11 times per year on average (range 1 to 104). Patients 
experienced a bottleneck with respect to the G P’s knowledge of HPN-related matters.
CONCLUSION: HPN patients visit the nutrition support team and their GP most frequently, and a lot 
o f attention is paid to medical and physical problems. Psychosocial problems, however, were only 
discussed in a minority of patients and this was experienced as a shortcoming. Patients' concerns must 
be integrated in contact moments, to enhance quality of life.
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Introduction
Home parenteral (intravenous) nutrition (HPN) is a lifesaving treatment for patients with severe 
intestinal failure who cannot meet their fluid- and or nutrient needs by means o f a normal enteral diet. 
Chronic intestinal failure is a serious complication of a number of gastrointestinal diseases ranging 
from inflammatory and vascular disease to radiation enteritis and motility disorders.1;2 HPN can 
provide a patients’ total nutritional requirements and/or can be a supplement to oral or enteral intake. 
Therefore, the frequency of HPN administration can range from 2 to 7 times a week. HPN has 
allowed more patients to be discharged from hospital who would otherwise have remained in hospital 
with increased healthcare costs.3 HPN may be administered as a 'cyclic' infusion over a number of 
hours per day (mostly overnight for a 12-14 hour period). A night-time cyclic infusion is preferred, 
because it frees the patient from carrying an infusion pump during the day, thus offering a more 
normal lifestyle, resulting in lower frequency of parenteral nutrition-associated liver disease.
Patient education is a crucial nursing intervention in ensuring successful outcomes for the patient on 
HPN.4 HPN education aims at the care o f the central venous access device, administration 
procedures, and monitoring for complications such as infection, occlusion, or central vein thrombosis. 
Sometimes, a partner or other caregiver is educated during the same training sessions. In some cases, 
when the patient and/or partner is not able to learn or perform all procedures, for instance following 
a neurologic event, home care nurses are engaged to assist with, or carry out the HPN procedures 
once the patient is at home.
Research indicates that because o f the complexity o f Total Parenteral Nutrition (TPN) therapy, a high 
level o f knowledge and expertise is required in the management of these patients.5 Evidence 
demonstrates that physicians have minimal training and experience in this area of nutrition support5, 
and consequently this has led to the development o f specialised multidisciplinary nutrition support 
teams in many health care facilities.6 It could be expected that outcomes of a multidisciplinary 
nutrition support team are influenced by the combined disciplines o f the TPN team members, and 
their knowledge and expertise.6;7 A multidisciplinary team can be expected to be able to assess the 
patients’ nutritional status, prescribe the nutritional requirements, and reduce the incidence of 
complications through regular monitoring.8;9 Several studies show that a multidisciplinary team is a
way of providing efficient service, and it can improve health outcomes and the quality o f patient
10-12care.
So far, however, little is known about the quality, extent and content o f the professional care given to 
HPN patients. These are important aspects o f care as patients, although well trained, must cope with 
high-tech skills at home as well as possibly life-threatening complications such as central line related 
infections, access occlusions, as well as a broad range o f psychosocial problems.13-15 Therefore, it is 
crucial to characterise professional care, in order to deliver effective, and patient-centred supervision. 
The aim o f this study is to describe the quality, quantity and content o f care given to HPN dependent 
patients in the Netherlands by the major academic HPN centre, and to point out potential 
shortcomings.
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Method
D e s i g n
A survey was performed between January and April 2009, using a patient questionnaire, patient file 
analysis, and interviews to detect contacts with professionals and possible shortcomings in care for the 
year 2008.
P a t i e n t s / p a r t ic ip a n t s
Adult patients from the Radboud University Nijmegen Medical Centre (RUNMC) in the Netherlands 
were included in January 2009 if they had been on parenteral nutrition in the home-setting for at least 
one year (n=64). Patients gave written informed consent.
S e t t i n g
In the Netherlands, the care for the approximately 180 patients on long-term (> 3 months) home 
parenteral nutrition is mainly carried out by the multi-disciplinary nutrition support teams of two 
university centres, in Nijmegen (currendy 105 patients) and Amsterdam (ca. 50 patients). Figure one 
shows the geographical spreading of HPN patients in the Netherlands, treated in Nijmegen. In our 
HPN centre in Nijmegen, this multidisciplinary nutrition support team is responsible for the HPN 
patients and comprises a physician (gastroenterologist), a dedicated HPN nurse and a dietician. 
Patients are generally hospitalised in one of these specialised centres for about two weeks, in order to 
obtain all knowledge and master all skills necessary for safe HPN, using protocols. If a partner or 
other caregiver is involved, this person too is educated during this two week period.
Figure 1 Geographical spread of H PN patients treated by the Radboud University Nijmegen Medical 
Centre (RUNMC) in the Netherlands
When new HPN patients are discharged from the hospital, a home-visit by the HPN nurse is a 
standard procedure (n=16 new patients in 2008). Issues that are discussed during home visits include 
physical, psychosocial, emotional, economic, and practical aspects. After this first visit, follow-up
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home visits only take place when indicated by the HPN nurse. In these visits, mainly physical and 
psychosocial problems are discussed.
In some o f the HPN patients, a specialised home care team is involved in case the patient cannot 
master all HPN procedures. Training for members o f this team is given when a new HPN patient is 
hospitalised. This education is given once by the HPN nurse, especially in teams who have no other 
HPN patients in care.
File  analysis
Nursing files kept by HPN nurses were reviewed for data over the year 2008 with a standardised 
record for data extraction. Two reviewers independently collected information, including age, sex, 
underlying disease, indication for HPN, years on HPN, type o f CVC (external tunnelled vs. implanted 
subcutaneous port vs. Arterio Venous Fisulae (AVF)), venous access complications, and frequency 
and content from all contact moments between patient and the nutrition support team, and other 
contact moments with the nurse. For each patient, venous access complications and hospitalisations 
due to these complications were checked in the patients' medical files as well.
Interviews
HPN nurses were interviewed to assess whether they experienced bottlenecks in daily care (n=4). We 
used an interview topic list based on the aims of this study. This list included content o f outpatient 
clinic visits, telephone/e-mail contacts, home visits, and contact with other relevant professionals. We 
started the interviews with a general question about qualities and bottlenecks experienced in HPN 
care. Further questions were based on what the respondent said. At the end o f the interview the 
researcher checked whether all topics had been covered.16 Information from these interviews 
complement information from the file review.
Primary responsible nurses from (specialised) home care teams were interviewed by telephone (n=13). 
A topic list was used, also based on the aims o f this study. Patients gave consent to contact primary 
responsible nurses. Interview topics were frequency and content o f care, protocols used, education, 
contact with nutrition support team and shortcomings experienced. All interviews took place in April 
2009.
Questionnaire
Patients received a written questionnaire by mail. Completion of the set took about 30 minutes. We 
evaluated general characteristics (3 questions), TPN characteristics such as HPN duration and 
indication (7 questions), frequency and content o f professional care (51 questions), and satisfaction 
with contacts with professionals (17 questions). Satisfaction was evaluated for all different 
professionals with two questions, 'are you satisfied with ..?', and in case the patient was not satisfied, 
'why are you not satisfied?'. The Sickness Impact Profile short form 68 (SIP-68) is a widely used 
measure of the impact o f disease on an individual's physical and psychosocial functioning.17,18 For 
every subscale, patients were asked if they had experienced problems, and if there had been a need for 
professional help (12 questions). Finally, frequency and satisfaction with home visits by HPN nurses 
were evaluated (3 questions). The feasibility o f the questionnaire set was tested in two HPN patients.
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These data were not included in the study. Based on the outcome, changes were made to the layout 
and introduction.
Statistical analysis 
File analysis/questionnaire
Descriptive statistics were used for all variables. These included means, medians, and standard 
deviations. All statistical tests were performed using SPSS version 16.0.
Interviews
The notes made by the interviewer during the interviews were typed out in full. After the interviews, a 
member check was done by giving the report to the interviewee in order to check the authenticity o f 
the work. The comments served as a check on the validity o f the interpretation.19 Content analysis was 
performed on the data obtained during the interviews. Central topics were summarised from the 
interviews.
Results
An overview o f patient care will be given. First the patients' general characteristics, results for the 
Sickness Impact Profile, and hospitalisations are described. Secondly, results for quantity and content 
o f care are reported. Finally, quality of care and experienced bottlenecks are presented.
HPN PATIENTS
The HPN population studied comprised 64 patients o f which 22 were males. The mean age was 53 
(±14.7) years (range 18-77 years). The mean duration of HPN use, counted from HPN start until 
December 31 2008, was 6.4 years (range 1.1-32.3 years). Indications for HPN in our population were 
mainly motility disorders (36%) and short-bowel syndrome (59%), the latter mostly related to 
inflammatory bowel disease or mesenteric thrombosis. Patients had three types o f  catheters, a Port-a- 
Cath (PAC, 35%), a central line (Hickman catheter, 41%), or an arteriovenous fistula (AVF, 24%). 
Most patients were independent in all HPN procedures (63%), in 16% a partner was involved, and 
(specialised) home care teams were involved in 21% of all patients (table 1).
Eighty percent o f all HPN patients completed the questionnaire (n=51). According to scores on the 
Sickness Impact Profile (Table 1), patients experienced most problems in the subscales social 
behaviour, psychic autonomy and communication, and emotional stability. Patients spent limited time 
visiting friends and family, joining sport clubs or other leisure activities. Somatic autonomy (e.g. 
general daily care, making transfers, walking) and mobility control (e.g. dressing, walking on the stairs) 
were also problematic.
Almost half o f the patients (47%, n=30) were hospitalised due to HPN complications in 2008 (table
1). The most common complications were catheter related blood stream infections (CRBSI) and AVF 
occlusions. In all patients CRBSI was treated with antibiotics. In 45% o f the infections, the catheter 
had to be removed, and a new catheter had to be inserted. AVF occlusions were treated with 
Percutaneous Transluminal Angioplasty in 86% of all cases. About one third of the patients (31%, 
n=20) were hospitalised due to their underlying diseases in 2008. Frequently reported reasons were 
abdominal pain and abdominal surgery.
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Table 1 Patient characteristics
Patient characteristics
Mean age, years (range) 53 (18-77)
Woman, % 66%
Married, cohabiting, % 81%
Patients with paid employment, % 21%
Years on HPN, years (range) 6.4 (1.1-32.3)
Hours on HPN/day, mean (range) 12.8 (4-24)
Type of catheter:
Implanted port , % 35%
Tunnelled catheter, % 41%
AVF (in combination with tunnelled catheter or implanted port), % 24%
Hospital admission due to catheter problems in 2008:
•  Admitted, % (n) 59% (30)
• If admitted, number of admissions, mean (range) 1.9 (0-4)
• If admitted, number of days, mean (range) 21 (0-161)
Hospital admission due to the underlying disease in 2008:
•  Admitted, % (n) 39% (20)
• If admitted, number of admissions, mean (range) 2.0 (0-7)
• If admitted, number of days, mean (range) 6 (0-60)
Sickness Impact Profile -  68 % patients that % patients that already have
experienced many or professional help (% patients
very many problems who lack, but would prefer
in this area professional help in this area)
- Somatic autonomy 34.3 28.6 (5.7)
- Mobility control 40.0 17.1 (2 .9)
- Psychic autonomy and communication 17.1 17.1 (5.8)
- Social behaviour 55.9 23.5 (5.9)
- Emotional stability
- Mobility range
20.6
35.3
12.0 (5.9) 
17.6 (5.9)
Quantity and  co ntent  of  care in  HPN patients 
N utrition support team
HPN patients visited the outpatient clinic, where they simultaneously saw their gastroenterologist, 
HPN nurse and a dietician (n=156 thirty-minute visits in 64 patients in 2008). The mean number of 
these visits in 2008 was 2.52 (sd 1.83, range 0-8). Most patients were seen every three to four months. 
Clinical parameters monitored during these visits were body weight, oral intake, hydration, and body 
temperature. Most frequently discussed subjects were physical complaints, venous access related 
problems, and there was communication about the composition or frequency o f administrating o f the 
parenteral nutrition (table 2). Only in 14% of all visits (n=22), nurses reported patients' overall well­
being, in terms o f 'he/she is doing well/reasonably well etcetera'. In 4% of the visits (n=7), 
psychosocial problems, like anxiety, depression, and finding new ways to cope with HPN were 
discussed. Seven patients did not visit the nutrition support team at the outpatient clinic in 2008, 
because they were treated by another gastroenterologist.
In 2008, five follow-up home visits were made by the HPN nurse. In all visits, patients' physical 
complaints like nausea and diarrhoea were discussed. In 4 out o f 5 visits, psychosocial issues like 
depressive feelings and ways of coping were the most important issues discussed. In December 2008, 
the most recent visit was 2.5 years ago on average (sd 1.4, range 0.6-6.0 years).
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Table 2 Subjects discussed during contact with multidisciplinary nutrition support team
Subjects
d iscu ssed
O utpatient clinic
n = 64 patients
n = 156 contacts (gastroenterologist, HPN 
nurse, dietician)
Consultation (H P N  nurse) by 
telephone/e-m ail:
n = 64 patients
n = 219 contacts by telephone n = 25 contacts by e­
mail
Overall well-being n
%
22
14% o f all visits (17 pat)
0
Physical n 132 58
complaints % 85% o f all visits (56 pat)
•  Abdominal pain
•  Nausea
•  Fatigue
•  Stoma leakage
•  Cramps hand/feet
24% o f  all contacts (31 pat)
•  Abdominal pain
•  Nausea
•  Fatigue
•  Diarrhoea
•  Vomiting
Venous access- n 55 83
related problems % 35% o f all visits (25 pat)
•  Exit site infection
•  Difficulties AVF puncturing
•  Crack in catheter
34% o f  all contacts (39 pat)
•  Fever/cold chills
•  Symptoms exit site infection
•  Difficulties AVF puncturing
•  Crack in catheter
Parenteral n 49 29
nutrition % 31% o f all visits (24 pat) 12% o f  all contacts (11 pat)
composition / •  Weight change •  Weight change
frequency •  Blood tests •  Complaints after nutrition change
Test results n 36 13
% 23% o f all visits (20 pat)
•  Bone density measurement
•  CT scan
•  Laboratory measures
5% o f all contacts (5 pat)
Medication n 19 24
% 12% o f all visits (8 pat)
•  Acid suppression
•  Analgesics
•  Diarrhoea inhibitors
•  Sedative drugs
10% o f  all contacts (12 pat)
•  Acid suppression
•  Diarrhoea inhibitors
•  Antibiotics
Practical problems n 6 28
% 4% o f all visits (4 pat)
•  Pump dysfunction
•  Accu problems
11% o f  all contacts (18 pat)
•  Pump dysfunction
•  Vacation
•  Order problems
Psychosocial n 6 5
problems % 4% o f all visits (4 pat)
•  Anxiety
•  Depression
•  Coping
2% o f all contacts (3 pat)
•  Stress
•  Anxiety
Contact other N 0 14
professionals % 6% (6 pat)
•  General practitioner
•  Home care teams
High-tech home care 115
In total, 244 other contact moments documented in the HPN nursing files (n=219 telephone calls, 
n=25 e-mail) were analysed. In 2008, patients called or e-mailed with the HPN nurse for an average 
number of 3.9 times (sd 4.2, range 0-22). Most contacts were because o f venous access device­
problems such as fever, cold chills or symptoms o f  an exit site infection, physical problems such as 
abdominal pain, nausea or fatigue, or about weight change (Table 2). HPN nurses told that telephone 
contacts often ended with more psychosocial counselling, but this was not registered in the HPN 
nursing files.
Other professionals
Apart from the outpatient clinic visits, patients visited other professionals. In 2008, the general 
practitioner (GP) was seen by 84% of the patients (n=43), with a mean of 10.6 times per year (sd 22.4, 
range 1-104). The type of care provided by the GP was very diverse (Table 3).
Sixty-three percent o f the HPN (n=32) patients also visited other medical specialists in 2008. The sub­
specialisms that were most frequently reported were vascular surgery, internal medicine, 
rheumatology, and cardiology. Twelve percent o f the HPN patients (n=6) received counselling from a 
psychologist or psychiatrist. About 16% o f the patients (n=8) had contacted peers during especially 
organised 'patient days' or by telephone.
Table 3 Contacts with professionals
Professional % patients 
seen by this 
professional
Mean frequency (per year) Satisfied,
%
Provided care
Gastroenterologist 94% 3.35 93% •  Monitoring clinical parameters
(sd 1.4, range 1-6) •  Answering patient questions
HPN nurse 86% 4.47 92% •  Instructions
(sd 3.1, range 2-12) •  Patient questions
•  Advice
Dietician 67% 2.8 94% •  Body weight
(sd 1.0, range 1-4) •  Parenteral nutrition composition
Other medical doctor 63% 2.8 93% •  Monitoring by different
(sd 2.1, range 1-7) specialism’s
General Practitioner 84% 10.6 92% •  Blood tests
(sd 22.4, range 1-104) •  Treatment o f  complaints
•  Psychosocial support (7%)
Psychologist / 12% 12 100% •  Psychosocial support (e.g.
psychiatrist (sd 15.3, range 1-40) depressive feelings, anxiety)
Peer support contact 15% Median 1 100% •  Patient meetings
(3x 1, 1x24, 1x70) •  Problems in daily life
Domestic help 30% 84.5 100% •  Housekeeping
(sd 45.6, range 26-156)
Home care team 6% 278 (mean 5.3 times a week) 100% •  Stoma care
(sd 150.7, range 104-365) •  Support with showering
Specialised home care 14% 339 (mean 6.5 times a week) 100% •  (support in) HPN procedures
team (sd 258, range 14 -  730)
A small group o f patients (n=13, 20%) were supported by (specialised) home care nurses in 2008. 
Three patients had received help with showering or stoma care (home care). In the other patients
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(n=10), nurses had carried out HPN procedures, like preparing and (dis)connecting the parenteral 
nutrition formulation or they had supported the patient doing the procedures themselves (specialised 
team). Nine out o f ten specialised teams had used protocols from the nutrition support team, and they 
were all educated by the HPN nurse. On average, patients saw 8 different nurses at home (range 2-16), 
and care was provided from two times a day to once in four weeks. Most patients (n=9) saw nurses 
daily.
Domestic help was given in 30% of the patients (n=15).
Quality of care 
N utrition support team
According to the questionnaires, HPN patients were satisfied about the professionals o f the nutrition 
support team (table 3). However, almost a quarter o f the respondents was not satisfied about the 
frequency of the home visits made by the HPN nurse. All o f these patients reported it was too long 
ago. Two patients mentioned the idea o f group meetings at the outpatient clinic instead o f home 
visits. In group meetings they would like to discuss problems and concerns due to HPN use, and hear 
from other patients how they cope with some problems.
The results from the interviews with the HPN nurses (n=4) showed that they were very positive about 
the nutrition support team. Accessibility was one o f  the most important strong points noted. There 
were two-weekly meetings with all members o f the nutrition support team, also including a 
pharmacologist, and there was a weekly combined outpatient clinic visit. Experienced bottlenecks 
mentioned in the interviews with HPN nurses were the waiting list for a surgeon (in case of the need 
for a new venous access device), and the considerable turnover in (relatively inexperienced) surgical 
trainees. Furthermore, registration of all contacts (especially e-mail contact) was only partial, and 
communication with other hospitals in case o f hospitalisation of HPN patients elsewhere was very 
limited. During instruction, hospitalisation or outpatient clinic visits, psychosocial issues were only 
occasionally discussed. HPN nurses would prefer a more frequent home visit, due to the lack o f time 
for psychosocial support during other contacts.
Other professionals
Almost all patients who saw their General Practitioners were satisfied (92%). One remark that was 
made by some patients (n=5) concerned a lack of knowledge regarding HPN practice of some GPs.
All patients were satisfied with their home care teams. However, two patients mentioned that they 
were previously supported by a specialised home care team. Because o f the considerable number of 
nurses and the various different ways in taking care o f hygiene issues during the HPN-related 
procedures, these patients decided to care for their HPN care themselves in 2008.
All o f the (specialised) home care teams (n=13) were satisfied about the accessibility o f the nutrition 
support team (mostly HPN nurse). No bottlenecks were noted by the teams.
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D iscussion
HPN patients and their family members (caregivers) face many lifestyle changes as they adjust to 
technology-dependent therapies such as Home Parenteral Nutrition. So far, this is the first study that 
shows part o f the quality, quantity and content o f care given to HPN dependent patients and as 
provided by various professionals o f the multidisciplinary nutrition support team, (specialised) home 
care teams, general practitioners and other medical doctors.
HPN patients visited a broad range o f professionals, o f which the nutrition support team (in our 
setting in Nijmegen comprising a gastroenterologist, HPN nurse, dietician) was primarily responsible 
for the HPN care. Most patients were seen three or four monthly. These results were also found in a 
European study in 42 centres.20 Besides the outpatient clinic visits, in practice, HPN nurses were 
frequently consulted by telephone or e-mail. Physical problems and venous access problems were 
main topics during outpatient clinic visits and HPN nurse consultation. Severe catheter related 
complications were nearly always handled by the nutrition support team in our centre.
Furthermore, most patients visited their general practitioner or another medical doctor for a broad 
range o f problems.
HPN patients were satisfied with the care provided by their professional caregivers. However, some 
comments can be made. In the first place, the frequency o f home visits was not satisfying in almost a 
quarter o f the patients. On average, a home visit had been made 2.5 years ago, but for some patients 
this period was 5 to 6 years. Since the patients reported a substantial need for this kind of care it could 
be considered important to aim to visit each patient once every one to two years. Patients and HPN 
nurses mentioned that psychosocial care sometimes is missing during hospitalisation and other 
contacts, due to a lack of time. According to the HPN nurses, home visits give the best opportunity 
for patients to discuss patient concerns like fatigue, and social or emotional problems. In 
haemodialysis patients, such regular contact with health-care professionals and other patients has been 
shown to contribute to better life satisfaction.21 Providing support for psychosocial adaptation to 
HPN and anticipatory guidance for integrating this care into a person's lifestyle is an important aspect 
o f the nurse's role. 22
Some patients were not satisfied with their general practitioner's knowledge o f the HPN treatment and 
- procedures. Malone (1988)23 tried to resolve part o f this problem by introducing an information 
package, including background information, HPN training, complications o f HPN, arrangements for a 
particular patient, and hospital management o f  HPN. Overall, the booklet was very well accepted by 
GPs. This kind o f information could be developed for the Dutch GPs as well.
Finally, some specialised home care team comprised more than ten individual nurses, leading to 
differences in the performance o f HPN procedures because o f lacking experience. Such problems also 
might promote the occurrence of venous access complications. For specialised home care teams in the 
Netherlands, HPN remains a somewhat exotic treatment modality, and therefore, these teams may 
benefit from retraining by HPN nurses.
HPN nurses aim to educate new HPN patients to perform all HPN procedures autonomously. 
Carlsson et al. (2001)24 concluded that the confidence a patient gets from handling his own HPN is
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one o f the main factors giving positive self-control. In our centre, only a small group o f HPN patients 
was supported by (specialised) home care teams.
Other patients were supported by their partner or other caregiver. Caregiving requires learning an 
extensive amount of information about illness, symptoms, medications, and technologic 
treatments.25’26 Reactions to caregiving are mainly positive, but common problems like depression, 
social restrictions, strain, frustration and anger are mentioned.27’28 In our centre, caregivers o f adult 
patients were only involved in the education process at the start o f the HPN programme. Home visits, 
made by the HPN nurse, should involve caregivers too, and experienced problems of caregivers 
should be assessed.
The strength of the present study is that we collected information on almost all persons involved in 
the provision o f HPN patient care. We collected data from nursing files, interviewed HPN nurses and 
nurses from (specialised) home care teams, and we also invited patients to evaluate care. We included 
80% of all our patients, and therefore we assume that the results o f this study can be generalised to 
the total group o f HPN patients in our centre. A 12 month period was evaluated, and therefore a 
relatively complete picture o f the content o f care can be expected to be given. A limitation o f our 
investigation was the presence o f certain lacks o f information in the nursing files. HPN nurses 
reported that especially e-mail contact was very poorly documented. In practice, they sometimes e­
mailed with patients two times a week, and most o f these contacts were not summarised in their files. 
A second limitation relates to the questionnaire. Most questions were developed by our research 
group, because no validated questionnaire was available. Finally, we did not interview the general 
practitioners and other medical specialists involved in the care for these patients with their various 
underlying diseases, and therefore we do not know whether they experienced bottlenecks in HPN 
care.
In conclusion, the findings o f this study provide insight and direction for clinical practice regarding 
medical and psychosocial support in HPN patients. While there was ample attention for medical and 
physical problems, there seems room for improvement by more discussion o f psychosocial issues by 
the nutrition support team, or by the HPN nurse during other contacts. Patient concerns should be 
integrated in the follow-up contacts to enhance quality o f life.28-30 The participation o f a social worker 
or psychologist in the nutrition support team appears a strategy that might well lead to improved 
patient outcomes, but further research in this area is clearly needed.
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Chapter 9
"Life revolves around HPN, around me'
Discussion and summary
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Total Parenteral Nutrition is a lifesaving therapy in patients who have severe chronic intestinal failure, 
defined as an inadequate intestinal function for the absorption o f sufficient nutrients, electrolytes and 
water.1 Total Parenteral Nutrition in the home setting (HPN) is a complex technology involving the 
intravenous infusion, performed by the patient or by another caregiver, o f a sterile aqueous nutrition 
formulation directly into a large-bore central vein. Without the intravenous infusion of nutrients and 
electrolytes, there is an almost inevitable progression from metabolic disturbance and malnutrition to 
death in HPN patients.2 Unfortunately, Venous access device (VAD)-related infections and occlusions 
remain very common and patient- and technique-threatening complications in HPN treatment so far. 
As such, VAD complications are the major challenge for HPN patients and professionals in that they 
are the foremost cause for HPN programme failure and the most high-ranked reason for renewal of 
the venous access.3
In order to transfer the care to the home, the patient and/or caregiver is taught to manage the 
complicated sterile routine. HPN is a time-consuming routine which may be required for many years 
or, in some cases, for the rest o f life. It has a severe impact on the patient's life and any alteration 
from the daily routine requires planning. Indeed it has been shown that HPN directly affects the 
quality o f life experienced by both the patient and his or her family.4 A study of Baxter et al.5 
concluded that clinicians have serious concerns regarding the quality o f life o f their HPN patients and 
are in need of guidance concerning the assessment of this problem. Another important reason for 
assessing quality o f life in HPN patients is that information concerning experienced problems can be 
brought back to professionals as well as patients and help to anticipate on and understand the 
consequences o f HPN treatment.
The overall aim o f the present thesis was to establish a body o f knowledge on the quality of life, 
including somatic, psychological, and social aspects o f daily life, as experienced by HPN patients. 
Furthermore, we described the concurrent Dutch population on HPN with respect to venous access 
related-complications and the interrelation with psychosocial problems and quality o f life. Finally, we 
evaluated the quantity, quality and content o f professional care for Dutch HPN patients.
This final chapter provides an overview of the included studies in this thesis, and discusses the main 
findings as well as methodological issues. Also, conclusions and suggestions for future research and 
practice are provided.
Summary of results
In chapter 2, various databases were searched for relevant studies on implications of HPN for the 
quality o f life as experienced by patients, as well as caregivers. A total o f 26 studies were included in 
this literature review. Results showed that HPN patients experience a moderate to good quality of life, 
but psychological problems, e.g. depression and anxiety, were common. Social restrictions because of 
the venous access device and the time schedule for HPN administration were also common. 
Furthermore, patients experienced gastrointestinal motility problems and physical complaints such as 
fatigue. Some o f the patients were not able to have normal intake. Caregivers (e.g. partners and 
spouses) experienced social restrictions, depression and fatigue in daily life, but quality o f life reported 
was similar to the norms for healthy populations.
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Chapters 3 and 4 presented a survey on 48 Dutch HPN patients. A questionnaire was used to arrive 
at answers to the question: 'To what extent do long-term HPN patients experience problems?' 
Complementary, patients were interviewed to explore which HPN-treatment-related problems had a 
negative influence on daily life.
The questionnaires showed different physical problems such as diarrhoea, nausea, and vomiting, 
attributed to the underlying disease. Physical problems related to the HPN were fatigue, an odour 
(nutrition fluid), and nocturia. Psychosocial problems comprised depression, social impairment, and 
anxiety. The interviews clarified that psychosocial problems were the main complaints in daily life due 
to HPN dependence. Negative moods and feelings (e.g. anxiety, depressive feelings), limitations in 
social life, lack o f freedom, and fatigue were most commonly reported. Patients had an ambivalent 
attitude towards the HPN treatment: on the one hand, life without HPN was felt to be impossible, on 
the other, living with HPN was hard and a considerable burden on everyday life. Some o f the patients, 
though, had adapted to a life with HPN. They were particularly pleased that it was keeping them alive 
and although well aware o f the limitations it was causing, they had learned to enjoy the remaining 
pleasures o f life, while others felt restricted because of the physical or HPN-associated limitations 
(schedule, anxiety). This work shows that to improve the quality of life it is important to focus on 
fatigue, sleeping disorders, anxiety, depression, and social impairment. Despite the fact that HPN 
patients experience many somatic symptoms, psychosocial problems were primarily reported as having 
the greatest impact on daily life.
The success o f HPN programmes is compromised by complications o f venous access devices, such as 
bloodstream infection and occlusions. These problems result in multiple hospital admissions and, in 
the end, pose the foremost threat to continuation o f HPN therapy. In chapter 5 we compared blood 
stream infection (BSI) and occlusion incidence rates during central venous catheter and arteriovenous 
fistulae use. From the start o f our HPN programme in the early 1970’s, in addition to central venous 
catheter's, our centre has used arteriovenous fistulae (AVF) for vascular access in HPN care. Data 
were collected by reviewing the medical records. The population consisted o f 127 HPN patients for 
whom 343 central venous catheters and 194 arteriovenous fistulae access years, represented by 62 
arteriovenous fistulae and 623 central venous catheters, were analysed. In total, 836 vascular accesses 
were created to administer HPN in our 127 patients (median 5 per patient, range 1-24). O f the 120 
created arteriovenous fistulae, 75 (63%) became functional; 6 failed during creation, and 39 failed 
during maturation, mostly due to occlusions. In functional arteriovenous fistulae the occlusion 
incidence rate was slightly higher compared with some types o f central venous catheters. Independent 
o f central venous catheter type, the incidence rate o f the most serious access-related complication, i.e. 
blood stream infection, was extremely low in arteriovenous fistulae compared with central venous 
catheters. These results suggest that arteriovenous fistulae can be safe and valuable alternatives for 
central venous catheters in certain patients on long-term HPN.
The aim o f chapter 6 was to present an overview o f venous access device-related complications and 
to assess whether these adversities are related to experienced psychosocial problems and quality of life. 
Information on venous access device -related complications was collected from the medical records o f 
all 110 adult HPN patients who were followed by the two major referral centres in the Netherlands. In
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addition, a survey was performed among this group to characterise psychosocial problems and assess 
their association with technique-related complications. Seventy-five o f the 110 patients (68%) 
responded. The overall incidence of access-related blood stream infection was 3 per 1000 venous 
access days. Venous access device occlusions had occurred 0.8 per 1000 venous access days.
Severe fatigue was reported by 66%, almost 57% percent o f the HPN patients had depressive 
disorders, and the results o f the SIP-68 questionnaire showed raised levels on the subscales Social 
Behaviour, meaning high social impairment. For quality of life , patients scored a 5.7 on average, on a 
visual analogue scale from 0 to 10, where 0 stands for the worst-, and 10 for the best quality o f life. 
There was a highly significant association between the incidence of venous access device -related 
complications and the occurrence of psychosocial complaints. Taken together, the results from this 
study showed that in patients on HPN, depression, fatigue, social impairment, and the quality of life 
experienced are closely related to previously experienced access-related complications. This notion 
should bolster our efforts to prevent such adversities and further optimise the quality o f HPN care.
In our interviews, HPN patients reported fatigue as the most bothersome problem in daily life. 
Therefore, chapter 7 describes the course of fatigue and the predictors o f persistent fatigue. Patients 
completed questionnaires at baseline and follow up (12 months later). Measurements included fatigue, 
depression, functional impairment, social support, self-efficacy, coping, anxiety and acceptance. 
Relevant laboratory measures were obtained from the medical records at baseline and follow up. At 
baseline, sixty-five percent o f the patients were severely fatigued (n=49). Eighty-nine percent o f them 
experienced persistent fatigue. Serum haemoglobin, creatinine, albumin and bilirubin did not explain 
the occurrence o f fatigue in this patient population. Baseline fatigue predicted 57% of the variance of 
fatigue at follow up, and the coping style avoidance was responsible for 3% o f the variance. A cross­
sectional analysis showed that 46% o f the variance in fatigue was explained by functional impairment, 
self-efficacy, and depression. The importance o f identifying modifiable factors to predict fatigue is 
that these can help in the prevention and treatment of this problem. We therefore recommend a 
treatment programme to reduce functional impairment and depression, as well as increase self­
efficacy.
In our final study, presented in chapter 8, our aim was to describe the quality, quantity and content o f 
care given to HPN dependent patients by various professionals in the Netherlands, and to detect 
potential shortcomings. To answer our questions, a survey was performed, using a patient 
questionnaire to assess contacts with professionals and possible shortcomings in care. Nursing files 
from HPN nurses were reviewed for information from all contact moments between patient and 
HPN nurses in 2008. HPN nurses and (specialised) home care teams were interviewed to assess 
nursing care and to detect whether they experienced bottlenecks in daily care. Sixty-four patients 
visited the outpatient clinic for 156 times in 2008 (mean 2.5, range 0-8). HPN nurses had 244 contact 
moments with HPN patients in 2008, mostly by phone. Major issues during outpatient clinic contact 
and telephone contact with the HPN nurse were venous access device-related problems like fever or 
symptoms of an exit site infection, and physical complaints like nausea and diarrhoea. Overall, patients 
were satisfied with care provided by professionals. Despite this fact, several patients mentioned that
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their general practitioner had a lack o f knowledge, and some o f the patients as well as the HPN nurses 
experienced bottlenecks in psychosocial care. Providing support for psychosocial adaptation to HPN 
and anticipatory guidance for integrating this care into a person's lifestyle seems an important aspect 
o f the nurse's role.
D iscussion  of the m ain findings
The main findings o f the studies in the present thesis can be categorised as follows: 1) quality of life 
and problems experienced by HPN patients in daily life, 2) venous access device-related 
complications, 3) the relation between problems experienced by HPN patients and venous access 
device-related complications, and 4) bottlenecks in professional care.
1) Quality o f life  and  problems experien ced  by HPN patients in  daily  life  
T he mean quality of life scores in our studies are about 6 on average, based on a visual analogue scale 
from 0 to 10, where 0 stands for the worst possible quality of life and 10 for the best quality o f life. 
More than one third of the HPN patients (35-42%) scored below 6. Results from other studies 
reported quality o f life scores in HPN patients, varying from 'low' or 'poor' quality of life, to 
'moderate' or 'good' quality o f life.4,6,7 A study by Carlsson et al.8 used an almost similar quality of life 
scale as ours. The Visual Analogue Scale from 0 to 100 mm (0 = worst possible quality of life, 10 = 
best possible quality o f life) was given to HPN patients, and their median score was 48.
Our review and survey showed that HPN patients had multiple physical symptoms, such as diarrhoea, 
abdominal cramps and nausea. Poor physical functioning has been reported in other studies too, and 
this influenced quality o f life.7,9 Psychosocial problems mentioned by HPN patients were fatigue, 
depression, and social impairment. These problems were also common in other studies.8,10-12 Our 
results showed that a low quality o f life was strongly related to an increment in fatigue, higher anxiety, 
more severe depression, and greater social impairment. Furthermore, there was a good 
correspondence between results from the review and our survey, with regard to physical and 
psychosocial problems, and quality of life.
The literature provides documentation that quality o f life is poorer in individuals receiving HPN 
compared with normal populations and with patients with intestinal disease not requiring nutritional 
support.12 Patients with end-stage renal failure (ESRF), treated with haemodialysis or peritoneal 
dialysis, have been shown to have problems similar to those treated with HPN.13 Both patient groups 
are dependent on a technology for survival that affects daily activities. Psychosocial problems in 
ESRF-patients were comparable to those found in our studies. Depression, limitation in activities, and 
fatigue were reported as major psychosocial stressors in patients with ESRF.14-16 Both groups of 
patients experience similar medical complications, for example septicaemia, electrolyte disturbances 
and venous thrombosis. There are, however, also differences, which account for a higher satisfaction 
o f patients with end-stage renal failure. In particular, the more regular contact these patients have with 
health-care professionals and patients with similar problems, seems to contribute to better life 
satisfaction.13 These differences may also be responsible for the differences in reported visual analogue 
scale scores. In patients with end-stage renal failure means between 59 to 86 on a scale from 0 to 100
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mm were reported. Quality o f life in our HPN patients is lower, with means between 5.7 and 6.2 on a 
scale from 0 to 10.
2) Veno u s access d evice  rela ted-complications
Venous access device related-complications were a major threat in the HPN population studied in this 
thesis, although, blood stream infection rates and occlusion rates were comparable to those reported 
in other studies.17-21 Consequences o f venous access device-related complications are access removal 
and subsequent replacement. Frequent replacement of the venous access device, eventually seriously 
compromises the possibilities to obtain central venous access and can necessitate small bowel 
transplantation.22 Intestinal transplantation (ITx) is the only curative therapy for irreversible intestinal 
failure and it is the ultimate lifesaving option when complications impede parenteral support.23,24 
Intestinal transplantation, however, most certainly is not the solution for all patients depending on 
HPN. Since its beginnings in the late 1980s, the 1-year graft survival rate in ITx improved from 30% 
before 1991, to 80-90% between the years 2005 and 2007.25 Intestinal transplantation continues to be 
one of the greatest challenges in solid organ transplantation and to date remains a relatively 
uncommon procedure with approximately 1300 transplants performed worldwide.26 In the 
Netherlands, patients are listed for transplantation in case of severe or recurrent life threatening line 
sepsis, progressive liver disease, and/or loss o f conventional venous access. The experience with ITx 
in our country remains limited: so far only five procedures (some multivisceral) have been performed. 
The successful emergence o f intestinal transplantation as a curative alternative has provided many 
patients with bowel failure to be independent from infusions on a daily basis. A review by Sudan et 
al.27 concluded that available (limited) data suggest that quality o f life was reasonably good after 
intestinal transplantation and perhaps similar to that o f normal individuals. Others found that most 
patients had few re-hospitalisations or complications. A  high proportion of patient underwent 
successful social and occupational rehabilitation.28-30
To become the standard treatment for intestinal failure, transplantation must offer better survival, 
better quality of life, and lower costs than TPN. Considerable progress has been made towards these 
goals, but further refinements are needed before bowel transplantation becomes a routine surgical 
procedure.26 Therefore, intestinal transplantation is only offered in case of HPN treatment failure. 
Evidence-based interventions which effectively reduce the risk o f catheter-related blood stream 
infection therefore are very important, and are implemented in our daily practice. These include the 
use o f single lumen, tunnelled or implanted catheters, use o f 2% chlorhexidine as skin antiseptic, 
appropriate dressing o f the exit site and regular change of administration sets.31 Furthermore, various 
substances for flushing and locking the catheter for the purpose o f reducing the colonisation o f the 
device and/or reducing the risk of catheter related blood stream infection are studied. Some studies 
are promising,32,33 but at this point, there is not enough evidence to give recommendations in this 
regard.
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3) Th e  relation  betw een  problems ex perien ced  by HPN patients and  venous access
DEVICE-RELATED COMPLICATIONS
The majority of patients experienced venous access device-related complications at some point during 
their HPN treatment, and hospital admissions were often necessary. Psychosocial problems, 
manifesting as depression, social impairment and fatigue, were also reported by the majority of HPN 
patients. In our study, we found that venous access device-related complications and psychosocial 
problems were strongly associated. Furthermore, HPN patients with more venous access device­
related complications and related admissions reported a lower quality of life. Psychosocial problems 
were more common in patients who did experience venous access device-related complications. 
Therefore, we assume psychosocial problems are a result o f venous access device-related 
complications. To our knowledge, no other studies looked at this relationship, making comparisons 
impossible. From our earlier interview study34 we know that some of the patients are anxious because 
o f earlier venous access device-related complications experienced. This risk of new complications, is 
the reason they do not go outside when they are hooked-up to the parenteral nutrition. For some 
patients this means they are not able to join social activities. From literature, it is known that social 
inactivity is a risk factor for depression.35,36 Other patients told us that mobility is a problem during 
infusion, because o f the weight o f the nutrition bag and pump. Patients were on parenteral nutrition 
for a mean o f 14 hours a day, not including HPN procedures like preparing the nutrition bag, and 
(dis)connecting the parenteral nutrition. Because of this time-consuming therapy and a decreased 
mobility, they also miss social activities. With this information on social inactivity in mind, we assume 
that a decrease in venous access device-related complications will lead to a better quality o f life, and 
therefore, prevention of venous access device-related complications is very important. Novel 
strategies to improve the quality o f the remaining small bowel during the adaptation process after 
major resection, such as the use of the intestinal trophic hormone GLP-2 (glucagon-like peptide-2) or 
its synthetic analogues (e.g. Teduglutide) might in the near future provide tools to lower the frequency 
and volume o f the TPN formulation that has to be administered, but currently these agents have not 
yet been accepted as a mainstay of treatment.
4) Bo ttlen ecks  in  professional care
The final study in this thesis provided insight in professional care given to HPN dependent patients in 
the Netherlands. In literature there were no studies reporting an overview of professionals contacted 
and the content o f these contact moments. Neither was information on the content o f care from 
(specialised) home care teams available. Our study showed that in our country the nutrition team is 
primarily responsible for HPN care. Recently published guidelines from the European Society on 
Parenteral and Enteral Nutrition (ESPEN), state that the impact o f a nutrition support team in the 
management of HPN is likely to be significant.37 Centres with a nutrition support team are likely to 
use monitoring protocols, allowing the patient to be independent from hospital with improvement in 
quality of life. Adequate, careful training allows the patient to become the 'expert' patient, thereby 
reducing the frequency o f venous access device-related complications and consequent readmissions to 
hospital. The nutrition support team should provide both physical and psychological or emotional 
support for all patients on HPN.37 Within the nutrition support team included in our study, HPN
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nurses were contacted most frequently. Main topics during these contact moments were physical 
problems and venous access related-problems. Because we know psychosocial problems are common 
in this patient group,34,38,39 and patients reported a need for psychosocial support, there seems room 
for improving psychosocial care. HPN nurses seem to appropriately fulfil this important task, but 
involvement o f a social worker or psychologist may be valuable to improve quality o f life. Although a 
study by Perl et al.40 from 1980 already reported that quality of psychological support appeared to 
affect the patient's mental, physical, and social wellbeing significantly, nowadays, this support is still 
not a standard part o f the treatment.
M ethodological considerations
We started our research programme with a review on the impact o f home parenteral nutrition on daily 
life. This review was conducted in a systematic and meticulous manner. However, there were 
limitations in the data o f included studies, most o f them being descriptive, and some of the included 
studies were difficult to compare because of the use of different instruments, scales, and lifestyle 
domains. Furthermore, almost all studies included small samples o f patients, possibly leading to a 
limited generalisability. In our own studies, the included patient group was rather limited in size too, 
but included significantly more patients when compared with other studies in HPN patients.34,39,41-43 
Importantly, we included a very significant proportion (about 75%) of all the Dutch HPN patients in 
our studies. Despite these limitations, we feel that it was possible to give an adequate overview of the 
problems experienced by HPN patients.
A strength o f all studies presented in this thesis, is that patients' and professionals' opinions were the 
starting-point o f our studies. At the beginning o f the studies presented, a pilot study was performed to 
draw up a set o f questionnaires to address the question: 'To what extent do long-term HPN patients 
experience problems?' Two group interviews were performed, one with patients on long-term HPN, 
and one with professionals involved. Patients and professionals were explicitly selected to have a 
variety o f characteristics. The most important topics which emerged from the interviews were 
included in our studies, e.g. bowel disturbances, complications, fatigue, sleeping disorders, anxiety, 
depressive disorders, social impairment, sexual functioning disorders, and care provider burden. 
Furthermore, in this thesis, we used a combination of research methods in which both surveys and 
longitudinal studies, and qualitative and quantitative studies were performed to arrive at our overall 
aim. Several advantages o f these methods can be mentioned. First, these study methods are 
complementary to one another. Second, this integrated approach gave us an extensive insight into the 
problems experienced by HPN patients, and in professional care given to these patients. In our 
interview study we audio-taped all interviews. To increase the reliability o f the data, summaries o f the 
patients' words were read back to the patient for confirmation. The notes taken by the interviewer 
were also read back to the patient to confirm their accuracy. Peer debriefing was used to check 
interpretation by colleague researchers, and peer examination was used to evaluate data analysis by an 
independent researcher.
From the literature we know that it is hard to distinguish between problems resulting from the 
underlying disease, and problems related to the parenteral nutrition treatment. Therefore, we always
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asked patients to state the problems in their daily life they felt were due to the HPN treatment. 
However, for patients it is sometimes hard to make this distinction . Nevertheless, we found that 
patients with different underlying diseases experienced the same problems. For example, patients with 
a mesenteric thrombosis experience less complaints due to their underlying disease compared to 
patients with motility disorders. Our results however, did not show a difference in psychosocial 
problems experienced by these patient groups. This might be due to the fact that we always asked 
patients to state whether they considered problems to be due to the HPN treatment. Therefore, we 
think that HPN largely impacted on problems experienced in daily life.
We explored patient problems and venous access device-related complications extensively. We 
included predictors o f one o f the main problems, fatigue, and furthermore, the relationship between 
psychosocial problems and venous access device-related complications was analysed. Venous access 
device-related complications were obtained from the medical records from HPN patients. A 
disadvantage o f using medical records is the possibility o f missing data, given that underreporting is a 
common problem. We tried to tackle this problem by including nursing files in the study. Therefore, 
we think a near-complete picture of venous access device-related complications is given. Furthermore, 
in these studies, data collection was carried out by two reviewers independently, both with clinical 
experience in the field o f HPN.
HPN patients were very willing to participate in the studies presented. During our studies, patients 
were frequently asked to participate and fill out extensive questionnaires. Patients were well informed 
and results were given back to them. In most studies, both Dutch HPN centres were included. Given 
the fairly high response rates and the non-selective non-response in the studies, we think that the 
results o f our studies can be generalised to all HPN dependent patients in the Netherlands. When 
generalising the results from our studies to the American and European situation, it should be kept in 
mind that in the Netherlands, HPN is not indicated for cachexia secondary to cancer or AIDS as it is 
in some countries.44 In the last study, presented in chapter 8, only one HPN centre was included. We 
acknowledge that there might be small differences in care provided by the two Dutch HPN centres, 
for example in the instructions to new HPN patients.
In the studies presented in this thesis several validated instruments were used, for example the 
Sickness Impact Profile-68,45,46 the Beck Depression Inventory,47,48 the Utrecht’s Coping list,49 de 
Checklist Individual Strength,50 the Stait-Trait Anxiety Inventory,51 the Social Support List,52 and 
Cantril's Ladder o f Life.53 Most questionnaires were validated and used in various populations. We 
used the subscale Fatigue o f the multidimensional Checklist Individual Strength (CIS) to measure 
fatigue in our population. The CIS demonstrated sensitivity to change, and therefore, was included in 
our longitudinal study. Although, the CIS-fatigue has not been tested for reliability or validity in HPN 
patients, it was previously used in patients with many different diseases and showed good reliability, 
discriminative validity, and sensitivity to change.54-56 In our first survey, the Stait-Trait Anxiety 
Inventory (STAI) was used, based on a high reliability.51,57 Surprisingly, anxiety levels in the HPN 
group matched those in the general Dutch population. In the interviews, taken at the same time,
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anxiety was mentioned as a very severe problem by one-third of all patients. Apparently, the STAI was 
not sensitive enough to measure the relatively high anxiety experienced by HPN patients. Therefore, 
in the following study, we used our own anxiety questionnaire, based on the interviews. Unfortunately, 
this questionnaire was not tested on forehand.
Conclusions
•  Quality o f life o f HPN patients reported in literature was moderate to good, but psychosocial 
problems are common, due to the HPN treatment.
•  In our Dutch HPN population, patient problems experienced in daily life were mainly 
psychosocial, including fatigue, depression, and social impairment.
•  Amongst physical problems, fatigue and diarrhoea have a major impact on daily life.
•  The venous access device is literally a patient's 'lifeline'. In the Dutch HPN populations, catheter- 
related blood stream infection and occlusions are common complications. These complications are 
an important cause of hospitalisation and patients often need a new venous access device.
•  Arteriovenous fistulae are safe and valuable alternatives for central venous catheters in patients on 
long-term HPN. This is o f major importance, because blood stream infection is the most frequent 
and most life-threatening catheter related complication in HPN patients.
•  Despite venous access device-related complications, HPN is fairly safe these days. Therefore, 
attention to quality o f life has increased over the last years. One of the goals o f HPN is to improve 
this quality of life.
•  Psychosocial problems and lower quality of life are associated with previously experienced venous 
access complications.
•  The main problem in HPN patients, fatigue, is a persistent problem and baseline fatigue is the 
strongest predictor o f fatigue one year later. Functional impairment, self-efficacy, and depression 
are strongly related to fatigue.
•  HPN patients visit a broad range o f professionals, including the nutrition support team and their 
general practitioner. Physical complaints and venous access device-related problems were mainly 
discussed, but next to these topics, there is a need for more psychosocial support.
Im plications for future research
Several implications for future research can be deducted from the results o f the present thesis.
First, weak study designs have been a major bugbear in many investigations into the effectiveness of 
HPN. Many studies are hospital based, and therefore, samples are small. Randomised controlled trails 
are unique in quality of life studies. Larger, multicentre studies should be performed. They should be 
prospective, with a clearly defined aim. Comparative studies should have a control group and be 
randomised. In different countries, different protocols and training techniques are used in HPN 
treatment in. Therefore, it is difficult to include HPN centres from different countries. Because o f the 
relatively small samples, and various underlying diseases, it is also difficult to randomise patients to a 
control or intervention group. Mostly, the numbers in the groups are too small for statistical analysis. 
International collaboration is needed to resolve these limitations in study design.
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Second, with respect to venous access device-related complications, catheter removal is often 
necessary. This raises problems with venous access for patients on long-term treatment and can be 
associated with significant morbidity and mortality.4 Arteriovenous fistulae therefore, can be a safe and 
valuable alternative for patients requiring long term HPN. Recent positive results on an antibiotic lock 
solution however, raise the question whether new arteriovenous fistulae have to be created, 
considering the main problem in arteriovenous fistulae of occlusion. In this study, the use of an 
antibiotic lock solution containing 2% taurolidine was compared to our previous standard practice 
where we used low-dose (150 U/ml) heparin to lock CVC's. Taurolidine has been shown to 
dramatically (>90%) reduce the recurrence o f catheter related blood stream infection in patients who 
had presented with such an infection shortly before and who were able to continue HPN 
administration, either with a new or with their old access device (Hickman® catheter or subcutaneous 
port).22 Based on these results we have changed our clinical practice and use taurolidine on a regular 
basis in high risk patients. In due time we will evaluate whether the new policy with taurolidine 
translates into improved long-term outcomes in regard to venous access device-related complications. 
Moreover, we want to study the effect o f reduced catheter related blood stream infection on quality of 
life as well as psychosocial outcome measures.
Third, the current literature on quality of life in HPN patients is quite difficult to interpret because of 
the limited number o f studies, the wide variety of instruments that were used, and the lack o f patient 
participation in part o f the studies. There is a growing demand for an HPN-specific quality o f life 
measure for use in routine clinical practice (Chambers & Powell-Tuck, 2007).58 Recently, a European 
study started with the aim to complete a large-scale population study to validate the HPN-QUALITY 
OF LIFE©  for use in an international population and to define the quality o f life o f patients receiving 
home parenteral nutrition for chronic intestinal failure, using the HPN-QUALITY OF LIFE©. This 
instrument will be validated using recognised psychometric methods. The use of this questionnaire in 
practice will ultimately provide considerable benefit to HPN patients because it identifies issues of 
relevance to HPN patients and it will be sensitive to issues that are o f particular importance in this 
patient population.5 Both Dutch HPN centres are included in this study.
Fourth, further evaluation of quality of life is necessary in several other HPN patient groups. Quality 
o f life should be assessed in patients with malignant diseases in the Netherlands, to evaluate the value 
o f this treatment in improving quality of life. Furthermore, survival and quality of life after intestinal 
transplantation in the Netherlands should be evaluated and compared with survival and quality of life 
o f patients receiving Home Parenteral Nutrition. Moreover, in the Netherlands, quality o f life in 
children on HPN has not been evaluated. From foreign studies, during the last three to four decades, 
use o f parenteral nutrition has been successful in supporting survival and normal growth in paediatric 
patients with severe intestinal failure. Children receiving HPN for short-bowel syndrome and Crohn's 
disease, may have a better probability o f survival (89% after 5 years)59,60 than adults (60-75% after 5 
years).61-63 Children can now survive to adulthood.59,64 Quality of life o f HPN-dependent children and 
siblings is not different from that o f healthy children, suggesting that these children actively use 
effective coping strategies. In contrast, the quality of life o f parents o f HPN-dependent children is
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low.65 Evaluation of quality of life in this patient group is necessary for caregivers, as this particular 
group is growing. Furthermore, in the Netherlands, no information is available on this topic. In 
practice, it is important for nutrition support team members that they can fit their professional care to 
the patients’ needs.
Finally, research is necessary for developing and evaluating psychosocial interventions in HPN 
patients. Interventions should focus on the main problems HPN patients experience in daily life: 
fatigue, social impairment, and depression. In relation to fatigue, a systematic review showed that 
there was limited evidence that psychosocial interventions during cancer treatment were effective in 
reducing fatigue.66 However, part o f the included studies showed that brief nursing interventions 
including education, self-care, coping techniques, and activity management were effective.67-69 
Godino70 also found a significant effect o f an individualised and structured nursing intervention with 
education in oncology patients. In this study, there was a decrease in the level o f fatigue in the 
experimental group, whereas the group o f patients that did not receive this intervention showed an 
increase in fatigue level along the treatment. For chronic fatigue syndrome patients, cognitive 
behaviour therapy has proven to be successful in reducing fatigue complaints.71-74 Besides reducing 
fatigue severity, cognitive behaviour also had a positive effect on functional impairment.73 
With respect to depression, Pariser and O'Hanlon75 conducted a study to detect the results o f a 
minimal nursing intervention (i.e., written information, goal-setting, and action plans) on positive 
changes in self-efficacy and depression in older adults with arthritis. In HPN patients, a study by 
Smith et al.76 showed that by means o f interactive education, depressive reactions can be prevented 
and the patients' own capacity to solve problems is promoted. This intervention also led to a higher 
health related quality o f life.
For social impairment, Skerrett et al.77 have shown that the ways in which patients interpret and 
respond to their symptoms (coping style), have a significant impact on the level o f social impairment. 
The most important correlates o f social adjustment were feelings o f embarrassment and 
avoidance/resting behaviours (for example "when I experience symptoms, I rest") Based on results 
from literature, research in our HPN patients is needed to develop and evaluate suitable interventions.
Im plications for practice
Because intestinal transplantation is not the standard treatment for intestinal failure, it is important to 
develop preventive methods for the number one complication, e.g. blood stream infection. Therefore, 
our Nijmegen HPN centre, recently compared taurolidine with heparin. As previously mentioned, 
taurolidine lock dramatically decreased catheter-related bloodstream infections when compared with 
heparin.22 However, the long-term use of taurolidine, and its effect on blood stream infection and 
occlusion must be evaluated in practice. Also, taurolidine cannot be used in patients who administer 
parenteral nutrition by means o f an arteriovenous fistula. In the mean time, taurolidine has become 
the standard of care in the two major referral centres in the Netherland. A  key issue that remains to be 
solved is whether it is necessary to use special catheter locks in all HPN patients, i.e. including those 
who have never developed catheter-related infections. It appears prudent to mention that a proper 
catheter care at this point has the most established effect on central line survival.
Discussion and summary 133
Besides attention for venous access-related complications, a psychosocial assessment is necessary at 
regular intervals throughout the years. The most relevant information on quality o f life comes directly 
from the patient, so preference is given to periodical assessment o f patient problems experienced, 
during outpatient clinic visits. Psychosocial and quality of life issues must be incorporated in the goals 
o f the nutrition support team.
Furthermore, in the nutrition support team, there seems to be room for improvement, i.e. 
psychosocial issues could be addressed more systematically and more in-depth. HPN nurses may be 
the right persons to provide psychosocial support, because o f their frequent contact with HPN 
patients. HPN patients feel a need for this kind o f care. Home visits would be appropriate to pay 
attention to psychosocial problems. In practice, home visits already are introduced, but should be 
performed once every one to two years, dependent on problems that the patient experiences. 
Furthermore, many studies have shown the effects o f support groups in terms of significantly 
improved physical condition, social support, and quality of life in patients with cancer and 
haemodialysis.78-80 This kind of support group may be beneficial to HPN patients.
The management of fatigue, being one of the main problems in HPN patients, represents a major 
challenge for HPN nurses. The nurse's role may include patient assessment to identify patients with 
(severe) fatigue and patients at risk for developing fatigue, evaluating potential causes o f fatigue, and 
implementation o f interventions to manage fatigue. Assessment of fatigue could be done with a short 
instrument. Interventions may include patient and family education, self-care activities, coping 
training, counselling, and interventions based on the principles o f cognitive behaviour therapy.81 HPN 
nurses are in the position to help patients manage the symptoms of the underlying disease and HPN, 
for example fatigue. Until specific interventions for the treatment of fatigue in HPN patients are 
available, the nutrition support team should be more aware o f this problem, and offer more general 
fatigue interventions like supportive listening and education on fatigue (e.g. explanation o f the feelings 
o f fatigue, causes, pattern, and consequences) Information can help the patient understand what is
happening and can increase the feeling of control and thus may have a positive effect on the
82symptom.
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Totaal parenterale voeding (TPV) is een levensreddende behandeling voor patiënten met ernstig 
darmfalen. Deze patiënten zijn zelf niet in staat om voldoende voedingsstoffen en water op te nemen 
uit het voedsel. De meest voorkomende onderliggende aandoeningen zijn het kortedarmsyndroom, als 
gevolg van uitgebreide darmresecties, bijvoorbeeld bij de ziekte van Crohn o f als gevolg van 
mesenteriaal trombose, en motiliteitsproblemen. TPV wordt toegediend via de veneuze bloedbaan, 
meestal in de vorm van een centraal veneuze catheter (Hickmancatheter), een geïmplanteerde 
onderhuidse poort (Port-a-Cath), o f een arterioveneuze fistel (shunt). Sinds het eind van de jaren ’70 
kan TPV ook in de thuissituatie toegepast worden (Thuis-TPV). Patiënten worden in dat geval in het 
ziekenhuis getraind door speciaal opgeleide verpleegkundigen. De patiënt en /of partner leren alle 
handelingen rondom het toedienen van TPV zelfstandig uit te voeren. Wanneer dit laatste niet 
mogelijk is wordt een specialistisch team van verpleegkundigen in de thuissituatie ingeschakeld. 
Patiënten kunnen volledig afhankelijk zijn van TPV, maar in veel gevallen betreft het een toevoeging 
op orale en /o f enterale (sonde)voeding. Ongeveer een derde deel van de patiënten is zelf geheel niet 
in staat om te eten en drinken. Afhankelijk van de behoefte van de patiënt, wordt TPV 2 tot 7 keer per 
week toegediend. Over het algemeen voeden patiënten thuis 's nachts, gedurende een periode van 12 
tot 14 uur, zodat zij overdag 'vrij' zijn van de voedingszak en —pomp. Dit cyclische voeden is ook van 
belang om TPV-gerelateerde complicaties, zoals leverfunctiestoornissen en het risico op infecties, te 
verminderen.
In de afgelopen jaren is er veel aandacht geweest voor de diverse aspecten van het medisch-technische 
handelen in deze patiëntengroep. In schril contrast hiermee is er echter weinig informatie beschikbaar 
over de kwaliteit van leven en de problemen die TPV-patiënten ervaren in het dagelijks leven. 
Complicaties van de toegangswegen komen bij deze patiënten regelmatig voor en leiden vaak tot 
ziekenhuisopnamen. We weten niet goed o f deze medische complicaties invloed hebben op ervaren 
problemen en is er onduidelijkheid over de zorg die TPV-patiënten ontvangen nadat zij geïnstrueerd 
zijn.
Het doel van dit proefschrift is het verkrijgen van kennis met betrekking tot verschillende 
onderwerpen die relevant zijn voor zorgverleners die betrokken zijn bij de zorg voor TPV-patiënten in 
de thuissituatie. Ons algemene doel is in drie subdoelen gespecificeerd:
1) Het beschrijven van beschikbare kennis over de kwaliteit van leven, inclusief somatische, 
psychologische en sociale aspecten van het dagelijks leven, zoals dat ervaren wordt door TPV- 
patiënten
2) Het beschrijven van de problemen die worden ervaren door TPV-patiënten in Nederland, de 
complicaties van de toegangswegen, en een evaluatie van een mogelijke relatie tussen deze 
complicaties en psychosociale problemen en kwaliteit van leven
3) Het beschrijven van de kwantiteit, kwaliteit en inhoud van de zorg van professionals aan 
Nederlandse TPV-patiënten.
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In dit proefschrift worden 6 studies beschreven in 7 hoofdstukken. In hoofdstuk 2 wordt een 
literatuurstudie gepresenteerd met als doel het beschrijven van de invloed die TPV heeft op de 
kwaliteit van leven van patiënten en mantelzorgers. Verschillende databases, zoals Pubmed, Cinahl en 
Psychlit zijn doorzocht om een antwoord te krijgen op onze vraag. In totaal werden 26 studies 
geïncludeerd. De resultaten laten zien dat TPV-patiënten een redelijke tot goede kwaliteit van leven 
ervaren, maar tonen ook dat psychosociale problemen, zoals depressie en angst, vaak voorkomen. De 
toegangsweg en het tijdschema voor het toedienen van TPV zijn belangrijke belemmeringen in sociale 
contacten. Daarnaast ervaren patiënten lichamelijke klachten zoals buikpijn en vermoeidheid die vaak 
samenhangen met de onderliggende aandoening die het gebruik van TPV noodzakelijk maakte. Een 
deel van de patiënten is daardoor ook niet in staat om zelf te eten of te drinken. Mantelzorgers (bijv. 
partners en echtgenoten) geven aan een goede kwaliteit van leven te hebben, maar ook zij ervaren 
problemen zoals depressie, vermoeidheid en sociale beperkingen.
In hoofdstuk 3 en 4 wordt een onderzoek onder 48 Nederlandse TPV-patiënten gepresenteerd. 
Centraal stond de vraag: ‘Welke problemen ervaren TPV-patiënten in het dagelijks leven?’ In 
Nederland is hiernaar niet eerder onderzoek gedaan. In hoofdstuk 3 worden de resultaten van een 
enquête weergegeven. De gebruikte vragenlijsten waren gebaseerd op resultaten van twee 
groepsinterviews: één met TPV-patiënten, en één met zorgverleners. De vragenlijsten hadden 
betrekking op verschillende onderwerpen, waaronder lichamelijke klachten, vermoeidheid, depressie, 
copingstijlen, angst, ziektegerelateerde disfunctie, slaapproblemen en kwaliteit van leven. De meest 
voorkomende lichamelijke klachten bij TPV-patiënten zijn misselijkheid, braken en diarree. Deze 
problemen zijn vooral een gevolg van de onderliggende ziekte. Klachten als gevolg van de TPV zijn 
vermoeidheid en 's nachts vaak moeten plassen. Psychosociale problemen zoals depressie, sociale 
beperkingen en angst komen vaak voor. H oofdstuk 4 beschrijft de resultaten van interviews die zijn 
afgenomen bij deze 48 TPV-patiënten. Patiënten werden thuis geïnterviewd. Aan patiënten werd 
gevraagd om de drie problemen te noemen die de grootste invloed hadden op het dagelijks leven ten 
gevolge van de behandeling met TPV. De resultaten laten zien dat psychosociale problemen de 
grootste invloed hebben op het dagelijks leven. Negatieve stemmingen, gevoelens van angst en 
depressie, sociale beperkingen, gebrek aan vrijheid door de TPV behandeling en vermoeidheid zijn de 
meest voorkomende problemen die genoemd werden tijdens de interviews. Patiënten hebben een 
ambivalente houding ten opzichte van de TPV: aan de ene kant is leven zonder TPV onmogelijk, maar 
aan de andere kant is het leven met TPV moeilijk en een behoorlijke belasting in het dagelijkse leven. 
Sommige patiënten hebben zich aangepast aan het leven met TPV. Zij zijn blij dat ze dankzij de TPV 
nog leven en alhoewel ze zich bewust zijn van de beperkingen, hebben zij geleerd om te genieten van 
de dingen die ze nog wel kunnen. Andere patiënten voelen zich met name beperkt vanwege de 
lichamelijke klachten o f TPV gerelateerde beperkingen zoals het tijdschema o f angst voor 
complicaties.
Dit onderzoek heeft laten zien dat het belangrijk is voor zorgverleners om zich te richten op de meest 
voorkomende problemen, vermoeidheid, angst, depressie en sociale beperkingen. Ondanks het feit dat 
TPV-patiënten veel lichamelijke klachten ervaren, vinden zij dat de psychosociale problemen het 
meeste invloed hebben op het dagelijks leven.
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Het succes van de behandeling met TPV wordt voor een groot deel bepaald door het uitblijven of 
optreden van complicaties van de toegangsweg, zoals infecties en verstoppingen. Deze problemen zijn 
aanleiding voor ziekenhuisopname, de toegangsweg moet eventueel worden vervangen, en uiteindelijk 
zijn deze complicaties een bedreiging voor het continueren van de behandeling met TPV. In 
hoofdstuk 5 zijn infecties en verstoppingen van verschillende toegangswegen (centraal veneuze 
catheters vs. shunts) vergeleken. De populatie bestond uit 127 TPV-patiënten bij wie het optreden van 
complicaties bij 623 centraal veneuze catheters (CVC's) en 62 shunts zijn geanalyseerd. In totaal 
werden er 836 toegangswegen gecreëerd bij 127 patiënten (mediaan 5 toegangswegen per patiënt, 
range 1-24). Van de 120 shunts die werden aangelegd, werden er 75 (63%) functioneel; 6 shunts 
mislukten tijdens de aanleg, en 39 shunts rijpten niet tot een bruikbare veneuze toegang. Bij de goed 
ontwikkelde shunts was de incidentie van verstoppingen slechts iets hoger vergeleken met 
verschillende typen CVC's. De incidentie van de meest voorkomende en mogelijk levensbedreigende 
complicatie, namelijk infectie, is extreem laag bij shunts in vergelijking met CVC’s. Deze resultaten 
laten zien dat shunts veilig zijn en een waardevol alternatief zijn voor CVC's in bepaalde patiënten die 
TPV thuis gebruiken.
Het doel van de studie in hoofdstuk 6 was het presenteren van een overzicht van lijncomplicaties en 
het analyseren van een mogelijke relatie tussen deze complicaties en psychosociale problemen en 
kwaliteit van leven. Informatie betreffende de lijncomplicaties werd verzameld uit de medische 
dossiers van 110 volwassen TPV-patiënten, die in de twee TPV centra in Nederland onder 
behandeling waren. Daarnaast werd er een vragenlijst afgenomen om psychosociale problemen in 
kaart te brengen, en om te evalueren o f deze problemen mogelijk gerelateerd waren aan 
lijncomplicaties. Vijfenzeventig van de 110 patiënten (68%) vulden de vragenlijst in. De incidentie van 
lijninfecties bleek 3 per 1000 catheterdagen en de incidentie van verstoppingen 0.8 per 1000 
catheterdagen te bedragen.
Ernstige vermoeidheid werd gerapporteerd door 66% van de TPV-patiënten, bijna 57% had last van 
depressiviteit en patiënten meldden veel sociale beperkingen. TPV-patiënten scoorden gemiddeld een
5.7 wat betreft hun kwaliteit van leven, op een schaal van 0 tot 10, waar 0 staat voor de slechtste 
kwaliteit van leven, en een 10 voor de beste kwaliteit van leven. Er was een significante associatie 
tussen de incidentie van lijncomplicaties en de aanwezigheid van psychosociale problematiek. De 
resultaten laten zien dat lijncomplicaties gerelateerd zijn aan depressieve gevoelens, vermoeidheid, 
sociale beperkingen, en een lagere kwaliteit van leven. Het is daarom belangrijk onderzoek te doen 
naar de mogelijkheden om lijncomplicaties te voorkomen en zo de kwaliteit van zorg voor TPV- 
patiënten te optimaliseren.
In onze interviews gaven TPV-patiënten aan dat vermoeidheid het meeste invloed had op het dagelijks 
leven. Daarom hebben we in hoofdstuk 7 een studie beschreven die het verloop van vermoeidheid en 
de voorspellers van aanhoudende vermoeidheid weergeeft. Patiënten vulden op twee momenten 
vragenlijsten in (baseline en follow-up, 12 maanden later). Deze vragenlijsten omvatten vragen over 
vermoeidheid, depressie, functionele beperkingen, sociale ondersteuning, self-efficacy, copinggedrag, 
angst en acceptatie. Daarnaast werden relevante bloeduitslagen opgezocht in de medische dossiers van 
de patiënten. De baseline gegevens laten zien dat vijfenzestig procent (n=49) van de TPV-patiënten 
ernstig vermoeid is. Negenentachtig procent van hen was tijdens de follow-up meting nog steeds
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ernstig vermoeid. Hemoglobine, kreatinine, albumine en bilirubine verklaren de aanwezigheid van 
vermoeidheid bij deze patiënten niet. Een longitudinale regressie-analyse laat zien dat baseline 
vermoeidheid 57% van de variantie van follow-up vermoeidheid verklaart, en dat de coping stijl 
'vermijden' verantwoordelijk is voor 3% van de variantie. Een cross-sectionele analyse laat zien dat 
46% van de variantie wordt verklaard door functionele beperkingen, self-efficacy en depressie. Het 
belang van het identificeren van deze factoren is groot omdat dit kan bijdragen aan de preventie of 
behandeling van vermoeidheid. Een behandelprogramma met als doelstelling het verminderen van 
functionele beperkingen en depressie, en het verbeteren van self-efficacy, zou positieve resultaten ten 
aanzien van vermoeidheid op kunnen leveren.
In onze laatste studie, die beschreven is in hoofdstuk 8, was onze doelstelling het beschrijven van de 
kwaliteit, kwantiteit en inhoud van zorg die de TPV-patiënten ontvangen van de verschillende 
betrokken hulpverleners in Nederland. Daarnaast waren we geïnteresseerd in mogelijke knelpunten in 
deze zorg. Om onze vragen te kunnen beantwoorden hebben we een survey uitgevoerd, waarin we 
vragenlijsten voor patiënten hebben gebruikt om het contact met hulpverleners te evalueren. De 
verpleegkundige dossiers van het voedingsteam van TPV-patiënten werden gebruikt om informatie te 
verzamelen over de contacten met de TPV verpleegkundigen. TPV verpleegkundigen en 
verpleegkundigen van de (gespecialiseerde) thuiszorg werden geïnterviewd om verpleegkundige zorg 
te evalueren en mogelijke knelpunten te inventariseren. Patiënten onder behandeling van het UMC St 
Radboud werden uitgenodigd voor dit onderzoek.
Vierenzestig TPV-patiënten bezochten 156 keer de polikliniek van het UMC St Radboud in 2008 
(gemiddelde 2.5, range 0-8). TPV verpleegkundigen hadden telefonisch en via de e-mail 244 
contactmomenten met TPV-patiënten in 2008. De meest besproken onderwerpen tijdens 
polikliniekbezoeken en contacten met de TPV verpleegkundigen waren lijnproblemen, zoals koorts, 
koude rillingen of symptomen van een infectie van de uittredeplaats van de catheter. Daarnaast 
werden lichamelijke klachten, zoals misselijkheid en diarree, veel besproken. Over het algemeen waren 
TPV-patiënten erg tevreden over de zorg van verschillende hulpverleners, maar enkele knelpunten 
werden genoemd. TPV-patiënten gaven aan dat de huisarts (te) weinig kennis had van de behandeling 
met TPV. Daarnaast gaven zowel de TPV-patiënten als de TPV verpleegkundigen aan dat de 
psychosociale zorg verbeterd kan worden. Psychosociale ondersteuning is nodig bij het accepteren en 
aanpassen aan een leven met TPV en bij het integreren van de TPV in het dagelijks leven. Deze 
ondersteuning zou door TPV verpleegkundigen gegeven kunnen worden.
In hoofdstuk 9 is een Engelstalige samenvatting van dit proefschrift gegeven en worden de 
belangrijkste bevindingen bediscussieerd. De belangrijkste bevindingen uit het proefschrift zijn 
onderverdeeld naar vier onderwerpen:
1) Kwaliteit van leven en ervaren problemen van TPV-patiënten in het dagelijks leven.
De kwaliteit van leven van TPV-patiënten, gerapporteerd in internationale tijdschriften, is matig 
tot goed. De kwaliteit van leven van Nederlandse TPV-patiënten is matig. Ruim een derde deel 
van de TPV-patiënten vindt de kwaliteit van leven onvoldoende. Psychosociale problemen 
drukken de grootste stempel op het leven van alledag.
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2) Complicaties van de toedieningsweg voor TPV.
De toedieningsweg is voor de patiënt een 'levenslijn', door de TPV blijven zij in leven. De meest 
voorkomende complicaties zijn infecties en verstoppingen. Deze complicaties zijn een belangrijke 
oorzaak van ziekenhuisopnames en patiënten hebben vaak een nieuwe lijn nodig.
In Nijmegen worden, als enige centrum in Europa, ook regelmatig shunts gebruikt voor het 
toedienen van TPV. Uit ons onderzoek is gebleken dat deze shunts veilig zijn in het gebruik en 
dat infecties, de meest voorkomende en soms levensbedreigende complicatie, veel minder vaak 
voorkomen bij shunts in vergelijking met centraal veneuze catheters en port-a-caths.
3) De relatie tussen ervaren problemen van TPV-patiënten en lijncomplicaties.
Psychosociale problemen (vermoeidheid, depressie en sociale beperkingen) en kwaliteit van leven 
hangen samen met ervaren lijncomplicaties. Eén van de doelstellingen van de behandeling met 
TPV is het verbeteren van de kwaliteit van leven. Dit zou mogelijk zijn door het aantal 
lijncomplicaties te verminderen, en meer aandacht aan psychosociale problematiek te schenken.
4) Knelpunten in zorgverlening aan patiënten met TPV.
Er is behoefte aan meer psychosociale ondersteuning vanuit het voedingsteam.
Aanbevelingen voor verder onderzoek
Internationale samenwerking is nodig om grotere aantallen patiënten te kunnen bestuderen. Op die 
manier is het mogelijk om gerandomiseerde onderzoeken uit te voeren, waarin een controlegroep 
wordt opgenomen en het effect van interventies kan worden onderzocht.
Zulk onderzoek zou zich bijvoorbeeld moeten richten op mogelijkheden voor het verminderen van 
complicaties van de toegangsweg, een voorbeeld hiervan is het gebruik van antimicrobiële middelen 
zoals taurolidine, om de katheter mee af te sluiten na het toedienen van de TPV. Daarnaast is 
onderzoek naar kwaliteit van leven in diverse patiëntpopulaties nodig, zoals bij TPV-patiënten met een 
kwaadaardige aandoening, bij kinderen met TPV en bij (ex TPV) patiënten die een darmtransplantatie 
hebben ondergaan. Tenslotte is er onderzoek nodig om psychosociale interventies te ontwikkelen en 
uit te testen voor de belangrijkste problemen bij TPV-patiënten (vermoeidheid, depressie en sociale 
beperkingen). Te denken valt aan verpleegkundige interventies met betrekking tot educatie, 
copingstijlen, cognitieve gedragstherapie en activiteitenmanagement. Uit onderzoek bij andere 
patiëntgroepen is gebleken dat dergelijke interventies positief van invloed kunnen zijn op 
psychosociale problemen.
Aanbevelingen voor de praktijk
Dunnedarmtransplantatie is op dit moment nog geen standaard behandeling bij ernstig darmfalen, ook 
al omdat patiënten met deze techniek tot nog toe minder lang overleven dan bij gebruik van thuis- 
TPV. Gezien de frequente medische complicaties van de behandeling met TPV is het wel van groot 
belang om strategieën te blijven ontwikkelen om vooral problemen met betrekking tot de veneuze 
toegangsweg te verminderen, c.q. te voorkomen. Op dit moment wordt er een studie gedaan naar de 
effecten van taurolidine op lijninfecties, waarin onder andere wordt gekeken naar de lange-termijn 
effecten. Tot de resultaten van deze studie bekend zijn hebben de twee TPV centra in Nederland 
(UMC St Radboud en AMC Amsterdam) ervoor gekozen TPV-patiënten met een centraal veneuze
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catheter o f poort standaard te behandelen met taurolidine. Daarnaast blijft het uiteraard van het 
grootste belang veel aandacht te besteden aan de juiste zorg voor de toegangsweg, omdat dit 
waarschijnlijk de grootste invloed heeft op de levensduur hiervan.
Verder moet er een periodieke evaluatie van psychosociale problemen bij TPV-patiënten worden 
uitgevoerd. Dit kan tijdens polikliniekbezoeken, waar ook psychosociale problemen kunnen worden 
besproken met leden van het voedingsteam. Daarnaast zouden thuisbezoeken met meer regelmaat 
moeten plaatsvinden, afhankelijk van de problematiek van de patiënt. Mogelijk kunnen 
ondersteuningsgroepen positieve effecten hebben op psychosociale problemen, en dus zouden 
mogelijkheden hiertoe moeten worden uitgezocht.
Het meest voorkomende probleem, vermoeidheid, verdient daarbij speciale aandacht. Periodieke 
evaluatie met behulp van een standaard vragenlijst is hier van belang. Zolang er geen interventies zijn 
ontwikkeld voor TPV-patiënten die ernstig vermoeid zijn, is het belangrijk dat TPV-verpleegkundigen 
zich meer bewust zijn van dit probleem, informatie kunnen verstrekken en het bespreekbaar kunnen 
maken met de patiënt.
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Abbreviations
AVF Arteriovenous Fistula
BDI Beck Depression Inventory
BDI-PC Beck Depression Inventory Primary Care
BSI Blood Stream Infection
CBT Cognitive Behaviour Therapy
CFS Chronic Fatigue Syndrome
CIIP Chronic Idiopathic Intestinal Pseudo-obstruction
CIS Checklist Individual Strength
CRBSI Catheter-Related Blood Stream Infection
CVA Cerebro Vascular Accident
CVC Central Venous Catheter
ESPEN European Society for Clinical Nutrition and Metabolism
ESRD End Stage Renal Disease
HAN Home Artificial Nutrition
Hb Hemoglobin
HLC Health Locus o f Control
HPN Home Parenteral Nutrition
GP General Practitioner
IBD Inflammatory Bowel Disease
ICQ Illness Cognition Questionnaire
ITx Intestinal Transplantation
MS Multiple Sclerosis
NaOH Sodium Hydroxide
PAC Port-a-Cath
RA Rheumatoid Arthritis
RET Stichting Registratie enterale En parenterale voeding Thuis /  Corporation Registration enteral 
And parenteral nutrition at Home
SBS Short Bowel Syndrome
SF 36 Short Form 36 health status questionnaire
SIP Sickness Impact Profile
SLE Systemic Lupus Erythematosus
SPSS Statistical Package for the Social Sciences
SSL Social Support List
SSL-I Social Support List -Interactions
SSL-D Social Support List -Discrepancies
SSL-N Social Support List-Negative interactions
SSQS Subjective Sleep Quality Scale
STAI Stait-Trate Anxiety Inventory
TPN Total Parenteral Nutrition
Q oL Quality o f Life
UCL Utrecht's Coping List
RUNMC Radboud University Nijmegen Medical Centre
VAD Venous Access Device
VAS Visual Analogue Scale
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Dankwoord
Een hectische tijd is voorbij nu dit moment is aangebroken. En toch is het snel gegaan. Binnenkort 
zal ik mijn, ons, project verdedigen. Samen met jullie leef ik naar dit moment toe. Een moment 
waarop ik zenuwachtig zal zijn, maar met name een moment waarop ik met trots ons werk mag 
presenteren. De afgelopen jaren waren voor mij zeer boeiend en heb ik met veel plezier aan dit 
proefschrift gewerkt waarbij ik veel heb geleerd van anderen.
Patiënten
Vaststaat dat mijn proefschrift nooit tot stand zou zijn gekomen zonder de medewerking van de TPV 
patiënten die deelgenomen hebben aan de diverse onderzoeken. Steeds weer vulden zij vragenlijsten 
in en kreeg ik op die manier de mogelijkheid om onze onderzoeksvragen te beantwoorden. Vooral de 
persoonlijke gesprekken gaven mij inzicht in de diversiteit van ziektebeleving, de dagelijkse 
problemen en de omgang met beperkingen. Deze informatie was de basis voor mijn proefschrift en 
leverde inspiratie op voor nieuwe onderzoeksideeën.
D e start van het onderzoek
Mijn eerste promotor, prof. dr. Theo van Achterberg, stond aan de wieg van het project. Samen met 
Anke Persoon, Peter Verbroekken en Ton Naber schreven we het onderzoeksvoorstel voor de TPV 
patiënten, dat werd gesubsidieerd door de Maag- Lever- Darm Stichting. Anke begon als onderzoeker 
aan de eerste studie waarbij ik haar ondersteunde als onderzoeksassistent. Toen Anke besloot om bij 
de afdeling Geriatrie als expert verpleegkundige te gaan werken, kreeg ik de kans, ondanks het feit dat 
ik mijn opleiding Gezondheidswetenschappen nog niet had afgerond, als onderzoeker het project 
verder uit te voeren.
Anke, bedankt voor je ondersteuning bij mijn eerste kennismaking met 'het echte werk'.
Promotores /  copromotores
Zonder promotores geen promotie. Ik heb zowel vanuit de afdeling IQ healthcare als de afdeling 
Maag- Darm- en Leverziekten veel steun gekregen.
Prof. dr. Theo van Achterberg, mijn promotor van afdeling IQ healthcare
Beste Theo, wat ben ik blij dat ik destijds bij 'jullie' terecht ben gekomen. Zonder jullie had ik mijn 
proefschrift nooit afgekregen. De begeleiding die jij me gaf, je deskundigheid en je betrokkenheid heb 
ik altijd zeer op prijs gesteld. De deur staat altijd open en altijd heb je tijd om weer 'even een vraag' te 
beantwoorden. Naast mijn promotieonderzoek gaf en geef je me ook de kans om me te ontwikkelen 
op andere gebieden en dat waardeer ik enorm.
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Prof. dr. Jan Jansen, mijn promotor van de afdeling Maag- Darm- Leverziekten
Beste Jan, jou wil ik bedanken voor het vertrouwen in mijn werk en dat je me dat ook liet weten. 
Ondanks dat je het onderzoek wat meer 'op afstand' begeleidde, heb ik nooit een drempel ervaren om 
naar je toe te gaan.
Dr. Lisette Schoonhoven
Beste Lisette, jij als copromotor op mijn project hebt me door alle fasen van onderzoek geleid. 
Jarenlang kwam ik tweewekelijks bij je langs. Behalve je belangstelling voor de vorderingen van het 
project en je kritische opmerkingen, heb je ook altijd persoonlijke aandacht. Even babbelen over 
'thuis', zowel dat van mij als dat van jou. Lisette, ik hoop dat we in de toekomst nog veel zullen 
samenwerken.
Dr. Geert Wanten
Beste Geert, jij nam als copromotor het stokje over van oud-collega Ton Naber. Het geld van de 
Maag- Lever- Darm Stichting was ondertussen op, maar omdat jij vertrouwen had in het project en je 
er het belang van inzag, kreeg ik de mogelijkheid om verder te gaan. Er is heel veel e-mail contact 
geweest om dit proefschrift tot een goed einde te brengen. Jouw snelle antwoord op mijn e-mails 
verraste me telkens weer. Onze schrijfstijlen liggen wel uiteen maar we hebben altijd een middenweg 
gevonden. Het is fijn om te weten dat het onderzoek nu niet ophoudt en dat we onze ideeën over 
toekomstig onderzoek kunnen delen. We zijn al van start gegaan met een nieuw project en ik hoop 
dat ook die samenwerking weer zijn vruchten gaat afwerpen.
De leden van mijn promotiecommissie, prof. dr. R. Bleichrodt, prof. dr. J. Prins en prof. dr. R. de Wit 
wil ik bedanken voor de tijd die zij aan mijn proefschrift hebben besteed. Ik hoop dat we een prettige 
discussie mogen voeren tijdens de verdediging.
M aag- Darm-Leverziekten
Drie hoofdverpleegkundigen hebben een gedeelte van mijn traject meegemaakt.
Peter Verbroekken, jij was er tijdens de start van het onderzoek, en kijk: Het is klaar! Willibrord 
Goverde, jij nam het stokje van Peter over en gelukkig zag ook jij het belang van het onderzoek in. 
Tenslotte nam Karin van Ditshuizen de functie van Willibrord over. Karin, door de promotie van 
jouw echtgenoot weet je als geen ander welke fasen ik heb moeten doorlopen. Bedankt voor je 
enthousiasme tijdens de laatste fase van mijn onderzoek.
Alle TPV verpleegkundigen uit Nijmegen en Amsterdam wil ik bedanken. Renate en Tirzah, jullie 
waren er in alle fasen bij betrokken! Bedankt voor jullie bereidwilligheid tijdens mijn dataverzameling. 
Ik hoop dat we in de toekomst wederom kunnen samenwerken.
Op E20 heb ik al die jaren met plezier gewerkt. Lieve collega's, bedankt voor jullie belangstelling en 
gezelligheid. Willem, jou wil ik bedanken voor je creativiteit bij de uitwerking van de lay-out van mijn 
proefschrift. Als grafisch vormgever had je veel ideeën en omdat je ook verpleegkundige bent weet je 
waar het over gaat! Volgens mij was ik best 'lastig' maar samen zijn we tot een mooi eindresultaat
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gekomen. Maria en Maaike, bedankt voor jullie hulp bij de dataverzameling, zonder nauwkeurige 
gegevens geen betrouwbaar resultaat!
Scientific Institute for Quality of Healthcare (IQ healthcare)
Alle collega's van IQ healthcare en met name de collega's van de sectie Verplegingswetenschap wil ik 
bedanken voor de gezellige momenten maar ook voor de leerzame en inspirerende tijd. Door de jaren 
heen heb ik verschillende kamergenoten gehad. In het begin waren daar Maud, Monique en Anke en 
later Lisette. Fijne collega's waarvan ik heel veel heb geleerd. Ik kwam in die periode ook nog maar 
net kijken, voelde me wel jong met weinig ervaring maar altijd door iedereen gesteund.
Toen we verhuisden naar de afdeling Kwaliteit van Zorg, kregen we in plaats van twee kamers een 
hele 'gang' tot onze beschikking. Enkele jaren heb ik daar doorgebracht met Monique en Erik en later 
met Ingrid en Peter. De laatste tijd deel ik mijn kamer met Ruud en Betsie. Het was altijd gezellig om 
even bij te kletsen en te horen waar een ieder mee bezig was. Tegenslagen en frustraties kunnen we 
altijd even kwijt bij elkaar, zodat we daarna weer met frisse moed verder kunnen. Ik heb het altijd erg 
gewaardeerd om 'op de gang van VW' een plekje te hebben.
Met de leden van de PhD groep heb ik vele interessante bijeenkomsten gehad. Fijn is het om met een 
groep mensen te kunnen delen wat je doet en van elkaar te kunnen leren.
Jolanda, dank voor je precieze werk dat je hebt verzet tijdens de laatste fase van mijn traject!
Co-auteurs
Hans Sauerwein, door jou was het mogelijk om de TPV patiënten uit het AMC te betrekken in ons 
onderzoek. Dat heeft onze studies sterker gemaakt.
Ellen Bazelmans, je was nauw betrokken bij het artikel over vermoeidheid; de tussenpozen hebben 
soms wel tot verwarring geleid maar uiteindelijk zijn alle analyses klaar!
Michelle Versleijen, wat een karwei, die database! Ondanks onze verschillende professionele 
perspectieven konden we elkaar aanvullen. Het was gezellig om eerst samen zwanger en later samen 
als mama (die onze kleintjes heel erg misten) naar de ESPEN  congressen te gaan.
Vrienden en familie
Ik ben heel blij met mijn vrienden en familie en wil jullie allemaal bedanken voor de gezellige en 
ontspannen momenten!
Barbara en Mirelle, fijn dat jullie naast mij willen staan op een bijzondere dag. Studeren was meestal 
gezellig, maar bijkletsen over allerlei andere dingen nog veel leuker. Mirelle, de vele autoritjes naar 
Maastricht hebben me ondanks de afstand nooit verveeld. Barbara, heerlijk is het nu als we met onze 
kleintjes bijkletsen en terugkijken op onze 'pubertijd'.
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Pap, mam, Henk en Tonnie, jullie wil ik bedanken voor jullie steun en liefde. Jullie zijn er altijd om 
ons te helpen waar nodig: het maakt niet uit o f het gaat om het opvangen van Fenne, een 
huishoudelijke klus, zwaar werk tijdens onze verbouwing of de verzorging van de paardjes. Ik geniet 
ervan als ik zie hoe jullie met veel enthousiasme genieten van onze kleine meid. Met een gerust hart 
kan ik naar mijn werk wetende dat het thuis goed gaat.
Mariska, met jou en de kinderen heb ik regelmatig op mijn vrije dag tussen de middag een 
boterhammetje gegeten. Even lekker bijkletsen, genieten van de kleintjes (nou ja, bij jullie worden ze 
al weer groot...) en een bezoekje aan het dorp of de kinderboerderij. Even geen werk.
Liefste Maarten, jou wil ik speciaal bedanken. Met jouw zorgzaamheid en liefde heb je mij 
onvoorwaardelijk gesteund. We zijn ons halve leven al samen en niets is zo bijzonder als onze liefde 
voor elkaar. Samen stappen, samen eindexamen, samen op vakantie, samen afstuderen, samen leuke 
dingen doen, samen klussen en tenslotte van samen naar met zijn drieën. Ruim twee jaar geleden is 
ons lieve meisje Fenne geboren. Na een minder leuke tijd rond mijn zwangerschap, konden we samen 
genieten van dit kleine wonder! Wat heerlijk is het om na een dag hard werken met jullie te knuffelen 
en alle andere dingen te vergeten.
Dank jullie wel voor heel veel!
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Curriculum Vitae
Getty Huisman — de Waal werd geboren op 29 april 1978 te Winssen. In 1996 behaalde zij haar 
HAVO-diploma aan het Pax Christi College te Druten. Vervolgens startte zij met de opleiding HBO- 
Verpleegkunde aan de toenmalige hogeschool Nijmegen. Met het verpleegkundig diploma op zak ging 
Getty in 2000 werken als verpleegkundige op de afdeling Maag- Darm- en Leverziekten (MDL) van 
het UMC St Radboud te Nijmegen. Naast haar werk als verpleegkundige begon zij met de opleiding 
Gezondheidswetenschappen aan de Universiteit Maastricht. In 2004 studeerde zij a f in de richting 
'Zorgwetenschappen'. Haar afstudeerscriptie richtte zich op angst en copingstijlen van patiënten die 
Totale Parenterele Voeding (TPV) gebruiken.
Na haar afstuderen werd de combinatie van zorg en wetenschap voortgezet. Als verpleegkundige 
werkte zij nog een aantal uren op de afdeling MDL, en als onderzoeker werkte zij bij de W OK 
(Werkgroep Onderzoek Kwaliteit), nu IQ healthcare, van het UMC St Radboud in Nijmegen. Getty 
ging verder met onderzoek bij TPV patiënten, waarbij de focus lag op psychosociale problemen, 
kwaliteit van leven en complicaties van de toedieningsweg. Het onderzoek kreeg na de eerste studie de 
status van promotieonderzoek. Naast haar promotieonderzoek werkte zij ook aan een studie over het 
bevorderen van gezond gedrag, waarin stoppen met roken, voldoende bewegen en een gezond dieet 
centraal stonden.
Ondertussen werden de werkzaamheden als verpleegkundige omgezet in een functie van 
verpleegkundig expert voor de afdeling MDL, die tot op het heden wordt uitgevoerd. Momenteel 
werkt Getty tevens als onderzoeker /  docent op de afdeling IQ healthcare.
Getty deelt haar leven met Maarten Huisman, en hun dochter Fenne (2008) in Winssen.
